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CHAPTER 1. INTRODUCTION 
Changes in food safety technologies offer the opportunity for improved food qual-
ity. foods with reduced potential for mi crobial or chemical hazards, and increased 
efficiency in food production and commodity processing. These improvements come 
from techniques which achieve greater cont rol OYer production and processing proce-
dures and the capability to make ne w innovations available for cost effective industry 
adoption. The primary goal of technology assessment is to provide information fo r 
decision making for public poli cy. allocation o f research effort, and investment on the 
potential for food safety technology innovation and adoption. Potent ial economic and 
social impacts and relat ed resource adjustment problems from commercialization of 
food safety innovatio ns need to be identified. 
Through proper use strategies. bo th produ ct ( input ) users and the food consumer 
can benefit . In t he analysis public health issues too must be considered. In recent 
years the continued usage of antibiotics in animals at sub-therapeutic levels has been 
t he center of controversy on two fronts, one involving residues in food supplies and 
the at. her , bacterial resistance. 
Discovery of ant ibiot ics has been one of the greatest achievements with therapeu-
ti c appljcabons both in human and veterinary medicine. Over 100 million kilograms 
of these drugs are being used worldwide annually. There are obvious impacts of 
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great proport ions on human and animal health. agri cult.ure, ecology, en vironment 
and public healt.h. 
The use of antibiotics has become an integral part of modern day medicine. 
There are implicit as well as explicit economic facto rs and considerations involved in 
the use of antibioti cs. Antibiotic production and antibiotic use in animal feed has 
provided demonstrable economic benefit s. Moreover, the level of use and availability 
of antib iotics for use in animal production has economic implications for consumers , 
producers as wel l as the meat industry. These issues need to be analyzed. The use 
of antibiotics helps prevent a.nd control spread of di seases in animals, promotes feed 
efficiency, and weight gain. Feed costs on average cons t itute about 60 percent of the 
costs of li vestock production, depending on production sys tem and type of livestock. 
Factors such as feed efficiency impact indust ry efficiency and profit . Embedded in 
antibiotic usage in animal feed are economic benefits whi ch result from lower average 
production cost s per animal , lower average feed cons umed per animal, and reduced 
days to market, etc. Such benefit s have enabled producers to enjoy improved pro-
duction efficiencies. Moreover , these benefits can be and are usually passed on to 
consumers in the form of cheaper and more readily available meat and meat prod-
ucts. 
Some groups and individuals have observed that a ban or further rest riction 
on the use of antibiotics in livestock production, at subtherapeutic levels, will likely 
transform into slo-wer animal weight gain, more di seases and associat ed increase in 
treatment expenses, higher feed expense per animal, and higher mort ality rates etc. 
for the industry. T his would transform into higher costs for producers and thus, 
higher consumer prices for meat products. The quanti ty of meat produced would 
3 
decline leading to market pnce increases. Although. in view of the complex market 
systems that exist, it is difficult to predict exactly what deleterious or positive effects 
a ban on drug usage would entail. it is possible to evaluate expected relative shift.s. 
Some have argued that, use of antimicrobial drugs has improved the life of both 
the animals and humans by controlling infectious diseases and promoting good health. 
Evidence suggests microbial diseases were a serious problem as far back as in the 
ancient civilizations of Egypt and Greece [l ]. Successful use of organic agents, for 
which evidence exists, dates back to 1633 with the use of Cinchona bark extract used 
for the treatment of malaria. It was later demonstrated that quinine was the active 
principle ingredient in cinchona bark. 
The ability to maintain or stimulate animal growth can be identified with the 
expanding animal industries. The advancement of hygiene in the control of disease 
unknowingly created nutritional problems that were first recognized in pigs taken 
from pasture to feedlots where debri s, excreta, worms and living organisms were no 
longe r recycled. By the 1920s the need for protein in the pigs diet was recognized, 
as an important feed input in the pig industry. 
An antibacterial agent with significant clinical potential was first developed in 
1932 by a group of scientists in Germany. T hey located and described a sulfonamide 
that was effective in treatment of certain bacterial di seases. Since that di scovery, 
different forms of sulfonamides have been synthesized . However , not all have been 
approved for usage. Some of the sulfonamides have been found to be therapeutically 
effective and of low toxicity and thus , approved for use in human and animal medicine. 
Discovery and use of sulfonamide has been an achievement leading to improved 
human and animal health and li vestock production. It is used for treatment in human 
illnesses . Additionally. it has been shown to be effective in fighting animal di seases 
as well. In li vestock production. it is used for t herapeutic as well as uh-therapeutic 
purposes . Sub-therapeutic use of drugs in veterinary treatme nt fo r disease prevention, 
growth promotion and feed efficiency constitutes about 40 to 60 percent of the value 
of antibiotics il.nd drugs marketed. 
Modern day antimicrobial drug usage as viewed by Dr. J.P t1tz, is sai d to 
have begun as early as mid 1930s with the introduction of su lfonamides . Despite all 
the advances in antimicrobial drug research, even today, some sulfonamides are fir st 
choice drugs for t reatment of uncomplicated urinary infections etc. Sulfonamides 
have also greatly contributed to the control of rheumatic fever. 
The antibiotic era began in the mid 1940s with the rediscovery of the activity of 
penicillin G and its use in severe human diseases . Soon after st reptomycin was iso-
lated from a culture in the laboratory of Waksman at Rutgers. This antibiotic was 
clinically very effective against gram negative organisms. as st udied by Herell and 
Nichols. This was followed up with the di scovery of aureomycin, the first of tetra-
cyclines, in 1948 by Duggar et al. It was found to be active against gram-positive . 
gram-negative bacteria. rickettsiae and plueropnuemonia-like organisms. The discov-
ery of terramycin in 1950. followed the di scovery of aureomycin . It is now argued 
that frequent or higher dosages of antibiotics are understood to make resistant strains 
more prevalent. in a patient originally infected with sensiti ve strains [l ]. 
The use of antimicrobial drugs at subtherapeutic levels in liYestock rations world-
wide is enormous. In United States, nearly 100 percent of chicken and turkeys. 90 
percent of swine and veal calves, and 60 percent of beef cattle recei\·e rations contain -
ing antimicrobials during some part of their growth stage. Approximately 70 percenl 
.s 
of beef consumed in the U.S. comes from cattle that received such feed supplementa-
tion at some stage of the product ion process and for veal. pork, chicken, and t urkey 
the figure stands above 90 percent. In 19.S l. of 0.4 million kg antibiotics used in U.S. 
excluding sulfonamides and nitrofurans. 2 percent or 0.1 million kg were used to 
feed livestock subtherapeutic. By 197 , total use rose 30-fold to 11.7 million kg, of 
which 4 percent was fed to 111 million beef cattle, 100 million swine 4 .. 5 billion 
broiler chicken, and 120.2 million turkeys in the nation [2]. 
With.in the category of food producing animals, principal benefactors have been 
the swine producers . Highly beneficial, economical and effective results have been 
obse rved with the sub-therapeutic use of antibiotics on swine producing farms [2]. 
Within the family of sulfonamides, it is principally sulfame thazine and sulfathi-
azole which are used at subtherapeuti c levels in rat ions or water provided for feed 
li vestock. This is especially true for swine producing farms . 
The beneficial modes of action in response to the use of antibiotics is still not 
fully understood. However, studies have shown. although not adequately elucidated, 
there is evidence for: 
1. direct growth promotion 
2. a metabolic effect 
3. a nutrient sparing effect 
4. a disease cont rol effect 
Sulfonamides and other antibiotics are primarily used as feed additives in animal 
production to increase feed efficiency, weight gain and prevent disease. 
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Use of antibiotics in feed rations modifies metabolic reactions in that the an-
tibiotics directly affect the rate or pattern of metabolic processes in the host animal. 
There is however , little evidence if any at this time that thi s mechanism is of major 
importance in the beneficial effects obtained in subtherapeutic use of antimicrobial 
drugs. 
Antimicrobial drugs have nutrient sparing effects which stimulate development 
of intestinal bacterial flora. Antimicrobial drugs synthesize essential vitamins by 
depressing micro-organisms in intestinal floras whfrh compete wit.h the host animal 
for essential nutrients by increasing availability of nutrients and or increasing nutrient 
absorption from the digestive tract. Livestock continuously fed rations containing 
antimicrobial drugs have a thinner , more absorptive intestinal wall structure. 
Disease prevention is the most beneficial of subtherapeutic feeding of antibiotics 
in food producing animals . Repeated studies show greater response to drugs in 
animals in poor or contaminated environmental conditions [24]. 
In swine the greatest effects of subtherapeutic feeding of antimicrobial drugs 
has been during periods of stress from weaning to about 75 pounds weight range. 
On average weaned pigs show 25 percent increase in weight gain and a 9 percent 
improvement in feed efficiency with the use of antibiotics. Beneficial results have also 
been observed in fini shing pigs under conditions of low sanitation and high stress [1]. 
Over the years, level usage of antibiotics has largely varied between 100-400 
gm/ ton feed. Declining costs of antibiotics has dictated thi s increasing use of drugs 
at such high levels. Economic considerations have contributed to thi s increasing trend 
in the use of these drugs. The relative costs of drugs has been on a decline compared 
to the benefits deri ved. 
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To remove these drugs from the market or to ban these drugs from usage in 
rations fed to food producing animals would impact on meat availability and prices. 
Retail pri ces could be much hig he r than current levels. 
In 1949 . when the effect of antibiotics on growth of animals was found by Jukes 
et al.. there was a tremendous surge of interest in this subject. and a ll over U.S. animal 
health scientists tested chlortet racycline, penicillin , and other antibiotics in chickens 
and pig production [2 J. 
As production and the use of antibioti cs increased. its price declined causing it 
to become more economically feasible to increase the levels of antibiotics added to 
a ton of feed [2 J. Highe r levels of chlortetracydine ( 100-200 gm/ ton of feed ) were 
shown to provide control of enteriti s in swine, a major source of economic costs or 
losses to swine producers and the industry in general. 
With the use of antibiotics came the issue of residues in food animal products. 
A tolerance level for residues in edible ti ssues for each antib iotic approved for use 
in li vestock production has been establi shed (Kiser ). This level has been judged to 
b e safe for human consumption and has been ident ified as tolerance. This tolerance 
level is based on the results of very extensive tests for toxicity and carcinogenicity. 
For sulfamethazine this tolerance level in swine tissues has been established at 0.1 
ftg / g (microgram per gram weight ). This is the same level for sulfathiazole . These 
levels would be as exhibi ted in uncooked , edible tissues. Withdrawal time periods are 
established such t hat. at the time of slaughter there is no violation of these tolerance 
levels established by the Food and Drug Administration {FDA ). 
Withdrawal ti me for feed containing sulfarnethazine is 15 days prior to slaughter , 
while for sulfathiazole it is 7 days. A withdrawal time is the time from the last 
availability of a medicated feed to an animal until its slaughter. This time is based 
on ti sue residue studies in which animals are dosed with the highest permitted level 
of drug in the feed for the longest time period permitted. Animals are killed at time 
of withdrawal of drug feed and at suitable intervals thereafter until the residue of 
drugs in tissues falls below the limit of detectability [28]. 
Continuous antibiotic usage at subtherapeutic levels in livestock is believed to 
cause and transmit resistance both in humans and animals. The use of sulfamet-
hazine in pork product ion has often been the center of such discussions. The purpose 
of this study will be to examine a small segment of this issue, the occurrence of sul-
famethazine residues in pork. and to identify alternatives and the economic impacts 
to sulfa use in pork production. 
After defining the problem and stating the objectives of this st udy the li terature 
will be examined in terms of benefits and concerns about antibiotic use in general. A 
brief summary of the issues confronting the usage of sulfamethazine in swine will then 
be presented followed by identification of some alternatives to sulfamethazine use in 
pork production. Finally, probable producer and consumer impacts of substituting 
these available alternatives for sulfamet,hazine will be presented. This will be followed 
by some conclusions and recommendations. 
1.1 St atement of pro blem 
Concern on the use of antibiotics in animals with special reference to the use of 
sulfamethazine and it's use in pork production has centered around the controversy 
of drug resistance an d tissue residue violations. The use of sulfamethazine in swine 
production has also brought to the forefront issues of environmental and feed cross 
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contamination. In view o{ these controversies su rrounding the use of sulfamet hazine 
use in pork production. there has been continued pressure to further limit the use 
of sulfa drugs in pork production. While t.he discussion conti nues the re is a need to 
evaluate the producer, industry and consumer impacts from possible limi tations to 
sulfa use. This study seeks to address these issues and identify economic impacts. 
Once an antimicrobial has been given to an animal, the compound is excreted 
from the tissues over a period of time. Any remnants of an antimicrobial or its 
metabolites found in the tissues at time of slaughter, over and above established 
FDA limits, is referred to as violative residue. 
The use o{ sulfameth azine in swine has shown some excellent results in terms 
of performance. The Hay's report summarized these effects of use of sulfamethazine 
and measured the response of 20,000 plus pigs during the starter stage. It showed 
an improved average daily gain of 23.l percent over control groups and an improved 
feed efficiency of .6 percent over the control groups. These results showed that 
sulfamethazine was a very effect ive compound for use in the livestock production. 
However, sulfa residues have remained of concern for several reasons: 
1. Sulfas are excreted from the t issues more slowly than some of the other antimi-
crobials. 
2. There is emerging evidence that sulfa residues are not broken down during the 
cooking process as are many other antimicrobial residues (Fischer et al ., 1990 ). 
3. It has been discovered that as little as 2 ppm of sulfamethazine in the feed fed 
during last 15 days prior to slaughter can cause violative residues in t he tissue 
{Ashworth et al .1 1986) . 
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4. There is some evidence that sulfamethazine may be carcinogen (Cordle. 19 9). 
Sulfamethazine in swine production is essentially used in t he treatment and 
prevention of Bordetella rhiniti s caused by Bordetella bronchiseptica. When used as 
a feed additive it helps in maintaining and promoting feed efficiency and average daily 
gain even under circumstances of diseases such as pnuemonia, Salmonella cholerasuis. 
atrophic rhini tis and other swine diseases. 
The use of sulfamethazine is permitted only in combination with ce rtain antibi-
otics. In swine sulfamethazine may be used at lOOg / ton feed with lOOg / to n feed 
chlortetracycline and 50g/ ton feed penicillin. Also sulfamethazine at lOOg/ ton may 
be used wi th tylosin lOOg/ ton feed for maintaining weight gains and feed efficiency in 
the presence of atrophic rhiniti s and lowering the incidence of B ordetella bronchisep-
tica infection. The use of this combination is the same as lOOg/ ton chlortetracycline 
as feed additive except that it is more effective t han chlortetracycline alone in pro-
moting growth and improving feed efficiency, maintainance of weight gains in t he 
presence of atrophis rhinitis, and treatment of bacterial swine enteritis. Sulfathiazole 
is also permitted as a feed additive at lOOg/ ton level in swine production only as a 
combination drug with chlortetracycline lOOg/ ton and penicillin 50g/ ton. 
It is argued that resistant bacteria can develop through excessive usage or higher 
dosage forms of antibiotics in patients with sensitive bacteria strains. Persistent usage 
of antibiotics has been argued to trigger resistance in the patients microflora thus, 
posing increased risk to patients. 
If the main deleterious effects of antibiotic use is the emergence of resis tant pop-
ulations , it is important to di scuss how such populations arise . Use of antibacterial 
agents selects resistant populations where resistant bacteria are already present. in 
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the population. Thus, it can be arg ued that i t is not really the use of antibiotics 
that causes resistant bacteria but that it may lead to the condition that expand the 
population of resi stant bacteria. 
Antimicrobial drugs are electing an ever widening range of resistant bacteria 
which seem to be ari sing by gene t ransfer. That number of resistant bacteria seems 
to be increasing at the moment is probably a reflection of the increased usage of antibi-
otics. It may be expected that incidence and types of resistant bacteria will continue 
to increase more so if the human race continues to use antibiotics as widely as at 
present [l ]. Antibiotic resistant bacteria move among aillmals and people through 
various routes, including the handling and ingestion of contaminated meats and other 
foods or feed through direct contact . This has been the primary objection with pork 
containing sulfamethazine residues. The tolerance level for sulfamethazine in pork 
has been established at 0.1µ/ g. Levels of sulfamethazine in pork in violation of the 
establi shed limits poses a potential threat of resistance. 
This analysis is an extension of Berger 's study in an attempt to identify and 
evaluate the producer, industry and consumer impacts from potential limitations t.o 
use of sulfamethazine in pork production in response to residue violations witnessed 
in the pork industry. 
Berger concent rated on an economic assessment of reducing sulfa residues in pork 
supplies . Her master 's thesis took two approaches. The first being the evaluation 
of potential testing procedures and respective market locations for identification of 
sulfa residues and t he second being an economic analysis of industry-level impacts 
from a complete removal of sulfa availabiLty for use in swine production. 
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1.2 Objectives of study 
An oversirnplifying assumption in Berger's study was that alternatives to sulfa 
in swine production were ignored. It evaluated a total ban on sulfamethazine use in 
pork production as it. compares to the current situation for sulfamethazine use. While 
perfect substitu tes do not exist, there are alternatives which would lessen industry 
impacts than would be the situation where no alternatives exist. Thus. this study 
expands the eval ua tion to analyze the potential substitution for sulfamet.hazine. 
The study objectives are to : 
1. Further identify products which are viable substitutes for sulfamethazine . This 
would involve identification of expected production adjustments for the respec-
tive alternatives . 
2. Provide an economic evaluation of the producer and indust ry im pacts from the 
use of the respective alternatives . 
The p urpose of thi s thesis is to identify these alternatives to sulfamethazine 
use in pork production and conduct an economic assessment at both the industry 
and producer level. Potential impacts on pork production, production costs and 
consumer demand will be analyzed for selected alternatives. 
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CHAPTER 2. LITERATURE SURVEY 
2.1 General overview 
Subtherapeutic use of compounds has played an important role in animal hus-
b andry by assisting in the cont rol or elimin ation of disease , and the improvement of 
growth and effi ciency of feed conversion. Livestock producers, industry, veterinary 
and regulatory personnel share responsibility to ensure that food products are free 
from met.aboli tes, residues, and other chemicals to which the livestock and poultry 
may be exposed. The predominant concerns are the potential adverse effects on 
human health. Data demonstrate that the feeding of subtherapuetic antimic robials 
to livestock and poultry increases the prevelance of R+ enteric organisms. Some of 
these organisms may be pathogenic for humans [20]. 
Over the last 50 years , the progress made in identificat ion , development, and 
marketing of antimicrobial agents can only be described as remarkable and a great 
credit to academia industry, research, and government which have made lasting 
contributions to this achievement. Sales of animal feed additives totaled more than 
1.1 billion dollars in 1983 270 million of which were antibacterials. Approximately 
one-half of the 35 million pounds of antibiotics manufac tu red in U.S. were provided 
to animals. 
The beneficial effects of antibiotic feeding such as growth promotion were di s-
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covered by accident. In the 1940s vitamin B-12 , a dietary component obtained from 
fermentation products of the micro-organism, Streptomyces aureofaciens. was be-
ing studied. Researchers found that feeding of crude fermented material containing 
Streptomyces aureofaciens produced growth in chicks beyond that expected from the 
vitamin B-12 factor. This was later substantiated to be a result of the chlortetracy-
cline present in the fermentation products [20]. 
Soon after t heir discovery and use in human medicine, antibiotics became avail-
able for use in veterinary medicine. Before the end of WVv II. infusions of penicillin 
in sal ine were used to treat mastitis in lactating dairy animals. It was the introduc-
tion of antibiotics into animal feeds during the early 1950s that ushered in a new era 
in livestock management and meat production. C'hlortet racycline was the first to be 
used in animal feed in 1950, and it continues to occupy a large share of feed antibiotic 
market. Although used at lower concentrations earlier , reductions in manufactur ing 
costs in t he 1950s allowed economic uses in feed at higher concentrations. At these 
new levels tetracyclines were found to play a significant role in control of livestock 
diseases. It was in the 1960s that scientists first became aware of plasmid-mediated 
resistance and found that clinical bacterial isolates resistant to several gram-negative 
antimicrobial products could transfer the genetic information encoding these resis-
tances to other bacteria. In recent years thi s has become the central focus point on 
antibiotic use in animal feed and human health risks. It was postulated that use of 
certain antibiotics in animals could generate resistance plasmids in the enteric flora of 
livestock, and that this genetic material might eventually encode antibiotic resistance 
in human pathogens. It was argued that the continuous use of antibiotics in animal 
feed could eventually lead to a loss of antibiotic efficacy in human medicine [21]. 
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Assessments of public health claims on feed antibiotics have been carried out by 
many a experts. The fir st studies in England had concluded that no alternation in 
t he use of antibiotics was warranted. The Swann committee of enquiry set up after 
the outbreak of salmonella in calves in mid-1960s. submit ted a report in 1969 recom-
mending t hat feed antimicrobials used for animals be regulated according to category 
of use [21]. Products that were used for growth promotion and feed efficiency could 
be continued to be used at producers discretion , however. antimicrobials with claims 
for disease prophylaxis or therapy would be used under the order of veterinarian only. 
This procedure continues to be used in England even today. 
Various U.S. expert commit tees have also submitted their reports on the an-
tib iotic controversy. In late 1987 , the FDA joined hands with National Academy of 
Sciences (NAS) to develop a risk assessment model for the feed antibiotic contro-
versy. The model was to use data on salmonella deaths in humans. In 1989, the 
report cautioned that the model presented could not yield hard and highly useful 
figures because the data that were used as inputs were in many cases sketchy and 
unreliable. The committee recognized that salmonella was used only because it was 
traceable, and that far less than 1 percent of the antibiotics used in U.S. are directed 
against infection by salmonella. To state otherwise the commit tee was unable to 
find direct evidence that established existence of a definite human health hazard in 
the use of subtherpeutic concentrations of penicillin and tetracyclines in animal feeds 
[21]. 
Research attempts have also b een made to study the effects of a significant de-
cline or elimination in the use of feed antibiotics in livestock. The university of 
Kentucky conducted one such study. A herd provided with chlortetracycline at levels 
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of 50 to 100 g/ 909 kg in feed since 1972. was used for the purpose of tudy and 
compared with another group raised since 1972 without exposure to either subthera-
pe utic or therapeut ic treatment. C'oliforms from both groups were observed over the 
years and prevalence of antibiotic resistance was determined. The results indicated 
that the pigs not fed any antibiotics showed a gradual decline o( antibiotic resistance 
[21]. They also showed a concomitant decline in performance as measured by litter 
size, litter weight, conception rat e, increased incidence of joint problems. and et c. 
When given a single dose of therapy, these pigs showed a rapid increase in resistance 
at levels compared to the group fed antibiotics. uch an experiment is of importance 
because it determines that a significant reduction in current use of these antibi-
otics wo uld not quickly restore a nti biotic sensitivity to the enteric flora of pigs and 
that any potential long-term reduction in resistance would probably be prevented by 
occasional therapeutic uses [21 J. 
Recent trends in antibiotic resistance in human clinical isolates is not increasing 
as originally feared. Atkinson and Lorian have reported results of a large data base of 
information on resistance to 16 commonly used antibacterials. They concluded that 
the antibiotic resistance to most antibiotics was not showing an increasing t rend. 
In his article in Food-Animal practice. 1993 Dr. Payne di scusses ways to max-
imize antibiotic efficacy and prevent drug residues on dairies. He suggests t hat Jil 
choosing appropriate t reatment, anti biotic susceptibility testing is a good way to 
start before deciding on the antibiotic t reatment. The cornerstone of modern antibi-
otic sensitivi ty is the determination of an isolates minimum inhibitory concentrat ion 
(MIC'). The development of resistance can lead to profound difference in the MIC's 
of different isolates of same pathogen species. Though antibiotic testi ng is useful a 
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an initi a l guide in election of treatment. it is not to be followed blindly. It i also 
true that ·uch a reliance may divert attention away from more important issue of 
d isease prophylaxis. 
Ext.ralabel use of drugs is unavoidable in the course of food-animal practice, as 
is also recognized by the FDA. Such ext ra- label use however. is g uided by criteria es-
tabLished by the FDA such as in a situation of client / veterinary / patient relationship 
where no effective labeled alternat ives ex.i st, where significantly extended withdrawal 
times are assig ned and no illegal residues occur. A Yeterinari an needs to select an 
effective treatment. while at the same time try to minimize costs of t he producer. For 
example treatment of a 300 pound cal f with ceftiofur co~ ts . 2. TO a day as compared 
with $0.27 when treated with oxytetracycline. In such a situation oxytetracycline 
would be a better choice for dairy where pathogen have not developed a resistance to 
oxytetracycline. If the owner and veterinarian want to reap max.imum benefit from 
treatment, then employees must be carefu lly instructed in each phase of procedure. 
The animal restraint facilities should facilitate treatments to be performed efficiently. 
Another practice of vital importance can be the training of dairy employees to recog-
nize the pnuemonic cal ves etc. Also treatment personnel sho uld be carefu lly trained 
in proper administ ration of the respective treatments. Maintaining records of treat-
ment will offer control in treatment and help realize safe ti ssue levels. .forbidity and 
mortality at the herd level can often times help determine efficacy levels of therapy. 
Finally, g uidelines should be establi shed for dairy employees to assi t them in deter-
mining when the treatment should be discontinued. wit hdrawal time obse rved. and 
the animal culled. Althouah, Dr.Paynes paper concentrates on the dairy indus try1 all 
other li ve tock and poultry raising producers have much to learn from this article. 
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S.C . Henry and D. v\'. Cpson in their paper entitled :Therapeutics'', have listed 
some of the therapeutic responsibilities and decisions. These are to sati sfy many 
parties to whom veierinarians and li vestock producers are responsible: 
Animal: The goal is to provide a specific , targeted. efficacious therapy that is de-
livered in a humane manner. 
Producer / Owne r of livestock : The producer expects a practical , applicable , ther-
apy that is cost effective and does not pose undue risk to the personnel admin-
istering the medication. 
Government r egulators: The government requires adherence to state. federal, and 
international constraints on medication of animals intended fo r human food, 
including responsibili ty for documentation of therapy. 
Pharmacuetical manufacturers : manufacturers expect app lication of products 
within their established envelope of safety and in a manner allowing efficacy at 
demonst rated potency. 
Consuming public : responsibility for therapeutic decisions is expected of li vestock 
producers and veterinarians. 
In a symposium in 1969 , James L. Goddard, expressed his view that veterinarians 
are working on faith rather than hard facts and data of veterinary medicine. He felt 
the urgent need for veterinarians to work more with hard data and present concrete 
results in connection to the various issues that h ad come up with the use of antibiotics 
in animal feeds. 
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According to Virgil Hays, antibiotic feed supplements have been used extens ively 
the world over fo r over .50 years now . T he wide acceptance of these antibiotics has 
been based on their benefit of increasing growth rate, improving feed effi ciency. and 
decreasing mortali ty and morbidity from clinical or subdinical infection. Although 
different in their chemical compositions and bacterial spectrum, antibiotics effect ive 
in improving performance of animals have one thing in common their ability to 
suppress or inhibit growth. 
In a comprehensive summary of effect s of antibiotics on beef catt le, Burroughs 
et al. had noted that animals fed diets that resulted in less rapid and efficient gains 
showed a greater percentage response to antib iotics. To cite an example of such an 
antibiotic would be chlor tetracycline. 
Numerous studies have indicated that t he major benefit of sub therapeutic feed-
m g of antibiotics is their suppression or control of subclinical diseases. Research 
shows the response of antibiotics to be less when fed provided a cleaned and disin-
fected pen. This was a result obtained by Speer et al. in hi s study on pigs . Although 
in theory it might appear correct that antibiotics are a substitute for poor environ-
mental conditions, in practice it is reasonable to suggest that all are needed, wise use 
of antibiotic complemen ts good husbandry and sanitation. 
Long term use of antibiotics in animal feeds has elici ted concern about poten-
tial harmful effects due to development of resistant strains of organisms or allergic 
reactions in consumers of meat, milk eggs from animals continuously fed antibiotics. 
Dr. Hays expressed a view that this controversy has lasted for so long now, t hat 
there is a need for ve terinarians to change their rational thinking leading to adequate 
evaluation of potential harmful effects as contrasted with proven health and economic 
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benefits . 
Hays indicated that practical use levels are not necessarily levels sufficient to 
eli cit maximum response. T he rate of increase in growth response decreases however, 
as level of antibiotic use increases . Thus, level of dosage is a compromise based on 
cost-benefit an alysis. 
Some have argued tha t antibiotics have lost thei r efficiency in treating animal 
illnesses . This has been explained as "organisms are developing resistance''. T his 
claim, however , is not widely su pported. Experiments such as those conducted by 
Peo summarized long term effects of antibiotic feed ing to swine a Nebraska study and 
concluded, that after more t han 10 years of extensive use of antibiotics, a response 
was still observed. 
Use of antibiotics leads to certain benefits in animal growth and improves the feed 
efficiency of t he animal. Subtherapeut ic treatment with antibiotics leads to thinner 
in testinal walls . T hinner intestinal walls are more efficient in absorbing nutrients 
than intestinal walls of conventional animal which undergoes thickeni ng as react ion 
to bacterial toxins or to some other damaging effect of microflora. This study was 
done by Gordon in chicks [5]. As per C.l(. Whi tehair and B.S. P omeroy. antibiotics 
at low levels inhibit growth of undesirable micro-organisms in in testinal t ract . The 
improved growth rate is a manifestation of increased feed consumption and better 
absorption of nu trients. At high levels these antibiotics are used in treatment of 
systemic infection with limi ted impairment of digestive system. 
Use of antibiotics has helped make substantial savings in other costs of produc-
tion by speeding growth process and by reducing death losses. According to Dr. 
H.R.Bird the biological bases for these economic effects are: 
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l. Antibiotics prevent bacterial de truction of feed protein in t he gut 
2. They inhibi t toxin-producing organisms. 
3. They prevent t hickening of gut wall and permit bet ter absorption. 
4. They prevent bacte rial dest ruct ion of vitamins and favor certain bacterial species 
which synthesize vitamins . 
Experience with use of antibiotics in treatment of livestock and poultry diseases 
appears to emphasize [4 ]: 
1. Feed may be used as the vehicle for antibiotic administration 
2. When di seases are properly diagnosed t he proper dosage of antibiotics is effec-
tive treatment for specific infect ious diseases of poult ry and livestock. 
3. Infection and nutrition are inte r-related 
4. Disease prevention practice must be used in conjunction with antibiotic the rapy 
to decrease poultry and livestock di seases more effectively 
Each drug in animal feeds is subjected to considerable study before it is proposed 
fo r use. There is however , a practical limit to the amount of testing that can be 
conducted before a drug is introduced. True and full evaluat ion of relat ive safety 
comes only finally when the drug is widely dist ributed and used under alJ so rts of 
condi tions. 
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2.2 Issues in antib iotic use 
There are concerns over drug residues in animal tissues. Wi thdrawal times have 
been established by the Food and drug Administration (FDA), in order to avoid 
tissue residue . fonth ly s tati stical samples of tiss ue collected at packing plants are 
tested for resid ues of antimicrobial drugs among other residues measured by Food 
Safety and Inspect ion Service (FSIS ). 
The residue avoidance program has been effective in eliminating antibiotics from 
animal products among major meat animals. Antibiotic residues in carcasses de-
creased between 197 and 19 6 by 4 percent in swine, /.5 percent in adult cattle 
66 percent in veal calves, 79 percent in poultry. An attempt to reduce sulfa residues 
during the same period did not meet with as much success. There was a 53 per-
cent decline in swine residues, i.e. , from 9.7 percent to 4.6 percent and poultry sulfa 
residues declined from 3.1 percent to 1.6 percent, i.e .. a decline of 4 percent [l ]. 
Failure to follow withdrawal times, use of unapproved levels. use of soluble pow-
der and contaminated water lines have in large been responsible for sulfa drugs. 
Hypersensitivity reactions have been principally concerned with penicillin and 
less with other drugs including sulfonamides. Sulfonamide residues in pork have been 
of concern in food mainly due to prevalence of residues and toxicity of drugs. Hyper-
sensitive reactions in sensitized human patients includes blood and kidney damage. 
The FDA has responsibility for regulating all animal drugs as safe and effica-
cious for their intended uses and for freedom from residues hazardous to human 
health when such drugs are used as approved. The responsibility for enforcing these 
regulations lies wi th the FDA.United States Department of Agriculture (USDA ) has 
the responsibility for licensing all veterinary biologicals for animal use and through 
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FSIS national residue program for nationwide monitoring of meat and eggs fo r drugs 
and chemical residues, as well as for inspection of all animals and poultry slaughtered 
in federally app roved packing plants. 
Lives tock animals and poultry, except a t certain small poultry slaughter oper-
ations, which are butchered for commercial sales are at least sample inspected by 
government inspectors under veterinary supervision [2]. In 19 6 antibiotic residues 
were reported in 1.2 percent of the animals and 0.5 percent of the poultry. Sulfa 
residues were found in 2.5 percen t of the anim als tested and 1.6 percent of the poul-
try tested . 
Subtherapeutic levels vary with different antibiotics, but are usually between 
30 and 300 milligram per ton of feed. These levels have increased overtime ma.inly 
because the compound costs have fallen in relation to observed benefits. early 0 
percent of t he Broiler chicken and turkeys, 75 percent swine. 60 percent feedlot cattle 
and 75 percent dairy calves marketed or raised in .S. have been fed antimicrobial 
compounds during some period of growth [2] . 
2.3 Total antibiot ic production 
Impact of antimicrobials on farm animals reqwres reliable data on the total 
amounts of penicillin and t he tetracyclines used annually in animals and medical 
use in humans. The data indicates that the percentage of total anti biotic production 
directed to animal feed and other uses increased from 16 percent in 1951 to 3 percent 
in 1959. In 1960s the average was 40 percent of total antibiotic production. This 
figure increased to 42-48 percent for the 1970s. It is also estimated that 36 percent of 
entire antibiotic production for 1983 consisted of antibiotics directed to feed addi tive 
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and other uses [26]. 
Penicillins and tetracyclines together made up 42 percent of the total 19 3 an-
tibioti c prod uction. Of the other .5 percent, on ly a few were approved for use as 
feed additives. The FDA, through use of 1979 data from International trade com-
mittee (IT C') has estimated that approximately 5.5-60 percent of the penicillin and 
tetracycline was used for subtherapeutic use in food animals. 
A sum mary analysis of antibacterials for livestock and poultry feeds , 19 0- 5. 
st udied by the Institute of Medicine indicated li ttle variation in this period in total 
feed use of antibacterials: 9.7 to 11.7 million pounds a year . Tet racyclines accounted 
for 57 percent of tltis production in 19 0 and -19 percent in 19 4 and 19 .5. Penicillin 
accounted for only 5-8 percent of this volume. 
Accordi ng to the U.S . Department of Agriculture, approximately 6.5 million 
pigs with an average weight of 110 kg were marketed in 19 5 [26]. Using the survey 
estimate figure of 6.6 g of tetracycline per pig , the committee derived total amount 
of tetracyclines used in the rearing of swine for 1985, to equal a figure of 0.57 million 
kg of tetracycline (i .e. 6.5 million pigs multiplied by 6.6 g tetracycline per pig). If 
all swine feed were to be medicated with tetracycline, the total wou ld be 1. 7 million 
kgs. 
It is understood that the use of antibiotics in animal production has led to the 
reduction in the incidence of several zoonot ic diseases [2]. This decrease is indirectly 
attributed to better control of these diseases in animal population through vaccines 
and antibiotic use . However, there is need to more firmJ y establish the posit ive role 
of antibiotic use in animal product ion and decrease in zoonot ic di seases. Leptospira 
interrogans ponoma was referred to as the "swine herds disease11 in humans . While 
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vaccines did help cont rol leplopira bacterium. the u e of antib iot ics cannot be ruled 
out since it is very sensitive to several ant ibiotic 2). Eryipelothrix rhusiopathiae an 
occupational disease associated with pa.eking plant \\·orkers. not unheard of in the 
early time period of mid 1930s is now a rarity. It is believed t hat ant.ibiotic usage 
has, especially in hog production , a ided in the reduction of inc idence of erysipelas 
[2]. 
2.4 Sulfonamides 
Sulfonamides have for long been accepted for human and veterinary treatment. 
Its beneficial effects as a growth promotant and effectiveness in controlling systemic 
diseases in animal production has been widely acknowledged in the literature. The 
drugs are a wide spectrum antibacterial, effect ive against both gram positive and 
negative bacteria and well abso rbed systemically. T hese drugs have enjoyed wide u e 
and were also recommended for t reatment of urinary tract infections, pnuemoccocal 
infections, gonococcal infection, rheumatic fever cholera etc. 
In recent years, however , there has been a reduction in the use of individual 
sulfonamides for the therapy of human diseases as a result of increased bacterial 
resistance to drugs and the development of more effective antimicrobial agents [4]. 
During the early 1940s sulfonamides found extensive use for treatment affecting 
pet and food-producing animals. Calf pneumonia. calf diahrrea , infectious entiritis 
in swine were some of the commonly t reated diseases. The use of sulfonamides , al-
though greatly reduced, has persisted in veterinary medicine mainly because they 
are easily administ rated in feed and water , are economical and have proven to be 
effec t ive for treatment of various livestock diseases. The 1950s initiated a new era 
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with commercial feed production of ulfamethazine and ulfathiazole in combination 
with other antibiotics. In swine. t.he e combination products, as feed additives, were 
extremely efficient in i ncreasing feed effic iency and improving rate of weight gain. l n 
swine, t hese combinations have particularly been effective under situations of atrophic 
rhiniti s. Currently. besides being used as a feed additive in animal production. sul-
fonamide are also used in treatment of re piratory diseases and infections in wine 
and cattle. Ce of these combina tion drugs in \Vine led to the realization of two 
major benefits namely, an increased an ti bacterial spect rum and decreased rate of 
development of bacterial drug resistance. 
ulfonamides can be administered ea ily via oral, intravenou . intramuscular. 
intraperitoneal, and intrauterine routes. Cattle and wine producers admin ister sulfa 
drugs orally by means of feed additive or by mixing with water . Sulfa drugs in swine 
production are used to promote growth , improve feed efficiency and reduce incidence 
of disease. 
It is estimated that in human use, at least 5 percent of the persons rece1v1ng 
sulfa treatment will experience some untoward reaction. \ ·ascular lesions, drug fever 
and lesion of skin are some of the common expressions of sulfa hypersensit ivity. 
Crystullaria. hematuria and blockage of renal tubules disturbance are urinary tract 
disturba nces which may result from sulfa use in humans. 
In animals toxicity occurs most frequently following rapid or excessive intra-
venous administration of drugs and is often referred to as "drug shock". Renal 
damage due to crystalli zation of sulfonamides i not uncommon. These, essent ially 
in pigs, are a result of inapprop riate husbandry practices. Most sulfonamides a re 
excreted primarily in the urine . Feces . mi lk , and sweat are excreto ry routes of lesser 
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importance. 
The Food and Drug Administration has set a tolerance level of 0.10 micrograms 
sulfonamide per gram of edible animal ti ssue. The FS IS monitors animal tissue for 
sulfonamide residues and tissue levels. C'hromotographic techniques, sulfa-on-site , 
and E-Z test are more prevalent methods of estimating tolerance levels in swine t is-
sue at farm levels. Sulfonamide concent rations above the tolerance limit are termed 
residues. Meat products in violat ion of these tolerance limits are subject to condem-
nation by FSIS. In 1978 10 percent of swine carcasses were deemed condemned for 
exceeding tolerance levels. T hese were attribu ted to failure of following withdrawal 
periods. Later , however . causes we re found to be wholesale contamination of ani-
mal feeds with sulfonamides, recycling of drugs from animal was tes, and failure to 
prescribe to withdrawal periods. The occurrence of sulfa residues obser ved in recent 
year or two are estimated to be below the 1 percent residue incidence permitted by 
the FDA (Teddi \Volff 1994 , private communication ). Better and appropriate man-
agement techniques, improved awareness, stringent measures by FDA , and granular 
sulfamethazine have helped reduce these violative levels in swine. 
In recent years use of sulfa drugs, with special reference to its use in swine pro-
duction , has been an issue of controversy regarding the issue of resistance. Long term 
use of antibiotics has shown to favor development of bacteria that are not. susceptible 
to antibiotic at that dosage level. Research has also shown that antibiotic resistance 
can be transmitted between some bacterial species and strains by plasmids (small 
pieces of genetic material termed R-factors) . The transmission of R-factors causes 
a further risk that resistant , but non-harmful bacteria, could t ransfer the genetic 
materi al necessary for resistance to other , disease causing bacteria. Such bacteria, or 
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an altered bacteria could then cause outbreak of disease in human population that 
wou ld be difficult to control due to resistan ce to antibiotics. 
The use of sulfa drugs in swine product ion ha a lso brough t to the forefront the 
iss ue of environmental contamination and cross-feed con tamination. 
Many producers, h ave as a resul t chosen to substitute sulfamethazine in pork 
production with sulfathi azole. a drug with very short biological half- life. The ra pid 
elimin ation of the drugs increases the level in the feeds necessary to cause violative 
residues. Wi th the use of sulfathiazole violative residues are uncommon [l J. 
2 .5 Effects of a ban on su bth erapeu t ic an t ib iotics in an i m al prod uction 
The effects of banning or reducing the use of antibiotics in animal feed fo r sub-
t.herapeutic disease treatment can be better understood when evaluated by industry 
segment such as : 
1. Livestock producers 
2. Consumers 
3. Veterinarian 
2 .5.1 Livestock producer s 
Livestock producers are among the principal benefactors of antibiotics use in 
animal production. Antibiotics are rout inely used as supplements to increase feed 
efficiency improve weight gain. and reduce mortality rates. These benefits save hog 
producers an estimated two billion dollars in annual production costs [47]. 
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Performance improveme nt s from the subtherapeutic use of antibiotics has led to 
an increase in ifs use from 2 million pounds in 1962 to 5.1 million pounds in 19 7 in 
the C.S. Approximately 45 percent of antibiotics used annually in the Cnited states 
serve as supplementation in animal feed [47]. A ban on subtherapeutic drugs would 
lead to a llied affects on the agribusiness industry. Feed tonnage would be reduced by 
a ban because of fewer hogs on feed. Animal health suppliers would lose profitability 
but might be encouraged to invest more heavily into a new product development. 
Veterinarians would lose a vital and conventional health management tool. A smaller 
number of lighter hogs would be available to pork packers. \•Vithout antibiotics, the 
cost of gain would increase resulting in shorter feeding periods and lighter hogs. The 
animal p roducing industry would have to explore changes in production, technology, 
and marketing in the face of a ban or further restriction s on antibiotic usage in food 
generating animals [4 7]. 
Research done by Wade and Barkley on ·'The economic effects of a ban on 
subtherapeutic antibiotics in swine production" compared welfare levels for producers 
as well as consumers after the ban. The mean retail price of $2.1 per pound of pork 
and retail quantity of 3305.5 million pounds of pork resulted in estimated consumer 
surplus before a ban of 4615.5 million dollars and producer surplus equal to .)193.5 
million dollars. Under certain assu mptions of a 4 percent decline in pork supply and a 
5 percent increase in demand for pork plus the assumption of constant price elasticity 
of supply and constant price flexibility of demand Wade and Barkley concluded that 
market shifts would lead to a new equilibrium price of $2.25 per pound and a post.ban 
equili bri um quantity of 3211 million pounds of pork. The ban was expected t.o result 
in increases of $6.19 mi llion in consumer surp lus and 6.97 million dollars in producer 
30 
surplus. It was estimated that each consuming household would benefit by an average 
of $0.09 per quarter if a ban were legislated, whereas producers would gain $29 
each (1987 dollars) . A sensitivity analysis was conducted to make the results more 
reliable. T he sensitivity analysis concluded surplus levels for both pork producers 
and consumers would not change drastically in response to a ban of antibiotics. 
Consumers were expected to benefit from a ban if their response to the ban is large. 
These gains in surplus are mitigated by increases in production costs and, hence 
shifts in supply. 
It was concluded t hat hog farmers could maintain preban output levels by either 
feeding the same number of animals for a longer period of time or feeding a greater 
number of hogs for the same amount of time. Output levels wo uld definitely reduce 
if hog numbers and feeding time were held at pre-ban levels after the ban. such 
responses would lead to increase in swine production costs, quantity supplied would 
be reduced at every given price of pork. In the long run some swine producers would 
find it convenient to move out of t he swine production market.. 
2.5 .2 Consumers 
According to Wade and Barkley, the demand for pork is conditioned by consumer 
perceptions and knowledge of the attributes of the product . In other words food safety 
is a n important determinant in demand for food products. In their study ·wade and 
Barkley referred to a survey conducted by the Good Housekeeping Instit ute in 19 5, 
which found that primary food concern of over 40 percent of women respondents 
was food safety. Also a 198.5 study of 390 Kansas residents indicated that 71 percent 
would pay more for safer meat. A similar study in 1990 had concluded that percent 
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of the :360 respondent s were willing to pay at lea.st .) percent more for re idue-free 
beef. and that 79 percent of these people had reduced their beef consumption with 
only 14 percent of it being price related. 
Given that consumer demand will likely inc rease fo llowing a ban on use of an-
ti biotic in swine production if legislated, the reaction of consumers to a potential 
ban is not known with certainty and t hus, mu t be projected . ~Wade and Barkley 
conclude that consumer welfare would probably increase because of elimination of a 
perceived health ri sk. which would offse t the increased production co ts associated 
with swine. 
2 .5.3 Ve t e rina ria n s 
Antibiotics have been an e.lfecti ve tool in a veterinarians pandora s box for 
t he treatment of bacterial di seases in animals. T hey have led to a better client-
veterinarian relat ionship and also improved relations between the an imal farmer and 
the veterinarian. As effective means of treating various illnesses antib iotics have 
offered veterinarians and farmers some control in the production process of food pro-
ducing animals and processed meat. ban on the use of antibiotics would be a big 
loss to the veterinarians since it would entail suspension of effective mode of treat-
ment unti l new research on bet ter and more efficient means of treatment is found . 
Thus, the farmers m ay observe huge economic losses until a time period whe n an 
effect ive treatment is found. At present no guarantees can be offered that any alter-
native mode of t reating animal illnesses will be as economically feasible as antibiotics 
are . 
2.6 Population of live tock and poultry 
Knowing; the population of livestock and poultry help estimate the penicillin 
and tetracycline used to medicate them. Food animal population in C .S . i ext remely 
large. much more than twenty times t he human population [26]. I n L9il and 19 5 . as 
an example. the total C.S. food animal population was 3.522 and 5.122 million head 
respectively. The number of head of liYestock (exclusi,-e of poultry ) for the same 2 
years was 211 and 206 million. \Vhile poultry production increa ed. the production 
of red meat in the intervening 14 years declined omewhat. A relationship between 
amount of red meat to white meat food is important in considering the magnitude of 
human expo ure to meat or poultry products contaminated with pathogenic bacteria 
of farm- animal origin. This magnitude can be understood by inspection of pe r-capita 
con sumption figures for meat and poultry in thi s country. The consumption of red 
meat per capita ranued between 16 pound in 1971 to a low of 153.2 pounds in 
19 .5 . In the arne period. the amount of poultry consumed increa ed from 49 to 69. 7 
pound . 
2. 7 Economics of drug use 
As per estimates provided by Beran , the cost of adding antimicrobial drugs to 
lives tock rations represents about 3. 75 percent of the total ration costs . The increase 
in daily rate of gain for swine have ranged between 9.7 percent and 17.7 percent, 
with feed efficiency increases from 3.3 percent to 7.6 percent in reported experiment . 
With the improved feed efficiency levels . return on investment appears to be about 
two dollars for each dollar invested, or about 3 .. 5 billion dollars a year for the LT.'. 
Beran indicates that in context of the present agricultural economy. an effect of a ban 
of subtherapeutic use will impact more heavi ly on livestock producers than consumers 
[2]. 
In an industry-level economic conceptual model , Buhr, Kliebenstein. Walker and 
Johnson estimated the effects of improved animal health . Livestock disease reduces 
production efficiency leading to producer, industry-level. and societal economic losses. 
Most animal health analysis have focussed at producer level. However. consumers 
can experience economic losses or decreases in welfare through higher food prices. 
In order to measure economic impact of animal diseases. it is important to study 
its effects on animal productivity. This is not always an easy task because [7]: 
1. the effects are not al ways pronounced and obvious 
2. they are influenced by other factors such as overall management , environment 
etc. 
3. they have a temporal dimension which adds to complexity of evaluating their 
impacts over time 
4. the effects often manifest themselves in an integrated complex with other dis-
eases. 
Quantitative measures of disease impacts can be categorized under traditional 
production-oriented data and non-traditional indicators of disease presence. Tradi-
tional data include factors as mortality rates and average daily gain. Non-traditional 
indicators include factors as mortality rates and average daily gain and also factors 
such as labor requirements, feed costs~ veterinary costs may be included. Veterinary 
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services will increase with the level of di sease, and thus can serve as indicator to a 
d isease. Other factors help as indicators on a similar basis . Feed costs may increase 
from necessity to feed medicated rations to control subclinical diseases. 
Numerous studies have indicated that pneumonia and rhinitis, even at subdin-
ical levels, can cause significant decreases in average daily gain a nd feed efficiency. 
Decreasing animal production efficiency leads to a decrease in economic efficiency. 
Research by Christian Boessen, James Kliebenstein, Ross cowart. Kevin Moore 
and Clark Burbee on determination of swine pneumonia and rhinitis, and impacts 
on production costs through slaughter checks concluded the increased costs per hog 
due to pneumonia for batch production at a weighted average of Sl.09 annually. 
The annual decline in the average daily gain due to pneumonia was estimated to 
be 2. 3 percent. For rhiniti s, the annual weighted average increase in cost per hog 
was estimated at $0.95. In some cases. the expenses incurred in disease prevention 
and / or control can be considerable. Without information on disease le,·els in the herd, 
producers can incur unnecessary expenses. Knowledge of a disease level can enable 
producers to improve disease management and possibly reduce levels of medication. 
Use of slaughter checks. a method of monitoring levels of subclinical diseases by 
examining the internal tissues and organs of an animal as it moves through slaughter 
plants, offers the poten tial result of healthier animals with lower levels of medication. 
The most evidence linking human disease to multi-res is tant bacteria of farm 
origin has been found in salmonellae. Most data linking incidence and associated 
morbidity and mortality of salmonella infection in farmers, slaugh terhouse workers . 
and their families is not available. Comparison of case reports on fa rmers who used 
subt herapeutic antibiotics as feed additives in animals with those on farmers who did 
Table 2.1: Frequency & percent deaths due to salmonellosis (196 - 19 5 ) 
Age 
Cnder 1 day 
1 - 6 days 
T - 27 days 
2 - 364 days 
1 - 4 years 
5 - 9 years 
10 - 14 years 
15 - 24 years 
2.5 - 34 years 
3.5 - 44 years 
4,5 - 54 years 
.55 - 64 yea.rs 
6.5 - 74 years 
7.5 - 4 years 
.5 -r years 
Unknown 
All ages 
. umber of death 
30 
16.5 
42 
12 
11 
14 
30 
42 
104 
176 
314 
296 
174 
2 
1421 
Percent per year of age 
0.1 
0.6 
1 2.1 
11.6 
3.0 
o. 
o. 
1.0 
2.1 
3.0 
7.3 
12.4 
22.1 
20. 
12.2 
0.1 
100.0 
Source: Institute of Medicine 19 9 
not might be particularly of interest. The only data available is in t he form of case 
reports or descrip t ions of smalJ nu mber of ou tbreaks in farmers and their families 
and not slaughte rhouses. 
The National center for Health Statistics has estimated the frequency and death 
due to salmonellosis by age fo r the years 196 - .5. Table 2.1 lists this data. The age 
group between 65-74 years represents the maximum deaths both in abso lu te numbers 
and in percent. The lowest figures are for the age group "under 1 day'. 
The number of salmonellosis incidence is suspected to be 10-100 times larger 
th an t hat reported to CDC (Center for Disease Control). This is mainly because 
many patients with salmonellosis do not seek medical attention since in most cases 
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Table 2.2: Resistance of salmonella to antimicrobials 
Rate of resistance of Low Mid-Range High 
Salmonellae to: Estimate Estimate Estimate 
At least one antimicrobial 16% 24% 31 3 
At least penicillin / ampicillin 10% 1.53 20% 
or tetracycline 
Source: Institute of Medicine 19 9 
salmonellosis is believed to be a simple case of cliahrrea. The proportion of salmonella 
isolates from humans with resistance to at least one antimicrobial was 16 percent in 
the 1979-80 CDC' survey and 24 percent in 19 4- 5 survey. The rate of occurrence 
of antibiotic resistance of salmonellae is shown in the Table 2.2 . The committee 
on human health risk assessment of using subtherapeutic antibiotics in animal feeds 
used a risk model and concluded that major consequences of feeding antimicrobial 
agents to animals or humans are likely to be: 
1. a tendency to increase the prevalence of drug-resistant st rains 
2. an effect on both the pathogen and the fecal flora that might alter t heir usual 
interaction 
The committee also constructed and used a risk model to estimate and plot 
annual number of deaths that result from subtherapeutic use of antibiotics in animal 
feed. Some o{ these results are presented in Figures 2.1 through 2.3. 
o/o C> C BsLima:1. t c. 
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Figure 2.1: Estimates of annual numbers of deaths from subtherapeuti c uses of any 
antibiotic for both prophylaxis and growth promotion 
Source: [nstitute Of ~l edicine, 19 9 
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F igure 2.2: Est imates of annual numbers of deaths from subtherapeut]c uses of any 
antibioti c for growth promotion on ly 
Source: Irtst itute Of Medicine. 1989 
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Figure 2.3: Estimates of annual numbers of deaths a.rising because of higher death 
rate and increased difficulty of disease treatment attributable to sub-
t herapeutic uses of any antibiotic for both prophylaxis and growth pro-
motion 
Source: Inst itute Of Medicine, 1989 
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The economic costs of human illnesses caused by Salmonella and Listeria have 
been used to extrapolate costs to other bacteri al caused human illness costs of hun-
dreds of million of dollars annually. Research estimated these human illness costs 
to be approximately $100 mill.ion or more [41]. Estimates could be enhanced by in-
cluding factors other than medical costs and productivity losses as has been done 
by economists Curtin, Harrington, Krupnick , and Spofford who estimated value of 
non-work t ime directly and by Fisher: Chestnut et al. who used willingness-to-pay 
estimat es of the value of a statistical life saved. 
Compensation fo r pain and suffering and other psychic losses has been granted in 
cour ts. However , if pain and suffering expenses were also to be added to estimates, 
death and illness estimates would increase by over half a million dollars for each 
category. T he costs incurred from exposure to foo dborne diseases is graphed in 
Figure 2.4 [41 ]. 
Foodborne diseases rank seventh in importance in terms of disability days, 
eleventh for number of deaths. and fourteenth in economic costs to society of the 
seventeen disease categories , as stated by Mushkin. In ligh t of such evidence it be-
comes irnperati ve that we estimate human illness costs of food borne bacteria. 
In using salmonella and listeria to extrapolate the economic costs of food borne 
diseases , they also represent diversity in foodborne diseases . Salmonellosis is typi-
cally of a mild severity, while lesteriosis cases usu ally require hospitalization. Cost 
estimates include medical and productivity losses excluding psychic costs as pain and 
suffering and leisure lost . Meclical costs are the expenditures for physician, hospi tal, 
and related ser vices plus drugs. Productivity losses are comprised of time loss from 
work evaluated at wage rate in case of listeriosis or at individual's wage reported in 
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a urvey. 
Four severity groups were identified under cases of salmonellosis and list.eriosis. 
These being deaths, hospitalized cases, physician visit s and mild cases [4 1]. The 
medical and productivity losses under each category of illness was estimated for 19 7 
data. The average costs per case of salmonellosis were estimated to be $372 000 in 
an event of death , $4,3.50 for hospitalized cases. $680 in an event of physicians visit 
and finally $221 for mild cases. Estimated cost per case over the four severi ty levels 
given outbreak data averaged $700. 
In an event of lesteriosis, fetal/ newborn cases resulting deat h were estimated to 
have an average cost of $1, 100,000 per case. the costs for su rvivors was estimated at 
$71,000. Adult deaths averaged $2 1,000 and for those who survived the estimated 
average was $17,000. In situation of maternal illnesses the costs were estimated as 
$7,100 on average. The average cost, for all three populations, per lesteriosis averaged 
$135,000. 
Extrapolating these cost figures to all other foodborne bacterial diseases , esti-
mated medical and product.ivi ty costs for the year 1987 stood at a total of $4.8 billion 
[41]. 
Research by Berger evaluated the concern for use of sulfonamides in pork pro-
duction in view of the frequency with which residues occur. There was an attempt 
to identify the point in the pork product chain that wo uld be the most cost effective 
and efficient to intervene to red uce the incidence of sulfa residues. The FAPRI pork 
model was chosen to asses the changes in pork production, consumption, farm level 
prices and retail prices. T he two main scenarios that were examined were: 
1. A supply only shift resulting from a total ban of sulfamethazine in pork pro-
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duction, a su ming no substitutes exist to sulfa use. 
2. A demand only shift re ulting from a 5 percent increase in consumer demand , 
arising from a perceived improvement in t he wholesomeness of pork products. 
Alternatives discussed were: 
1. A ban on sulfamethazine use implemented by the FDA 
2. Increased testing by FSIS 
3. Implementation of tes ting programs by p ork processors, both pre- and post 
-slaughter . 
4. Implementation of a " bill back'' law that would allow processors to t race and 
charge sellers for animals that are violative . 
. 5. Implementation of a selected supplier program by processors. 
6. Implementation of output testing programs at the producer level. 
7. Implementation of input testing programs at the producer level. 
Implementation of a combination of input/ output testing programs at the pro-
ducer level. 
A ban of sulfa use in pork production by the FDA, would result in higher 
pork prices and reduced supplies. Producers would receive higher pri ces than before. 
however it was found to be hard to estimate if these higher prices were sufficient 
to compensate for the higher production costs . Also some pork producers would 
be driven out of the market due to increased production cos ts. Pork production 
following the e restrictions showed a. decline by 1A3 percent under t he base cenano 
at the end of ten years. Farm prices showed an increase of 4.96 percent over the ba. e 
by the end of tenth year of pork production without the use of sulfamethazine. For 
the same analysis , pork retail prices increased 2. 7·-1: percent while pork consumption 
declined 1.3 percent over what it was projected to be wit.houl the ban. 
An increase in demand by l percent in re pon e to safer meat supplies indicated 
a decline of 1.16 percent in pork production at the end of ten years . while a .j percent 
change in demand indicated almost negLgi ble effects in pork production by end of 
tenth year . Farm prices increased 5.21 percent in response to an assumed 1 percent 
change in demand, while the change observed with a 5 percent change was a 6.20 
percent increase. Pork consumption showed a decline of 1.10 percent in response to l 
percent change at the end of the tenth year and was negligible for a .5 percent change. 
Finally, the retail prices increased 3.53 percent for a period ten years into future with 
a ban on sulfa use for a 1 percent change in demand. For a .j percent change this 
figure stood at 6.67 percent. 
Increased testing by FSIS would also lead to increased retail prices and farm 
prices but could also lead to increased pork supply . In this scenario. tax dollars will 
have to be used in instituting this practice inlo the pork production chain. 
Implementing either pre- or post-slaughter testing will lead to higher prices due 
to increased production as well as macro effects. Pork producers would be facing 
lower prices, although it was not clear if this was sufficient to offset the increase in 
prices resulting from macro effects. 
The bill back proposal was estimated to have negligible effects on pork supply 
and demand. Also a careful analysis brought to question as to how to identify viola-
tors, and the relationshjp between producer and processor, if such a proposal gained 
acceptance. 
The selected supplie r program showed to lead to decreased pork supplies and 
higher prices at both farm and retail level where a majority of the cost was to be 
borne by producers. 
The impact of the final three st rategies depends on t he producer participation. 
If a sufficient number of producers were to participate. consumers may perceive meat 
to be safer and demand more. As a result there wo uld a decreased pork supply and 
increased pork farm and retail prices. 
Berger s analysis revealed that the optimal solution is to institute a program of 
combination testing and management safeguard at producer level. I t may be neces-
sary to combine such a program with increased penalties from regulatory agencies or 
controls. This combination of strategies appears most efficient in control over residue 
violations at point of origin with least cost to any given group [3]. 
Substituting sulfamethazine with other drugs as alternatives in pork production 
is expected to have/ create an economic impact . In the following chapters an attempt 
to identify these alternatives to suliamethazine and conduct an economic comparison 
to study the economic effects is carried out. 
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CHAPTER 3. SULFA RESIDUES: A MANAGEMENT ISSUE 
The use of sulfamethazine has brought two main quest ions to the forefront in the 
usage of antibiotics in food generating animals. The emergence of the residue is ue 
with the use sulfamethazi ne as a feed additive in pig production has lead to the real-
ization of potential problems associated wi th the use of antibiotics in food producing 
animals. The questions rai sed have been that of environmental contamination and 
feed cross contamination on hog and other animal rai sing farms. 
Sulfamethazine has been linked with the environmental contamination of farms 
since sulfa is a compound that remains present in the environment and acti,·e for a 
long period of time. Contamination of water and the movement of sulfa contamin ated 
water between pens poses a potential threat of environmental contamination and 
residue violations. Additionally since sulfa granules tend to stick to grinder / mixer 
walls, there is a possibility of feed cross contamination. Issues such as this have 
led to the question of Management techniques' in antibiotic and drug use on food 
producing animal farms. T hi s chapter deals wit h the use of sulfamethazine and the 
management issues which have been developed to reduce the chance of residues. 
Efficacy, applicability and economy (costs) are primary concerns of swine pro-
ducers and veterinarians when treating respiratory diseases. The goal of acute res-
piratory disease treatment is to rapidly attain therapeutic levels of appropriate an-
timicrobial in the blood supply and affected tissues. The choice depends on drug 
ensitivity. Adding medication to water or feed is a popular method because it saves 
time and la.bar in addition to achieving rapid blood coverage. However, pigs with 
acute respiratory illness have severely curtailed feed and water consumption, resulting 
in sub-optimal levels of compounds in blood and tissue. Atrophic rhinitis is caused 
by Bordetella brochiseptica. Sulfamethazine. a sulfonamide. is a highly effecti\·e com-
pound in the treatment of atrophic rhinitis. 
·when continuous low levels of antibiotics and sulfonamides are added to diets 
of pigs in affected herds, they help pigs maintain weight gain. minimize disease and 
the negative effects of the disease on growth rate and feed efficiency. 
Preventive medication schemes are aimed at primary pathogens that cause chronic 
respiratory diseases. A sow/ gilt passes atrophic rhinitis to offspring through respira-
tory aerosol exchange. 
The greatest cost of swine pneumonia is due to increased feeding periods and 
development of ··low-value" or "no-value" animals (CYANAMID. 1994) . This has 
by and large resulted in the use of sulfamethazine as the feed and water additive in 
pigs to contain the respiratory problem because of good absorption and it's ability to 
remain in the body for extended periods of time. Thus, for the little water and feed 
the pigs may consume, sulfa.rnethazine remains in the body for a longer period and 
is quite efficient in combating respiratory problem. No other drug shares this prop-
erty of sulfamethazine leaving less effective alternatives which may add to the pork 
production costs if replaced. loreover, expensive, long acting forms of antibiotics 
may increase the per pig medication cost and extend withdrawal times thus delaying 
marketing after removal of the product from the production process. 
Thus, there are trade-offs with t he use of sulfarnethazine in pork production. 
While sulfamet hazine can be continued to be used as before and benefits of its broad 
spectrum drug activity be realized. there are perceived ri sks of residue violation . 
Sulfamethazine residues have largely been t he result of inappropriate management 
practices rather than by t he use of sulfamethazine itself. The following present some 
of the inappropriate management. practices followed by pork producing farmers which 
have caused or led to residue problems in pig meat . 
1. Crowding: a large numbe r of pigs in a confinement pen 
2. Poor cleaning and washing of pig facilities 
3. Not maintaining written records of medication 
4. Use of powdered sulfamethazine 
.5. Following of "extra-label" and "off-label" practices 
T hese management pr act ices largely refer not to pig handling techniques but to 
facili ty management or environment management. 
To effectively use sulfamethazine and gain best resul ts . good management prac-
tices need to be followed. T his may mean improved techniques for some producers. 
Studies indicate that crowding of pigs in confinement systems may lead t o stress in 
pigs . nder stress. animals tend to loose their appetite fo r food and water. This 
makes water and feed medicat ion less effective as a mode of t reatment. Moreover , 
the animal becomes more susceptible to di seases . To cite an example would be where 
Salmonella choleraesuis organisms tend to become active under pressure or stress. 
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Poor appetite for feed and water supplemented by increa ed susceptibility to 
diseases influences the ave rage daily weight gai n and feed effic iency of the animal. It 
is also true that for the more congested herds, disease sp read among the herd can 
quickly reach epidemic situations. For some producers poor environmental condi-
tions have been offset to some degree through the the increased use of antibiotics and 
drugs in general. E venthough antibiotics are more effective in poor environmental 
conditions. this is not t he best practice to follow [l ]. Regular cleaning of pens 1s 
a better management practice in reducing the chances of residue violations. It 1s 
important to clean the pens 4-.5 days after t he withdrawal of sulfamethazine. Addi-
tionally. medicated pigs should be moved to a new pen once the medicated feed has 
been withdrawn. 
What is needed at many of the farms is to minimize water and manure movement 
between pens on the farm . Water and manure movement can cause recycling of 
excreted sulfamethazine. Winter periods tend to be a Li ttle less of a threat mainly 
because water and manure tend to freeze . However 1 severely low temperatures do 
not deactivate sulfamethazine, instead as the water and manure thaws , ri sk of residue 
violations rea ppear. 
Sulfamethazine powder has the electrostatic property of gett ing charged and as a • 
result if used in the feed grinder/ mixer to prepare medicated feed, it tends to stick to 
the walls of the grinder . This may be a potent ial hazard especially if non-medicated 
feed mix was to be prepared using the same mixer/ grinder. The non-medicated 
feed will tend to get contaminated by sulfarnethazine thus recycling sulfamethazine 
back into swine 's body. Better facilities needed to clean t he mixer/ grinder need to be 
maintained. One such way is to use a flush feed of .500 lbs to eliminate all the possible 
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sulfamethazine from t he gri nder [26]. Also. the use of granular form of sul famethazine 
wo uld be a much better since it does not have the property of gett ing charged as does 
powdered sul famet hazine. 
It is wise to use at least 100-300 lbs of cracked corn or an amount equal to 
5 percent of mixer capacity as feed flush in order to reduce sulfamethazine level 
in the mixer below a level sufficient enough to cause residue violations. as part of 
better m anagement practices. It is also essent ial that farmers maintain dosage and 
medication records for easy reference and convenience. This will in part help reduce 
the incidence of resid ue violation. 
Combining medications or using "off-label' is currently under review by the 
FDA. Combining drugs or using higher-than-labeled dosages can lead to reduced 
effectiveness, increase withdrawal time, and/ or change the safety profile of the drugs 
in the animal. It is illegal for non-veterinarians to compound medications or use 
them in an off-label manner unless a veterinary-client-patient relationship is in place 
and the veterinarian has directed the producer to do so. 
In summary, many residue violations faced in livestock production are a result 
of inappropriate management practices. It is estimated that no more than 2.5-30 
percent of hog farmers are using sulfamethazine as a feed add itive even t hough it 
offers economic benefits in terms of better feed efficiency and average daily weight 
gain (Dr. Teddi Wolff, 1994, private communication). Most farmers are giving up 
some of the economic benefits to stay away from the perceived danger of residue 
violation. 
It has been suggested by many scientists that sulfamethazine may be substituted 
by sulfathiazole, especially since it belongs to the same family of sulfonamides and 
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thus, has t.he same pharmacological properties. Moreover, residue Yiolations have 
not been shown to occur with I he use of ulfathiazole since it is rapidly excreted 
from the pig's body. But this is also precisely the reason why we need approximately 
twice as much sulfathiazo le as sulfamethazine to obtain results close to that obtained 
with the use of s ulfamethazine(C'YANA~IID. 1994). Thus. to maintain therapeutic 
blood levels in swine. it is necessary that sulfat hiazole be administered six times a 
day at approximately twice the recommended dosage for sulfamethazine. Also unlike 
sulfamethazine, sulfathiazole cannot be used as a water additive. 
Thus, despite the fact that both sulfathiazole and sulfamethazine belong to the 
same class of broad spec t rum s ulfa drugs, they differ in their properties of absorption 
excretion and solubility. Studies have concluded sulfamethazine to be a far more 
superior product in terms of effectiveness in combating swi ne di seases when compared 
to sulfathiazole. 
Sulfamethazine in feed at sub-therapeutic level complements the treatment of 
many diseases. One of them is acute respiratory problems in swine which pose 
extremely high economic costs in terms of treatment expenses . longer duration of 
stay in the pen ,and slower achievement of market weight. 
An effective and an efficient use of sulfamethazine is the use of sulfamethazine 
medicated feed during the starter or grower phase (i.e. upto 75 lbs of production ). 
Beyond this weight level , s ulfamethazine can be withdrawn in favor of aureomycin or 
terramycin. This will help farmers reali ze efficient and effective use of sulfamethazine, 
since it is an established fact that pigs respond the best to antibiotics and drugs 
during their initial growth stage. Younger pigs are more susceptible to disease and 
stress than older pigs because their immune sys tem is still developing. As pigs grow 
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older. they develop greater immunological protection and are better able to cope with 
disease causing organisms in their environment. 
A point made by some is that the declining use of sulfamethazine has coincided 
with an increasinO' incidence of ·'Salmonella choleraesuis' . According to results ob-
tained from a study conducted by ('YAN AMID and also Dr. Kent Shwartz of Iowa 
state University, a decline in the use of sulfamethazine between 19 1-90 has coincided 
with a increase in incidence of Salmonella cholerasuis. The · ational Animal Health 
Moni toring services has estimated the cost of Salmonellosis in Iowa alone to be 27 
million dollars annually. Salmonella is estimated to be the most costly problem facing 
hog producers today [44]. 
Salmonella cholerasuis can cause intestinal inflammation and respiratory prob-
lems. Pneumonia is very often cited as a result. Salmonella choleraesuis invades the 
blood st ream and spreads t.hroughout the ti ssues and lungs. The efficiency and use of 
sulfamethazine appears more evident in such a case since sulfamethazine effectively 
invades the bloodstream and rapidly spreads throughout the tissues and organs. Be-
sides it is very well absorbed systemically. Sulfamethazine penetrates well into the 
lungs and provides an effective treatment. Drugs such as lincomix and carbadox etc. 
are very poorly absorbed and thus inefficient and uneconomical for treating systemic 
diseases. 
Salmonella cholerasuis is estimated to have cost about 100 million dollars in the 
US during the period 1992-93 [44]. It is the most frequently found pathogen in grow-
ing and finishing pigs. It is estimated that 60-70 percent of the pig population today is 
infected with this pathogen. Stressful circumstances trigger the organism to develop 
and spread very rapidly. It is suspected that in many cases Salmonella cholerasuis 
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goes unnoticed and untreated becau e of it·- subtle character. thus, causing even 
larger economic losses. 
In an experimental study of the effectiveness of Al'REO SP-250. a feed additi ve 
containing sulfamethazine, in the treatment of Salmonella cholerasuis, conducted by 
CYA -AMID . pigs were broadly categorized under treatment group l, i.e., the control 
group not fed Al REO SP-250 and group 2, i.e. the group receiving AUREO SP-
2.jO. The results were in favor of using AUREO-SP 250. Mortality rates due to 
Salmonella choleraesuis were observed to have declined by 83 percent for the group 
using A REO SP-250 when compared to the control group. Group 2 observed 67 
percent fewer scour days and ..J.9 percent fewer septecemia days than group l. The 
feed conversion rate for group 2 observed a 29 percent improvement over the control 
group. Also group 2 observed a 62 percent increase in average daily weight gain over 
the control group. 
Recent studies have also shown a decline in the percentage of sulfamethazine 
residue violations. A residue violation of 0.61 percent has been observed to exist 
currently, which is much lower than the acceptable rate of 1 percent laid out by FDA 
(Dr. Teddi Wolff, 1994, private communication). This has been largely responsible 
due to the extensive education programs and better management practices. A rapid 
decline in the usage of the drug may be partly responsible fo r this low figure. Increas-
ing use of screening tests which make detection easy have also helped reduce residue 
violations , since any residue violations implies economic costs to the producer. 
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CHAPTER 4. IDENTIFYIN G THE VIABLE ALTERNATIVES TO 
SULFAMETHAZINE IN P ORK PRODUCTION 
Sulfonamides have become an effective compound for use Ill the pork produc-
tion. They are easily admini tered in feed and water. are economical to use and 
have proven to be effective for treatment of livestock diseases. Additionally, they 
promote and improve feed efficiency and average daily weight gain in herds. They 
are effective in treatment of atrophic rhinitis. Sulfamethazine or Sulfathiazole is also 
used for t reatment of respiratory infections . Sulfamethazine and sulfathiazole being 
sulfonamides are broad spect rum compounds which are readily absorbed into and, 
slowly eliminated from the body. 
However , recently the use of su lfamethazine in pork production has elicited con-
cern and been associated by some individuals with development of bacterial resistance 
through gene transfer. The associated costs for both the producer and consumer af-
fected by the resistance problem have been estimated to be high . Additionally there 
are associated economic costs of residue violation to the producer [3]. The use of 
sulfathiazole, however as a feed additive in swine feed has not been plagued with 
accusations and controversy of bacterial resistance. 
This chapter , analyzes in detail the various possible alternatives which could be 
used to replace sulfamethazine in swine production. Each will be evaluated as an 
• 
55 
alternative to sulfamethazine in pork production. 
Sulfa.met hazine has the property of being slowly excreted from the body of the 
animal. This is precisely the reason it is as effect ive as it i in it ·s use and in attaining 
effective therapeutic levels. However , this is also the reason why many of the residue 
violations occur with the use of sulfamethazine. Use of sulfarnethazine has been 
suggested by some as a compound which can contaminate the animals environment. 
Sulfamethazine is used mainly as a feed additive in the form of Aureo SP-250 which 
contains 100 g/ ton feed each of sulfamethazine a.nd chlortet racycline, and 50g/ ton 
feed of penicillin. Tylan 40-Sulfa G is also a feed additive containing sulfamethazine 
whose active ingredients are 40 g/ lb of product of tylosin and 40 g/ lb of product of 
sulfamethazine. Sulfamethazine helps maintain weight gain and feed efficiency in 
the presence of atrophic rhinitis. 
The recommended dosage level for Tylan 40-sulfa G is 100 g/ ton tylosin and 100 
g/ ton feed of sulfamethazine. At similar dosage levels, it helps in Lowering incidence 
and severity of Bordetella bronchiseptica rhinitis, and the control of swine pneumonia 
caused by bacteria pathogens. It must be thoroughly mixed in feed before use. is not 
meant for use in finishing feed and has a wit hdrawal period of 15 days prior to 
slaughter. At the onset the criteria for selection of the possible alternatives needs to 
be established. T his implies understanding the properties of sulfamethazine. 
Sulfamethazine is an effective drug which helps combat both systemic and enteric 
diseases. Swine diseases can be broadly categorized as systemic and ente ric. Enteric 
diseases primarily involve the gastrointestinal t ract (gut) . Systemic diseases involve 
blood, tissues and organs. Symptoms of systemic disease may involve coughing, 
respiratory di sease, difficulty in walking etc. Indications for an enteric disease include 
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animal cliahrrea (scours). Salmonella is of special interest in that it begins as an 
enteric di sease but rapidly progresses to be a y temic di sease. 
Feed additives and water solubles can also be classified as being eit her sy temic 
or enteric in act ion. Since all feed additives are adminis tered orally they have some 
enteri c act ivity. Systemic activity, however , requires that medication be absorbed 
through the wall of the gut and be carried to effected tissues and organs via the 
bloodstream. For effective disease prevention and or control , it is necessary that a 
drug be first absorbed and then attain effective concentrat ions at site of action. 
Effective use of feed additive and water soluble compounds and t heir selection re-
quires that the therapeutic goal be first identified and then it be determined whether 
the purpose of medication is to prevent / control or t reat an ente ric or systemic dis-
ease. T his will guide in our selection of the appropriate enteric or systemic medi-
cation. An understanding of comparati ve blood and lung concentration level of the 
compound can further guide our selection. It is also useful to know the sensitivity 
of the organism. An understanding of comparative sensitivities may also help in the 
determination of the appropriate medication. Withdrawal times should be noted and 
followed to avoid residues. Lastly. it is important that before a choice be made on 
the compound for using as a feed addi tive. that it be cost effective and provide a 
positive return on investment. 
In searching for an alternative . it thus becomes important to identify the prop-
erties of t he compounds such that they come the closest in sen;ng the purpose of 
replacing sulfamethazine. This implies that the alternative compounds be well ab-
sorbed both sys temically and enterically. Slow excretion from the body would provide 
an added advantage. The remaining part of thi s chapter evaluates the properties of 
the othe r drugs which may be con idered as alte rnat ives to su lfamethazine u e 1n 
wine production. 
CSP 250/ Aureozol: The active ingredi ent s of CSP 2.50/ Aureozol are lOOg / ton feed 
of chlortet racycline 1 100 g / ton feed of sulfat hi azole and 50 g / ton feed of Peni-
ci llin . 
T he main difference between Aureo P -250 and CSP -250 / Aureozol is the ub-
stitution of sulfamethazine with ulfathiazole in C'S P-250. B roadly speaking 
since both sulfamethazine and sul fa t hi azole belong to the same family of sul -
fonamides , sulfathiazole is expected to be alleast as effective as sul famet hazine. 
However , since sulfathi a.zole is excreted more rapidly from t he ho t body, (' P 
2.50 / Aureozol is not as effective as Aureo SP -250. Thus eventhough sulfat hi -
azole is broad spectrum a nd as well absorbed sys temically as sulfamethazine 
it is not a perfect a lternat ive to sulfamethazine. C urrently, CSP -2.50/ Au reozol 
is used fo r reducing cervical abscesses and in t he t reatment of swine ent irit is . 
Sulfathiazole helps maintain weight gain in presence of a t rophic rhjnitis besides 
promoting feed effi ciency and average daily weight gains . CSP 2.50 / Aureozol is 
benefic ial in the t reat ment of swine raised in confinement . 
The wit hdrawal period for sulfathiazole is 7 days and no issues of residue vi-
olation have emerged with it 's use . To achieve desired performan ce, animals 
should consume indicated rations in minimum amounts . 
Prestarter: for a body weight of 20 lbs, minimum daily feed intake is to be 1.0 
lb. For starters weigrung .50 lbs, minimum daily feed intake is 1..5 lb. For grower 
with weight level of 0 lbs , the feed intake is 2 lbs and for fini sher weighing 150 
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lbs, the minimum feed intake is 3 lbs . 
D enagard: the active ingredient i tiamulin at 10 g/ lb of product. It is u ed in the 
control of swine dysentery and its usage level is 35 g/ ton feed. A withdrawal 
period of 2 days needs to be fo llowed . Denagard is also used as a growt h pro-
motant in starter grower feeds at a level of 10 g/ ton of feed with no withdrawal 
period prior to slaughter. However, Denagard is not for use as an undiluted 
feed premix and in swine weighing greater than 250 lbs. Alternatively, with the 
emergence of toxicity, it's use needs to be di scontinued. 
Mecadox: The active ingredients a re carbadox at a level of 10 g/ lb of produc t. I t 
is used for controlling swine dysentery/ bacterial swi ne entiritis . 
It 's use promotes feed effi ciency and ra te of weight gain. 
l.\Iecadox can be used up to levels of 2.5 g/ lb product in swine supplements used 
for producing complete feeds containing not less than 15 percent crude protein. 
5 lbs/ ton of complete feed is used for the treatment of swine dysentery/ entiri t is. 
Mecadox also promotes feed efficiency and aids in the improvement of average 
daily gain. 
Mecadox is not meant for use in swine weighing greater than 75 lbs. and in 
feeds containing less than 15 percent crude protein. The withdrawal period is 
70 days prior to slaughter. 
i\Iecadox has proven e ffective rn controlling scours and promoting improved 
growth. There are however, cost prohibitions with the use of mecadox. it is 
extremely expensive to purchase. In terms of abso rption mecadox is not well 
abso rbed systemically, i .e .. it does not penetrate effecti vely into t he blood t is-
sues and lungs. 
Experi ments with more t han 7000 pigs have shown mecadox to be a superior 
drug in t he control of scours and highly effect ive in enhancing growth in com-
parison with some of the ot her drugs [17]. 
N eo-Terra 20 / 20: Active ingredients are terramycin ( oxytet racycline) 20 g/ lb prod-
uct and neomycin sulfate at 20 g/ lb product. It is used in wine (baby/ growing-
fi ni shing) for preventing and t reati ng bacteri al entiri tis, baby pig diahrrea, 
salmonellosis, vibrionic and bloody dysentery. T he recommended dosage level 
fo r prevention is 50 g terramycin/ ton feed and 3.5 g/ ton feed of neomycin. At 
treatment levels t he recommended dosage is terramycin 100 g/ ton feed and 70 
g/ ton feed for neomycin. 
Neo-terra aids in weight gam and feed consumption in presence of atrophic 
rhinitis. Also, it aids in the t reatment of bacteri al entiri tis. eo-terra is used 
in dry feeds only and follows a 5 day withdrawal t ime prior to slaughter. 
Terramycin is a broad spectrum drug, effective again st di seases caused by su -
ceptible gram posi tive and gram negative bacteria. 
Neomycin on the other hand is effective in t reatment of scours and gram neg-
ative bacteria including E. Coli and salmonella. 
Neo-terra 50 / 50: Active ingredients are neomycin sulfate and te rra mycin at .)Q 
g/ lb product each. It is used as prevention and t reatment of bacterial enti ri-
ti s/ baby pig diahrrea, vibrionic dysentery and salmonellosis. It aids in rn ai n-
tainence of weight gains and feed consumption in presence of a trophic rhiniti . 
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It may be used as a dry feed only and a 5 day withdrawal period prior to 
slaughter needs to be ob erved. 
Aureomycin: contains chlortetracycline only. A dosage of 10-50 g/ ton feed is used 
to promote growth and improve feed efficiency. At levels of 50-100 g/ ton feed 
it prevents scours/ swine entiritis and help maintain weight gains in presence 
of atrophic rhinitis and reduces cervical abscesses. This dosage level is also 
sufficient to prevent bacterial entiritis during stress. At a level of 100-200 
g/ ton feed, ch1ortetracycline is used as a. treatment of scour while a level of 200 
g/ ton feed simply helps reduce spread of Leptospirosis. A dosage of 400 g/ ton 
feed may be used in the starter phase as the sole medication for no more than 
14 days. There is no withdrawal period for au reomycin. 
Lincomix 50: Lincomycin at 50 g/ lb of product is the active ingredient. It helps in 
controlling swine dysentery and reducing severity of swine mycoplasmal pneu-
monia. Lincomix also promotes rate of weight gain in growing-finishing swine. 
Recommended dosage is at 100 g/ ton of complete feed as ration for 3 weeks 
in treating swine dysentery. In a situation of swine dysentery where there is a 
history of dysentery but the symptoms have not yet appeared. a dosage level 
of 40 g/ ton as the sole ration is effective while at 20 g/ ton of complete feed as 
sole ration it promotes weight gain from weaning to market weight . 
At a level of 100 g/ ton feed until symptom of swine dysentery disappear and 
then follow it up with 40 g/ ton of feed is an effective means of treating swine 
dysentery. 
Use of lincomycin feed is followed by diahrrea/ swelling of arms within the first 
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two days. This is usually self correcting. Lincomix is not for use m sw1 ne 
weighing greater than 250 lbs. A withdrawal pe riod of 6 days prior to -laughter 
needs to be observed. 
It is extremely important that the feed additive be thoroughly mixed before 
use. Cleanout procedures a re important to avoid cross-contamination of feed. 
Strep-Pe n: 75 g/ lb of product of streptomycin and 25 g/ lb of product procaine 
penici llin constitutes t hi s combination which is used as a growth promotant 
and to increase feed efficiency at a level of 7.5 g/ 1.5 ton feed . At levels of 31 .. 5 
g/ 7.5 ton feed. it aids in prevention of bacterial entiritis and at leYels of 75 g/ 
15 ton feed it t reats swine entiritis. 
Tylan 4 0: This drug contains 40 g/ lb of product of Tylosin. It helps maintain weight 
gains and feed efficiency in the presence of atrophic rhinitis. [ncreased rate of 
weight gain and feed efficiency is achieved by the use of this drug. The drug is 
also used in the p revention of. treatment and control of swine dysentery. It is 
essential that the drug be mixed in feed before use. 
Most alternatives listed here haYe a withdrawal t ime period established by guide-
lines prescribed by the FDA. It. is important that these withdrawal periods be ob-
served by users to keep violati ve residues at a minimum. This is true for all <l rugs 
listed with withdrawal periods and not only sulfamethazine. 
Absorption and excretion differences cause some systemic feed additives or water 
solubles to provide greater and higher concentration and absorption in the blood and 
lung tissue thus providing better respiratory di sease prevention and control. 
62 
m cg/ml 
_/;··-. ·-------. ·----. ----........ -. -............ -. 
.. ····· 
l l o u rs .P ost.t:rcot..mcnt. 
Figure 4.1: Aureomycin and terramycin levels in swine plasma 
Source: CYANAMID 
An attempt to understand systemic absorption between aureomycin and ter-
ramycin revealed aureomycin concentrations in plasma and lung tissues to be much 
higher t han terramycin (oxytetracycline) when fed in drinking water or as a feed 
addit ive. This can be seen in Figures 4.1 and 4.2. This level remained far beyond 
two days post-treatment. 
A study measuring au reomycin and terramycin levels in swine blood and lung 
tissues until seven days post-treatment, Figures 4.3 and 4.4 also indicate higher 
levels of a ureomycin at all times. In comparing aureomycin with terramycin thus, it 
became clear that there is a better systemic absorption and concentrat ion in blood 
with a ureomycin. A similar analysis between sulfamethazine and sulfathiazole for 
blood and lung levels indicated a higher sulfamethazine concentration as is indicated 
in Figure 4.5 a nd Figure 4.6. 
A study of "Comparative Efficacy of Sulfathiazole and Su lfamethazine in feed 
for Bordelella bronchiseplica infection in Swine., by Kopland , Gale, Maddock, Graces 
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Figure 4.2: Aureomycin and terramycin levels in lung tissue 
Source: CYAN AMID 
and Simpkins concluded that Bordetella bronchiseptica isolation rate decreased faster 
in sulfamethazine group than in the sulfath iazole group. By day 42, sulfamethazine-
medicated pigs were negative for Bordetel/a bronchiseptica, whereas 8-17 percent of 
sulfathiazole medicated pigs were positive between day 42-56 (Figure 4.7). Turbinate 
spacing averaged 11 percent less in sulfamethazine t.han in sulfathiazole treated group 
(C YANAMID. 1994). 
fn an experiment carried out by CYA NA MID which studied the comparative 
effi ciency of Aureomycin and Aureo SP-250 in prestarter and starter diets of weaned 
pigs, the average daily gain of pigs under Aureo SP-250 increased 24 percent compared 
to t.he control group , 4 percent faster than group fed aureomycin at 400 g/ton for 
the first 14 days and 200 g/ton for t he next 28 days and 10 percent faster than 
experiment.al group fed 200 g/ton of aureomycin (Figures 4.8 and 4.9) . The feed/gain 
in Figure 4.10 shows an increase of 10 percent with Aureo SP 250 and there was also 
a 27 percent improvement in total pounds of pork produced. 
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Figure 4.3: Aureomycin and terramycin levels in swine blood 
Source: CYAN AMID 
Upon comparison, it can be concluded that su lfamethazine is a superior drug 
when compared over any other drug such as au reomycin , terramycin and sulfathiazole 
when looking at rate of gain and feed efficiency. Since a primary use of sulfamethazine 
is in treating respiratory ailments which requires rapid systemic absorption and con-
centration, we can eliminate all possible alternative compounds except aureomycin, 
sulfathiazole and terramycin as alternatives to sulfamethazine. (Figure 4.11). 
Thus in analyzing the possible alternatives to sulfamelhazine it is encoded that 
none of the alternatives really serve as a perfect substitute. Most alternatives dis-
cussed at the beginning of the chapter appear to serve the purpose of promoting 
growth and feed efficiency as well as maintaining them under conditions of atrophic 
rhinitis. It should be noted that although growth promoting functions are well per-
formed by alternatives, they arc not as efficient as sulfamethazine. If owevcr an 
important use of sulfamethazine, is its use in treating and preventing respiratory ail-
ments which requires the drug to be well absorbed systemically. Fewer compounds 
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F igure 4.4: Aureomycin and terramycin levels in swine lung t issues 
Source: CYA NAMID 
serve as a lte rnat ive in t his function. 
In concluding brie fly, alterna ti ves exist for t he growth promoting function of 
sulfamethaz ine in swine. T hese include: 
l. Sulfathi a.zole (CS P 250/ Aureozol), 
2. I eomycin-Oxytelracyclinc combination ( eo-Terra), 
:3. Carbadox (Mecadox) 
•I. Lincomycin (Lincomix), 
5. Chlortctracycline (Aureomycin), 
6. Tylosin (Tylan), 
7. T ia mulin (Denagard ), and 
Strep-pen combination 
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Figure 4.5: Comparative sulfa concentrations. Blood levels ppm 
Source: CYANAMID 
However, our analysis also indicates that theoretically except for chlortet racy-
clinc, sulfathiazole and oxytetracyline none of the other drugs a re well absorbed 
systemically eventhough they are well absorbed enterically. This would severely re-
st rict our selection of alternatives since an important property of Sulfamethazine is 
that it is well absorbed systemically. The alternatives need to meet this condition as 
well. 
Thus, it is concluded that the alternatives for analysis are: 
L. Chlortetracycline, 
2. Oxytetracycline and 
3. Sulfathiazole 
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Figure 4.6: Comparative sulfa concentrations, Lung levels, ppm 
Source: CYA N A llD 
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Figure 4.7: Comparative efficacy of sulfamethazine and sulfa thiazolc in treating 
Bordetella bronchisept ica 
Source: CYANAMID 
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Figure 4.8: Average daily gain of star ter pig 
Source: CYANAMID 
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Figure 4.9: Average daily gain of st.art.er pig (percent) 
Source: CYA NAMID 
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Figure 4.10: Feed/Gain of starter pigs 
Source: CY AN A 1ID 
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Figure 4.11: Comparative absorption chart for swine feed additives 
Source: Veterinary Pharmacology and Therapeutics 
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F.igure 4.12: Response of pigs to antibiotics during the starter stage (Hays Report ) 
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Figure 4.13: Response of pigs to ant ibiotics during the star ter stage (Hays Report) 
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Although not as well absorbed ys temicall y tylosi n and lincomycin a re being used 
as alternatives t.o su lfamet hazine in the treat ment of at rophic rhinitis . because of their 
observed effectiveness in treating and preventing the disease. Thus . this report will 
incorpo rate tylosin and lincomycin also as alternatives to u se of sulfamethazine in 
pork product ion for purposes of economi c comparison. 
The Hays report measured t he response of pigs to antibiotics during the tarter 
stage on more than 20.000 pigs and estimated average responses. The results of 
this analysis are graphed in Figures 4.12 and 4.13 . The report concluded that the 
response of pigs during the starter stage was maximum in response to Aureo P 2.50 
both in terms of feed efficiency as well as average daily gain . 
CHAPTER 5. FAPRI PORK MODEL 
This study uses the Food and Agricultural Policy Research Inst itute ( FAPRI ) 
annual econometric model of the l .. li\·estock sector. The model aids in compre-
hensively ynthesizing data and cau al relation hips. The model can be u ed for 
analyzing changes in policy. technology, structure and forecasting. Thi model i 
u ed a part of the project to analyze and quantify the effect of a ban on ulfamet-
hazine in pork production 1 while at the same time, allowing similar products to be 
used as alternatives. Attached as Appendix to the tudy can be found a concise 
summary of the model equations and the variable names. 
5. 1 M odel d ocumentat ion 
The - hog industry has undergone dramatic st ructural changes a the trend 
for fewe r producers continues with increased ente rpri se size. Technology-intensi\·e 
production practices and techniques, efficient u e of inputs and improved di ease 
control measures have enabled producers to attain more production per sow, more 
production per unit housing, and lower feed co ts [27]. 
The use of antibiotics, technology and capital intensive confinement sy terns has 
along with management changes enabled year round production of hog and lessened 
the seasonal component that historically existed in hog production. upplement u ed 
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in pork production . such as anti biotics . have also aided in these shift . However , even 
with more cap tia1 intensiveness pork produc tion remains regionally concentrated. 
Seventy pe rcent of the production is concentrated in t.he corn belt states. There 
has been some significant growth in production in t he southeast especially in orth 
Carolina, bu t their production is s liU small relat i,·e to the overall corn belt tates. 
Production is dominated by the farrow-to-fini h operations, with producers retain ing 
control over the entire production phase from breeding to bi rth to slaughter (27,. 
However , even as these changes have occurred in hog production, the biolog-
ical nature of growth process ha remai ned unchanged e\·en when litter rate, feed 
efficiency, and the time of weaning have changed. 
5.2 Model overview 
Economic and other complex relationships between variables are built into t he 
FAPRI pork model by means of regression equations. The model merits some expla-
nation which would better enable us to understand these relat ionships and the results 
obtained . Figures 5.1 and 5.2 present an overview of how the supply and demand 
interact in the FAPRI model at both the farm and retail level. 
The supply estimates recognize that current supply is conilitioned on past breed-
mg decisions. The size of the breeding herd determines the industry 's production 
capacity. The stages of p roduction fall sequentially from the determination of the 
breeding herd size. 
Producers usually expand the breeding herds by retaining gilts and / or sows from 
s laughter in response to investment decisions which entail higher pork production. 
This investment decision is reflected by the number of hogs entering the breeding 
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herd and the number of sows retained in the breeding herd. During expansion, sows 
may be retained in the breeding herd even with reduced productivity. A higher rate 
of sow laughter indicates disinve lment deci sions by producers. The net difference 
between sow addit ions and sow slaughter reflects the changes in the breeding herd. 
The ize of t he breeding he rd determines the size of the pig crop. The pig crop 
is either fini hed and slaughtered or retained for breeding purpose . Ba rrow and gilt 
slaughter is dete rmined by t he size of the pig crop. ow slaughter . is determined by 
the size of the breeding herd and the incentives lo inves t or disinvest. 
Total po rk production is determined by sum to ta l number of sow and boars 
slaughtered as we ll as the total number of barrows and gilts slaughtered, wh ich in-
cludes hogs imported for slaughter. 
The lag structure in t he supply block is gove rned by the biological timetable in 
sequential phases of the production process. These biological relationships inherent in 
pork production are incorporated in t he beha\·ioral equat ions, placing the restraints 
on supply response. The supply response is aovernecl by time lags in breeding. gesta-
tion birth, finishing and slaughter. Also the supply response is a function of producer 
investment decisions. This need Lo identify and incorporate the biological restrictions 
in pork supply were first identified and incorporated by J ohnson and MacAulay in a 
quarterly beef model, 19 2 [27]. 
The pork demand block represents consumer behavior and response. Pork is 
compared with other m eats such as chicken and beef in formu lating t he decision to 
consume. 
The equilibrium of retail su pply and retai l demand determine retail price for 
pork. Since supply cannot respond immediately to increases in price due to the 
I I 
Table .5. 1: L1 .s. pork supply and utilization 
1992 1993 1994 1995 1998 1997 1998 1999 zooo 2001 2002 
Hog' o n F•rm' ( M 1Jllon Head I 
Market H og o(Dcc I ) 5 1 0 • 9 8 50. 4 50. 7 5 1.5 51 49 .9 50 2 51.9 51.8 51.4 
B ree ding Hog tt D ec l ) 7 . 3 7 .OJ 7 07 i . '16 i .33 6 .87 6 63 6 . 98 1.04 6 . 81 6 . 60 
Toh.I H og Sh.ugh 1c r 9 4 . 9 93 ,0 91 l 93. 9 96 .6 95 5 93 . 1 95 .2 9 7 6 95 6 95 .0 
(Million P o unds) 
S upply 18.267 18 , 200 17 ,6 13 18, I 73 18 ,697 18 ,655 18 ,234 185H 18 ,9i5 18 . H I 18 .4 0 I 
Beginn i ng S 1odt 1 388 385 375 354 38 0 400 380 367 J9 1 408 381 
lmpo u s 6 45 720 roo 6 8 7 688 73 0 743 &68 5 41 529 526 
Prod action 1; .234 1 7 ,095 16,538 l 7, 1 31 1 7 ,649 11 ,525 I 7, 111 17.509 18.01 4 17,634 17, 4 9& 
Diu.ppca r.u 1cc 17,882 17,825 11 ,259 I 7.793 18 ,291 18 .275 17,867 18, 15 4 18,537 18, 19 1 18.024 
Do mca ttc Lite: i r ,4 i!> l 7 . 4 13 16 ,8 59 1 7, 3 81 I 7 ,865 17.905 17,5 10 11 , 112 11 .978 17,620 17 ,HO 
Expo rt • 40i '11 2 400 41 2 432 370 3!.7 432 559 ~ 71 !>74 
Ending S tocki 385 375 354 38 0 400 380 367 39 1 40 8 381 J77 
Per Caph• C o o1umpt ion (Pound1) 
C1u e&u Wdgbt 6 8 . 4 6 7 . • 6i 6 66 .0 67 . I 66 . 7 6 4 .6 64 a 65 2 63. 3 62 .2 
R etail \.\'e•ght 53. 1 52.3 50 I 51.2 52 .1 51. 7 50 .1 50 .J 50. 5 49 . 1 48 .2 
C haog e S. .-1 % • l.5% ·• 2,.. 2 . 1 ~. 1.8'r. ·O '"• .3, 1 V. 0 . 3% 0 6% -2 8 % ·I 8% 
Pnces 
230· 250 lb 
tow& S ou thern !\lina c 1ota ( Dollau Per Hu ndrcd weight ) 
B•rrow• •od Gilu • 3 .03 46 .07 48 .!>3 45 .8 3 • 2 II 45 . 79 H .8 3 H 0 6 H . 05 •6 82 50 .19 
C hange · 13 . 4% 1 IV. 5 .3% . ; .6% .3 1 v. 8. 8 % 8 .8% .; 6% ·6. 4 % 6 . J,.. 72% 
6 Markel S o w 1 3 4 .00 37.07 H H 32 .5!> 33 86 35 . 65 34 . 17 31. 77 33 21 H 76 
C hange -1 8 .3'l"· 9 .0V. 0 .5% . 4 8 % ·8. 2% •. ov. &.0% .3 9% • 7 .ov. 4 .S~ 4 7% 
(Do llu1 Pound•) 
Po rk Reta.H l.98 L.98 2 .00 1.96 1.89 1.95 2.02 I 99 1.94 2 . 0 • 2 . 13 
C hange -6. 6% .o. 2"P". 1 .2% · I 7% ·3.8% 3 .3% 3 .4 % • 1.6 v. ·2. 6% 5 2~. 4 .6% 
Net Return• (Dollar< P er Hu n dredweight ) 
Parrow . Fiailh I 28 3 T3 4 .i8 J 36 ·O 62 2.33 6 .1!> 2 .41 ·l 21 0 . 6 8 2 10 
biological lags in the production process, pnces respond more to changes in demand 
rn the very short run. 
Included is the baseline results obtained from the model. This 1s given m Ta-
ble 5.1. Results from this table are used as baseline levels for purpose of our study 
• 
in t he next chapter. 
5.3 Farm leve l equations 
The pork model is broken down into the farm level supply and demand and 
retail level supply and demand . At the farm level, two behavioral equation capture 
the demand for sows and the demand for barrows and gilts. Supply and demand 
at the farm level i quoted live animals while at the retail le,·el upply and demand 
refer in terms of the proces ed product. 
5 .3.1 Farm le vel s upply 
The su pply of hogs and pigs are determined by the following relationships at the 
farm le\·el: 
1. Co t of production equations 
2. Number of breeding hogs on the farm 
3. umber of market hogs on the farm 
4. Pig crop 
5. ow and boar slaughter 
6. Barrow and Gilt slaughter 
The cost equat ions determine investment, and di sinves tment deci ions of produc-
ers. Net returns on pork are an ind ication about the health of the pork industry. 
Based on figures obtained for net returns . the producers decide to inve t or disinvest 
in the pork market. The cost equations are estimated as : 
1. Pork. Cost of production, laughter hog receipt s 
CP PKSLHG - 1.2 
+ 0.957*PKBAGPM 
2. Pork, Co t of production, Cull sow receipts 
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CPPK C' L W = 10.91 
- 0.066*PKSOWP 
- l.377*PI<PIG LIT 
- 0.469*D 01234 
3. Pork C'ost of production, cash expense for grain 
CPPKGRA - 1.67 
+ 4.042*C' RP FRl\I (- l ) 
+ 2.97 *CRPFRM 
4. Pork , Cost of production , Cash expense for protein supp lements 
CPPK UPP = 3.529 
- 0.042*S MP44D (-1) 
- 1. 713*D734 
.5. Pork Cost of production, Cash expen e for veterinary and medicine 
CPPKVET = 0.067 
+ 0.005*PPIW 
+ 0.0.5 *D7 56 
6. Pork. Cost of production , Cash expense for lives tock h auling 
CPPKHAUL = 0.024 
+ 0.001 *PPICFULW 
+ 0.032*SHIFT 6 
0 
1 . Pork, Cos t of production. Cash expense for marketing 
CPP IARK = 0.06i 
..j.. 0.002*PP IW 
I 0.001 *PKBAGP I 
- 0.044*DLT f 7 
. Pork, Cost of Production. Cash expense for beddinu 
C'PPKBED = - 0.00 .5 
+ 0.001 *PPIW 
+ 0.039*DU f 1 
9. Pork, Cost of production, Cash expense for fuel , lube, and electricity 
CPPKFLE = 0.166 
+ 0.01 *PPIC' F ULV\T 
.l.. 0.327*SHIFT 6 
10. Pork , Cost of production, Cash expense for repairs 
CPPKREP = 0.193 
+ 0.020*PPICMETW 
- 0.166*DUM 
11. P ork . Cost of production, Cash expense for hired labor 
1 
CPPKLABR = - 0.212 
+ 0.166*ZWRHP20W 
+ 0.09l*D 45 
12. Pork . Cost of production. Cash expense for manure credit 
CPPKMANU = - 0.05 
- 0.000 *PPIC'HMW 
- 0.0006*PPICPETW 
13. Pork, Cost of production, Cash expense for general farm overhead 
CPPKGFO = - 0.279 
- 0.025*PPIW 
7 1.504*0 67 
+ 0.508*SHIFT 
14. Pork, Cost of production, Cash expenses for insurance and taxes 
CPPKTAX = 0.225 
+ 0.0004*FI LAND 
+ 0.002*ZTXCBSPW 
+ 0.115*D I 5 
15. Pork Cost of production. Cash expense for interest 
CPPKINT = 0.738 
2 
+ 0.011 *(C'PPKEXP*ZINTAA . ..\) 
+ 2.4 L 7*DU1\I 2 
- 2A07*DU1\l 6 
16. Pork, Cost of production, Cash expense for capital replacement 
C'PPKCAPR = 1.937 
+ 0.03i*PPIW 
- l.623*DUM74 
+ l.136*DUM79 
The number of breeding hogs on the farm is an identity equal to 99 percent of 
the number of breeding hogs on the farm in the previous year plus gilts added to 
the breeding herd less the sows slaughtered. This identity is given by the following 
equation in the model: 
PKHOGNBR = 0.99*PKHOGNBR(-1} + PKGLTADD - PKSOWKS 
Where, PKGLTADD is a behavioral equation which provides gilts added which 
is rep resentative of the investment decisions of producers. This equation is identified 
in the model as: 
Hogs , umber of breeding hogs added to herd 
PKHOGNBR - PKHOGNBR(-1 ) = - 3132.2 
+ l.522.06*(( CPPKSLHG )/ (CPPKGRAN + CPPKSUPP )) 
+ 21.22*(( CPPKSLHG(-1 )) / (CPPKGRAN(-1) 
+ CPPKS PP(-1) ) - 43.23*TREND 
+ 534.44*D778 - 779.04*D 67 
3 
The number of breeding hogs added to the herd i a relationship defined by 
cost of pork production. both grain and protein supplements cash expenses and the 
slaughte r hog receipts. These costs of production are ordinary lea t quares estimates 
given as l inear linkages to price changes . 
Wage ra tes and inflation are both determined exogenous to our model. 
5.3.2 Farm le ve l d e mand 
The farm level demand on t he other hand is defined by: 
1. Sow slaughter demand 
2. Barrow and gilt Slaughter demand 
The ow slaughter demand is a deri ved demand determined by : 
l. Sow price: this equat ion is expressed in units of number of animals and is given 
by log of sow slaughter adj usted or deflated by the producer price index for all 
items in -nited States. 
7-market sow price / P PI, All items, U.S 
LOG( PKSOWPM / PPIW) = 3.677 
2. Retail pork price 
- 0.305*LOG(PKSOWKS ..L PKBORKS) 
+ l.269*LO G( PKRETP / PPIW ) 
- 1.30 *LOG(ZWRHP20W / PPIW ) 
- 0.233*SHIFT 
..1... 0.217*D723 
3. \\'age rate : these a re determined exogenous to the model 
4. ln Ration : i t is determined exo~enous lo the model 
T he bar row and gilt slaug hter de mand is a de ri ved demand too . Thjs is deter-
mined by 
1. Bar row and Gilt price: thi s is giYen by log of I-market barrow and gilt pri ce 
adj usted o r deflated for producer price index for ail item in r nited tates. 
I-market Barrow and gilt pri ce I PP L,. II items. U . ' 
LOG(PKB. GP :\I 1PPI\V ) - .427 
- 0.453*LOG(PKBAGKSD - PKBAGKSI ) 
+ 1.396* LOG( PI<RETP / PPIW ) 
- 0.664*LOG(ZWRHP20W / PPIW ) 
- 0.130* RIFT 
- 0.13 *D667 
2. Wage rates: t hese are determined exogenous to the model 
3. Inflation : it is determined exogenous to the model 
5.4 Retail level equations 
In t he following section we look at the retail level components of both demand 
and supply. 
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5.4.1 R etail level s upply 
T he retail level supply is determined by the following se t of equations: 
1. Sow and boar slaughter 
2. Barrow and Gilt slaughtered 
3. Trend 
At th e retail level. the number of animals slaughtered is converted into pounds 
of pork via the total pork production equation defined as: 
PKPROD = 594.207 
+ 0.330*( PKSOWKS + PKBORKS) 
+ 0.147*( PKBAGKSD ..L PKBAGKSI ) 
- O.OQQ.S*(TREND*(PKBAGKSD T PKBAGKSI)) 
In some models the conversion of the number of animals slaughtered into pounds 
of pork is made wi th an identity allowing the carcass yield to vary through time. 
However in this version of FAPRI pork model, pork is converted from live animals 
to pounds of pork via a behavior response equation. The pork production equation 
is estimated as a function of the number of barrows and gilt slaughtered, sows and 
boars slaughtered , and a time t rend. T his time trend is a variable reflecting the move-
ment towards leaner barrow and gilt carcasses with less waste and higher dressing 
pe rcentages. 
The sow slaughter equation identified as PKSOWKS and the barrow and gilt 
slaughtered equation identified as PKBAGKSD are mentioned elsewhere earlier in the 
' 0 
chapter. The number of imported boar and gilts la11ghtered. given by PKB GK I. 
is exogenous lo our model. Boar laughte r identified a~ PI\ BORK · i given a follow : 
Hogs. Boar slaughte r 
PKBORKS = - 993. i43 3 
- O.ll.5*PKHOG~BR( - l) 
+ 0.0 4*(PKSOWKS - PKGLTADD) 
+ 332.462*LOG(TREND ) 
- 219. 29•DL 1\166 
The other behavioral equation which defines the identity is given by sows slaugh-
tered. This equation is representati\·e of di inve- tment decisions taken by producers 
in response to market changes. An increasing number of sows slaughtered indicates 
di sim·estment decisions taken by producers which may be in re ponse lo hiO'her costs 
of swine raising etc. This equation is given by: 
Hogs, ow slaughter 
PKSOvVKS = -126 .3.5 
+ 0.304*PKHOGNBR(- l } 
- 113 . *((CPPKSLHG + CPPKCL W) / (CPPKGRAN 
- CPPKSUPP - C'PPKPA T - CPPKVET - CPPKHAuL 
- C'PPK IARK - CPPKBED - CPPKFLE 
T CPPKREP + C'PPKLABR + CPPKMANU)) 
- 720.659* HIFT75 
+ / .56.027* D M66 
- 93 . 293 * D Ul\173 
c I 
The num ber of market hogs on the farm i defined as an identity which equals 
market hogs on the farms in previous year le s market hog death loss les barrow 
and gi lt domestic and imported laughter plus the pig crop. This is given in the 
model by: 
PKHOC: FRM = ( 1-PKPCG D )*( PI<I-IOG FR).J (- 1)) 
- PKPIGC' RP - PKBAG KSD - PKBAGK I 
The beha,·ioral equations supporting thi identity include barrow a nd gilt do-
me tic sla ughter: 
PKBAGKSD = - 15754. L3 
- 0.502*PKPIGC'RP 
+ 0.943*P KHOGFRM(-1) 
- 6116.49* RIFT 3 
- 457 .. 51 ~DC\173 
- 3614. 79* Dl'M'i6 
T he coefficient on barrow and gilt slaughter uggests that 50 percent of the pig 
crop on farm is slaughtered to obtain total barrow and gilt slaughtered. Ninety four 
percent of the market hogs on farm a re t a ken in fo r sla ughter from previous year . A 
higher pig crop indicates a higher availa bility of pigs for slaughter and market sale. 
The pig crop equation an identity, and the imported hogs slaughtered, deter-
mined exogenously are beha,·ioral equations explai nincr the number of market hog 
o n the farm. 
• 
The pig crop , Pl{PfGCRP. i an identity equal to the number of ow farrowed 
times the number of pig per litter. The number of sows farrov.:ed is a behavioral 
equation defined as follows and i identified by PK O\VFAR. Pigs per litter is iden-
tified exogenous to the model. 
PKPIGCRP = PK O\VFAR*PKPIGLIT 
W here. 
PK O\\'FAR = 9 6.17 
- 0.9 Ll *PKHOG;.JBR(- 1) 
- 0.01.5 ~(TRE:.JD*PKHOGXBR( -1) ) 
- 0. 36*PKGLTADD 
- 0.3 3*P K O\VK 
- 9 7.67*DU M7 
- 941.72 *DUM75 
+ 946 .. 56* D701 
The sows farrowed is a functi on of the trend, and the gilts added to the breed-
ing herd which is a positive function reflect ing that an increase in it's number will 
lead to an increase in the sows farrowed. The sows farrowed is also ex pres ed as a 
neaati,·e function of the ow slaughter reflecting that lesser number of sows will be 
farrowed with a larger numbe r of them being farrowed. There is also a posii i ve linear 
relationship of sows farrowed with t.he number of breeding hogs on farm both for the 
present period and those on farm in the last period. 
T hus, sows farrowed is a funct ion of number of breeding hogs on the farm 
(PKH OGNBR), an identity and gilts added (PKGLATDD ) and sow slaughtered 
(PK O\VK ). two beha\·ioral equations and finally the trend. The equation rep-
9 
resenting gilts added and sow slaughtered are mentioned elsewhere earlier in the 
chapter . 
5.4.2 R etail level demand 
At th.is level the demand component is captured by two equations , the per capita 
consumption and ending stocks. Per capita consumpt.ion is influenced by exogenous 
factors as income, inflation relative prices of other meats, population above 7.5 years 
of age and finally. retail price of pork. Price determination is assumed to occur at 
the retail Level. The retail price is linked to the farm price. Civilian disappearance is 
determined from the market closing identity. This identity is given by 
PKCDIS = PKSUPP - PKEXPT - PKSTK 
Where. 
PKSUPP = Total pork supp ly 
PKSTK = Total ending stocks 
PKEXPT = Pork exports 
Log linear form of equations is used to express demand equations such as Pork 
consumer demand given by LOG(PKPCC\ iV ) and on the farm level demand by 
LOG(PKSO\tVPM/ PPIW ), the 7 market sow price and LOG(PKBAGPM/ PPIW ). 
The Last two equations are also adjusted or deflated by the producer price index for 
all items in United States. The pork consumer demand equation is given by the log 
of per capita pork consumption and is writ ten as 
LOG(PKP CCW ) = 0.335 
- 0. 61 *LOG(PKRETP / P CIUW ) 
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+ 0.360*LOG( BFRETP PC'Il \V ) 
-t 0.00 *LOG( C'KRETP I PC'IU\\i) 
+ 0.145*LOG((ZC'E F. BW / POPTOTW )/ PC' lUW ) 
- 0.907*(PO P75PW / POPTOTW ) 
- 0.047*D 4.5 
The retail price of beef and chicken are reflected as conditioning variables in pork 
demand equation. Per capita food expenditure, and consumer price index for food , 
proxy for all competing food products is also included. variation in the taste of the 
earlier generations is reflected by the US population for people aged above seventy 
five years. This is expected to be a negative relation mainly because people of earlier 
generations represented by people above the age of seventy five years tend to demand 
lesser of pork. 
In the short run, the a...x.ioms of consumer behavior do not hold mainly due to 
the reason that there is a lag in the consumers reaction to price and income changes. 
In the long run however , these axioms hold. The model, as given in the appendix, 
expresses these equations with the anticipated signs. 
Ylarket ing cost index includes both meat packers wage rate and a measure of 
fuel and utilities cost. The fue l and utility index reflects changes in general overhead 
costs. [n certain cases, the equations have been deflated by producer price index. 
Packers bid up farm prices in response to higher by-product. prices . 
The ending stocks is also a retail demand component. It is a function of retail 
price of pork today less lag pork retail price, adjusted for producer price index. and 
total pork production. The equation is given as follows: 
PK 'TK = 
91 
- l6i.12.5 
- L4i6 .6l"'(PKRETP - PKRETP(-1 )) PPI\\" 
+ 0.030 .. PKPROD 
+ .52.639*S HIFT7 
I :39.51i*Dl-:\Ii3 
l 2i .501 *Dl":\-17.5 
The retai l price of pork has a negative effect on ending stocks mainly because 
as pri ce increa es. packer are le s willing to hold excessi,·e stocks. Total commer-
cial production and beginning tocks. which is previous years ending stocks, have a 
positive influence on ending stocks because as total available ~ upply increases, given 
existing demand, ending supply will invariably increase. 
The retail demand is defined by equations for civilian disappearance (PKCDIS ). 
and per capita por k consumption ( PKPCC'W PPKC'C'R ). 
Market clearing equation equates pork supply and demand. From this iden-
tity total pork civilian disappearance is obtained. Exogenous supply and demand 
components include on farm pork production exports and imports . 
!)2 
Table .5 .2: Definitio n of mnemonics used in FAPRI pork model 
Abbreviation 
PKBAGPM 
CPPKC LSW 
CPPKSLHG 
PKSOWPM 
PKPIGLIT 
CPPKGRAI 
CRPFR~I 
C PPKSl:-PP 
S:\IP440 
CPPK\'ET 
CPP KHA UL 
PPIW 
PPICFULW 
CPPKMARK 
CPPKBED 
CPPKFLE 
CPPKREP 
PPICMETW 
CPPKLABR 
ZWRHP20W 
CPPKMANU 
PPICH:\IW 
CPPKGFO 
CPPKTAX 
CPPKINT 
CPPKCAP R 
PKHOGNBR 
PKPROD 
PKSOWKS 
PKBORKS 
Definition 
Hogs , Barrow and Gilt , Seven market price 
Pork , Cost of production, Cull sow receipts 
Pork . Cost of production. slaughter hog receipts 
Hogs , Sow seven market price 
Hogs, Pigs per litter 
Pork , Cost of production, Cash expense for grain 
Corn season average farm price 
Pork , Cost of production , Cash expense for protein supplements 
Soybean t-.leal price, Decatur 44 3 protein 
Cost of production, Cash expense for ,·eterinary and Medicine 
Pork, Cost of production , Cash expense for Livestock hauling 
Producer price index, All items , US 
Producer price index, Industrial commodity, Fuel and related 
Pork , Cost of production, cash expense for marketing 
Pork, Cost of production, Cash expense for bedding 
Pork, Cost of Prod uction , Cash expense for fuel , lube and Electricity 
Pork , Cost of produiction , Cash expense for repairs 
Producer price index, lndustry commodity, metals and products 
Pork. cos t of production, Cash expense for hired labor 
Average hour earnings , Food and kind products 
Pork , Cost o f production , cash expense for manure credit 
Producer price index , chemicals and allied products 
Cost of production , Cash expense for general farm overhead 
Pork , Cost of production , Cash expense for insurance and taxes 
Pork , Cost of production , Cash expense for interest 
Pork , Cost of production, Cash expense for capital replacement 
Number of breeding hogs added to the herd 
Pork , Total production 
Hogs , Sow slaughter 
Hogs , Boar slaughter 
• 
93 
Table .5 .2 (Continued ) 
Abbreviation Definition 
PKBAGSKD Hogs, Barrow and gilt domestic slaughter 
PKBAGKSI Hogs , barrow and gilt imported slaughter 
PKGLTADD Hogs , Gilts added to breeding herd 
PKPIGCRP Hogs , Pigs crop 
PKRETP Pork retail price 
BFRETP Beef retail price 
CKRETP Chicken retail price 
P CIUW Consumer retail price 
POPTOW Total population , Including armed forces overseas 
POP75W Population - U.S. - Age 75+ 
ZCENFABW Personal consumption exp., Food and beverage 
PKSTK P ork ending stocks U.S. 
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CHAPTER 6. DIS CUSSION 
In the previous chapters the purpose of thi s thesis has been outlined , the alter-
natives to sulfamethazine in pork production li sted , and the techniques for analysis 
have been di scussed. In the following chapter the analysis and the final results will 
be presented along with observations and comments. Assumptions inherent to the 
analysis wilJ be outlined and conclusions presented. An attempt to evaluate which of 
the suggested st rategies appears to be most effective in achieving a stable long term 
supply of a safer residue free pork product is also presented. 
Io an earlier chapter. the persistent pressure on the FDA to further restrict the 
use of sulfamethazine in pork production for reasons as residue violations and transfer 
of antibiotic resistance through meat was discussed. Comments and particular refer-
ence was made to sulfamethazine residue violations in pork. There has been pressure 
on the swine industry to lessen the use of sulfamethazine due to perceived economic 
costs which result from sanctions imposed upon the producers by the FDA in re-
sponse to detection of sulfa residues in pork which are in violation of FDA standards. 
Earlier in the thesis possible alternatives to sulfamethazine use in pork production 
were discussed , these may be broadly categorized as follows: 
1. Ban sulfamet.hazine and continue pork production in the absence of any alter-
natives 
!).5 
2. r se of tetracycline - ch lortet racydine and oxytet racycl ine. as a u b tit ute for 
su lfa.met hazine 
3. [ se of tylosin as a subs titute fo r sulfamethazine 
4. l se of lincomycin as a substitute for sulfamethazine 
.5 . [ e of sulfathiazole as a substit ut e for ulfamethazine 
r e of a ny of these alternatives will ent ail cos t increases fo r the farmer primarily 
because of the potent ial for elevated a nimal disease le\•els, and slower and less efficien t 
an imal g rowth. Implementing any of these a lternatives would also imply changes in 
\\:ine production management practices. Cos t increases will vary with the alterna-
tive s trategy of pork production. However the potential for reduced sulfamethazine 
residues can improve the quality and wholesomeness of the food supply thus impact-
ing consumer demand by increasing consumer confidence. Anothe r potential benefit, 
not di scussed in this study but common to all proposed strategies is t he po sibility 
of r educing costs associated with economic sanctions imposed again t producers for 
,·iolation of residue levels in swine carcasses. 
6.1 Supply shocks 
A ban on the use of sulfame thazine, assum ing no substitutes are available, will 
cause the swine producer to face reduction in feed efficiency. The feed efficiency for 
a ban is projected to decline by .6 percent [23 ]. Thus, there will be an associated 
increase in feed costs and protein supplements needed to rai se swine. Average a nd 
marginal costs will increase with a ban on sulfamethazi ne use. Mortality rates are 
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Figure 6.1: Effects of increased production costs on the indi-
vidual pork producer and the pork industry 
expected to increase by 5-6 percent. This shock will however, be softened when the 
alternatives are considered. 
The market for all agri cultural products is competitive and the demand for 
such products has been shown to be inelastic. This holds true for pork. A ban on 
su lfamethazine with no alternative substitutes wi ll cause the industry pork supply to 
decrease (S1 to S2 ), and producer production costs to increase as seen in Figure 6.1. 
The total cost for the producer increases due Lo reduced production efficiency. causing 
an upward shift in the marginal cost ( MC1 Lo M C'2) and average cost (AC1 to AC2) . 
In a competitive market, equil ibrium level of pork production for the producer can 
be found at the intersection of marginal cost and average cost equal to price. f n the 
example, equilibrium quantity declines from Q1 Lo Q2 . Prices increase from P1 lo 
P2. Shifts in the marginal cost curve of individual farmers will cause the industry 
supply curve to shi ft to the left (S1 to S2 ), since t he industry supply curve is simply 
a summation of producer marginal cost curves. The magnitude of the shift in the 
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supply curw will depend on the pen·asl\"enes of increased costs. ince the pork 
market i highly inelastic, a one percent decline in quantity will cause the price to 
increase by greater than one percent. An increase in co t can drive producers out of 
the market. causing the industry supply to decrea e ( 2 ) . Also, increased prices will 
serve to hold producers into the market. However. if we a sume the cos t increases 
to be permanent and pen-asiYe, new producers will not be attracted to the industry 
and the new industry supply (S2 ) would remain lo the left of the old upply curve 
( 1 ) and t he industry quantity will decline from Q1 to Q2 . In this study the cost 
increases resultin.,. Crom a movemen t away from sulfamethazine u e are pervasi,·e and 
permanent which causes a hift of the supply curve to the left. Thus. pork pnces 
increase and the quantity produced declines in response . 
For purpo e of t hi s study the FAPRI livestock model a long is used for the eco-
nom ic analysis . The study ass ume that feed efficiency will be used as a proxy to 
reflec t average daily gain changes associated with the alternative scenarios ernlu-
ated. This is so because the FAPRI model lacks average daily gain equations. Also 
we need to incorporate into the model the fact that not all the hogs produced in C. 
are treated with sulfamethazine. This is so because some hog producers choose not 
to use sulfamethazine for fear of economic embargoes in an event of residue violation. 
They are making decisions to reduce the probability of violative hog carcas es. How-
ever the number of hogs actually treated with sulfamethazine is not known. It is 
true that the average daily gain improvement resulting from antibiotic use is as urned 
to be reflected by the feed efficiency number. It is also a fact that only some un-
known percent of the hog produced in the l:. i raised with sulfamethazine use and 
thus there is the need to adju t the feed efficiency number obtained from Table 6.1 
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Table 6.1: Re ponse of pigs to antibiotics during the starter stage (Hays Report ) 
Anti biotic Feed Efficiency Average Daily Gain 
{in percent) (in percent) 
AUREO SP 250 {Sulfamethazine) 8.6 23.1 
CSP 250 (Sulfathiazole) .3 19.4 
TYLAN (Tylosin) 6.0 14. 
LINC'OMIX (Lincomyci n) 7.6 11.l 
TETRACYCLINE 6.3 10. 
to reflect this. The study assumes that in adj usting the feed efficiency equation for 
the percent of hogs actually rai sed with sulfamethazine, the average daily gain is 
underestimated. Thus for purpose of economic analysis the feed efficiency numbers 
are assumed to be those represented in Table 6.1. Also inherent in our assumption 
of a ban on sulfamethazine is the (act that the ban is imposed completely effective 
beginning the year a law is passed rest ricting the use of sulfamethazine in pork. In 
our analysis. this ban on sulfamethazi ne is assumed effective beginning year 1 (1993) 
in the results. 
In projecting the results fo r changes in pork prod uction and prices for an irnpo-
sition of a sulfamethazine ban, the Food and Agricultural Policy Research fnstitutes 
FAPRI li\·estock model was used . The first scenario assumes that t here are not any 
alte rnatives to sulfamethazine available for use in swine production. Equations ad-
justing for changes in cost, of grain and and protein supplement were shocked by a 
value of 8.6 percent, with a decline in the swine feed efficiency of .63 in response 
to the sulfamethazine ban [23]. In the absence of any equation accounting for the 
average daily gain factor. feed efficiency was assumed to reflect the lo s in average 
• 
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daily gain of 23.l percent. In addition , an increase in the mortality rate of 6 percent 
over the baseline was assumed in the absence of any other alternative to sulfamet -
hazine use. The pig death rate loss was hocked to reflect this increase in mortality. 
The results that were obtained are tabulated and presented in Tables 6.4 - 6.9 and 
Figures 6 .. ) - 6 .. The tables provide for comparative analysis between the baseline 
levels, which is the original (current state ) pre-ban model and is presented in chapter 
5. and the results obtained with sulfamethazine restrict.ion without the availability. 
The tables li st the changes in prices, production and consumption levels. Table 6.4 
provides for the changes in pork production levels, Table 6.5 lists changes in retail 
prices. changes in farm prices and sow prices are listed in Table 6.6 and Table 6. 
respectively and finally changes in consumption are given in Table 6.9. 
The analysis is further extended by assuming the use of alternative compounds in 
swine p roduction in response to a ban on sulfamet hazine use. Since suJfamethazine as 
a feed additive in pork production is primarily used at pre-starter and starter levels, 
the alternatives presented here replace sulfamethazine sub-therapeutic use at pre-
starter and starter stage only. Iortality rates are assumed constant over the original 
sulfarnethazine pre-ban levels (baseline) since mortality rates are expected not be 
significantly higher or different between different alternative compounds. Using the 
FAPRI pork model changes in prices, production and consumption levels were again 
projected for each scenario and compared with the baseline prices and production 
and consumption levels. The baseline levels are the original pre-ban levels or the 
current state as it exists now. With no changes in mortality rates, only the grain cost 
equation and protein supplement cost equation were shocked for the relative decline in 
feed efficiency for a ban on sulfamethazine and use of the respective alternative com-
lOO 
Table 6.2: C hanges in feed efficiency a.nd morta.lity associated with the use of dif-
ferent alternati\·e compounds 
Compound 
AUREO SP 250 (SuHarnethazine) 
'0 E (Ban ) 
CSP 250 (Sulfathiazole) 
TYLAN (Tylosin) 
LIN COMIX (Lincomycin) 
TETRAC'YCLI:\fE 
Feed Effic iency 
(percent change ) 
0.0 
.6 
0.3 
2.6 
1.0 
I 2.3 
Change in Mortality 
(percent change ) 
0.0 
6.0 
0.0 
0.0 
I 
0.0 
0.0 
pound. For example. in substituting tetracyclines to replace sulfamet hazine , changes 
in feed efficiency associated with using tetracycline over sulfamethazine can be read 
[rom Table 6.2 & Table 6.1. The feed efficiency was assumed to increase by .63 over 
control group wit h sulfamethazine while for tetracycline it was estimated to be 6.33 
improvement over t he control group. T he cost equations in the FAPRI model were 
thus, shocked for 2.33 (i.e. .6 - 6.3) decline in feed efficiency fo r a subst it ution of 
sulfamethazine by either of the tetracycline. chlortetracycline and oxytetracycl ine. in 
pork production. Similar calculations were done for other alternatives and different 
estimates obtained which were then used to shock the cost equations to obtain differ-
ent scenarios. The decline in feed efficiency with tylosin substitution was calculated 
to be 2.63 , for li ncomycin it was 1.03 and fi na lly, for sulfathiazole it was estimated 
to be 0.33 . 
In general , the alternatives reduce the impact of a ban on sulfamethazine use 
in swine production . This can be seen from changes in production, consumption 
and price levels indicated in the respective tables. The changes in prices, production 
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and consumption are cushioned with the use of alternat ives over t he levels obtained 
for a sulfamethazine ban with no alternat ives. Changes in supply at the producer 
and industry level in response to a ban on sulfamethazine and use of alternatives 
is given in Figure 6.2. The level of supply shift to the right over the ban level 
without alternatives, depends on production cost adjustments of the alternatives. 
Thus, for each alternative considered there will be different results. General results 
are discussed. 
<>-•.,,. 
Figure 6.2: Effects of increased production costs on the indi-
vidual pork producer and pork industry with use 
of alternative compounds to sulfamethazine 
Results from the first scenario are shown in Tables 6.4 - 6.9. A ban on sul-
famethazine assuming no alternative substitutes exist , projected a decrease in pork 
production (Table 6.4) of 2.32% by t he end of the fourth year over t he baseline lev-
els. This est imate declined to 1.62% by the end of ninth year and then was at 2.01 % 
by Lhe end of tenth year. Retail prices, farm prices for barrows and gilts, and sow 
prices all showed a significant increase over the pre-ban or the baseline levels. The 
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retail price (Table 6 .. 3) for example increased by 2.353 over the baseline level by 
the end of the tenth year. Increase in farm prices (Table 6.6) for barrows and gilts 
was projected to be significant ly higher at 4.263 over the baseline farm prices for 
barrows and gilts fo r the tenth year o( our stud y. Sow prices (Table 6. ) were up 
3.39% over the baseline level. For most of the analysis. it can be generalized, there 
is a trend such that percentage change over the baseline is very small in the initial 
years of the supply shock as the industry adjusts. This percentage change over the 
baseline increases, in absolute value. with time as producers adjust to the alternative 
trategies. This adjustment is followed by a decline in the percentage change over 
baseline values before indicating an increase again by the end of the eighth year. 
There is a projected decrease of 2.0 l % (Table 6.9) in consumption of pork over the 
pre-ban levels by the end of tenth year. Our results indicate changes in consumption 
t.o be very closely followed by changes in production. However , this is not surprising 
si nce the product produced (pork ) can not be stored over long periods of time and 
production is consumed at some price. 
se of tetracycline as a substitute for sulfamethazine cushjoned the decrease in 
production and consumption le,·els and the increase in price leYe]s of pork over the 
scenario of a ban on sulfamethazine without alternative substitu tes. The production 
levels are projected to decline to a low of -0.i 3 (Table 6.4) over the baseline by 
end of third year as compared with -1.993 for the scenario where there is a complete 
ban on use of all compounds. This value declined further to -1.023 over the baseline 
by end of tent h year for the scenario run with tetracycline replacement and was 
lower t han the -2.013 decline observed for the scenario with a complete ban on 
all compounds. In comparing tetracycline projected levels with sulfamethazine ban 
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levels tetracycline levels indicate higher production for all years except the year of 
the shock. By the end of tenth year tetracycline production and consumption levels 
are projected to be sti ll higher and price increase lower than ban levels . The retail 
price was projected to be 0.943 over the baseline by the end of the tenth year a 
small increase when compared with the 2.3.53 increase over baseline projected for a 
scenario where use o{ all chemical compounds in pork production is assumed banned. 
The farm prices for barrows and gilts increased 2.073 (Table 6.6) over the baseline 
at the end of tenth year while sow prices were projected to be 1.703 (Table 6.8) over 
the baseline levels for the same year. 
In using tylosin , an estimated loss of 2.63 (Table 6.2) in feed efficiency was 
assumed over pre-ban levels. Wi th tylosin as an alternative to sulfamethazine in pork 
production, production is projected to decline 1.153 (Table 6.4) over the baseline 
level by end of the tenth year. Percentage decline in pork production (Table 6.4) is 
projected to remain lower with use of tylosin as an alternative than with a ban on 
sulfamethazine with no alternatives. Retail price (Table 6.5) by the end of tenth year 
is projected to be 1.413 higher over the baseline year. Sow prices were projected to 
be higher by 1.903 (Table 6.8) over the baseline at t he end of the tenth year. Pork 
consumption with a decline of -1.153 (Table 6.9) over the baseline by the end of the 
tenth year still remained higher than the -2.01 3 decline projected over baseline for 
the first scenario where no alternatives to sulfamethazine are assumed. Farm prices 
for barrows and gilts (Table 6.6) showed an increase of 3.01 3 over the baseline by 
the end of the fifth year before declining to 2.333 over the baseline by the end of 
tenth year. Comparison between changes over baseline with the use of tylosin and 
with a ban on use of sulfamethazine without alternatives is presented in the tables. 
L04 
Lincomycin was projected to how a decline in production le\·els O\'er baseline 
levels but not by a ve ry ignificant amount. The f<'ecl efficiency decline over sulfamel-
hazi ne or pre-ban le\·els in this case was l.03 . The decline in production (Table 6A) 
is projected at only 0.45% by the end of tenth yea r over the baseline level. Changes 
in retail price (Table 6.5) indicated a higher but insip;nificant increa e in all years of 
analy~is ranging anywhere between -0.51% to l.O:J C:(,. By the end of the eighth year, 
percentage increase in retail price for lincomycin replacement wa estimated to be 
oc( before increasing to 0.4 7~ by the end of the tenth year. 
ulfathiazole howed to be the best alternatiYe to sulfamethazine as the re ults 
for baseline level and those obtained with sulfathiazole replacement were quite similar . 
The feed efficiency in swine is estimated to decline 0.33 over wine production with 
sulfarnethazine. Production changes with sulfathiazole are projected to be negligible 
over the baseline levels for our analysi (Table 6A. ). Prices cLid not show a ignificant 
change over the baseline levels. Pe rcentage increase in retail prices (Table 6.5) is 
projected to vary between high of 0 .. 51 3 and a low of 0%. For much of the study years, 
including the tenth year the percentage increa e in retail prices was obserYed to be 0% 
over the baseline leYels. In other words retail prices with the use of sulfamethazine 
were the same for almost all years as with the u e of sulfathiazole. Farm prices for 
barrows and gilts (Table 6.6) indicated a mall increase of 0.273 over the baseline 
levels at the end of the tenth year and remained within the range of 0.3 .53 to 03 above 
the baseline in the study. Sow price (Table 6. ) also indicated a small increase of 
0.23 % over the baseline by the end of the tenth year . Percent change in consumption 
(Table 6.9) levels for all years kept pace with percent change in production. By the 
tenth year consumption declined by -0.13o/c over the ba eline le,·els. 
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Table 6.3: C' hanues over baseline levels following restriction (ban) on sulfamethazine 
use in pork production by the end of tenth year 
Compound Production Retail Farm Sow Cons umption 
pnce pnce price 
Sulfamethazine 17495 2.13 50.19 34.76 174.50 
Sulfathiazole 17471 2.13 50.33 34. 4 17427 
Lincomycin 17417 2.14 50.64 35.01 17373 
Tetracycline 17316 2.15 51.23 35.42 17273 
Tylosin 17293 2.16 51.36 35. 3 17250 
With Restrictions 17143 2.1 .52.33 35 .94 17100 
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In generali zing, significant increases in sow and farm prices, decrease in con ump-
tion and production le,·el a re ob erved over the baseline le,·els ( nlfamethazi ne u e ) 
wit h further re~trictions (ban) on sulfamethazine u:.e in pork production. Thee re-
su lt s are also true when replacing sulfamelhazine in pork production with curre ntly 
available alternatives. This incorporates retail por k price. farm price for barrow 
and gilts, sow prices , and production and consumption levels. The change in the e 
vari ables are p rojected to be the least with use of sulfathiazole as an alternative. The 
chan1Yes in expected net return is used to reflect producer investment and disinve l-
ment decisions and is rep resented by changes in production levels. In our analysis 
we repo rt the actual net returns for each year. However. it is assumed that current 
year return work as expected returns for the following year. For a ban in sulfamet-
hazine with no a lternatives considered. t he price increase was much hig her than any 
of the projections obtained for a ban on ulfamethazine with a substitute replace-
ment. For all alternatives, production and consumption levels are projected to be 
higher and clo er to the base line than those obtained for a ban in sulfamelhazine 
without alternati,·es. In mo t part. use of sulfathiazole led to the least deviation 
from baseline levels, indicating minimum producer industry. and consumer shock . 
The results projected with t he use of ty losin as an alternative for sulfarnethazine 
provided the worst scenario amongst all other scenarios with alternati,·es. A quick 
look at Table 6.1 will help in terpret and understand t hese observation . 
Table 6.4: Changes m pork production following restrictions 
and use of different alternatives (million pounds) 
ur • e' racyc rne 
ch ange 
0 17234 17234 0 .00 17234 
I 17095 171 01 0 .0 49' 17098 
2 15538 16H7 •.559' 16489 
3 17131 111790 -1.999' 16997 
4 17649 17239 -2.329' 17460 
5 1H25 17158 ·2.0 49' 17329 
ti 17111 1584S · 1.54" 15937 
1 1H09 17310 ·l.147' 17353 
8 1801 4 17797 -1.20% 17877 
9 17534 17349 -1.629' 17482 
10 1 7495 I 7143 .2.01 % 173111 
CO R: Change on Restriction 
WR : With Restrictions (ban) 
0.00 0 00. 17234 o .oo 0 .00 17234 
0.029' .o 029' 17099 0 .029' .0.029' 17097 
·0.309' 0 .269' 15483 ·0.33% 0 .229' 15517 
.o 189' 1.239' 15980 ·O SS'K 1.139' 17072 
· l 079' I 289' 17435 -1.209' 1.14" 17666 
·I 129' 0 939' 17303 -1.279' 0. 799' 17439 
-1.0291. 0 539' 11191& -1.159' 0. 409' 17035 
-0.839' 0 .309' 17346 -0.939' 0.209' 17445 
. o 7t19' 0 .459' 17860 ·0.869' 0.359' 17954 
·O 809' 0 779' 17'62 -0.989' 0 tl59' 17567 
· l 029' I 019' 17293 • 1.159' 0 .889' 1741 7 
(ban) on sulfamethazine 
0 00 0 00 17234 0 .00 0 00 • 
0 019' .o 029' 17096 0 0059' .o 039' 
·0. 13'K 0 439' 16532 .o 049' 0 .51% 
.o 3 49' l.68'K 17114 .o 09'K I 939' 
. o 4 79' I 909' 1762 4 .o 149' 2 .239' 
. o 509' I 589' 17499 .o 159' l 93% 
-0 .44 " l 109' 17088 .o 139' I 439' 
.o 379' 0. 789' 17490 .o 119' I 04% 
.o 339' 0 879' 17995 .o 109' 1.119' 
....... 
0 
. o .389' l 259' 17614 ·0. 119' I 919' -...:J 
.o 459' 1 609' 17471 -0. 149' I 919' 
Pork Production x 103 
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Figure 6.3: Changes in pork production following restrictions (ban) on s ulfamet-
hazine and use of d ifferent alternatives (million Pounds ) 
Table 6.5: Changes m retail price following restrictions (ban) 
use of different alternatives( dollars per pound) 
cu 
0 1.98 0 00 1. 8 
l 1.97 -0.51% 1.97 
2 2 .01 0 .50% 2 .0 1 
3 l 96 2 .00 2 .0 49' 1.99 
4 I .SQ 1.95 3 . 179' 1.92 
5 I 95 2 .01 3 .089' 1.98 
8 2 02 2 .06 1.989' 2.05 
1 l 9, 2 .01 1.01 % 2.01 
8 I 94 l 98 1.03% 1.95 
9 2.0 4 2 .07 1.47% 2 .05 
10 2 13 2 .18 2.35% 2 15 
COR: Change on Restriction 
WR : With Restrictions (ban) 
0 00 .00 • 1.98 0.00 o.oo 1.98 
-0.51% 0 .00% 1.97 -0 .51% 0.00% 1.97 
0 50% 0 00% 2.01 0.50% 07> 2 00 
I 53 Yo -0 .50% 1.99 1.539' ·0.509' 1 97 
1.599' -1.&119' 1 .92 1.599' · l .$89' 1.90 
1 .649' . J.519' 1.99 2 .059' .1.009' 1.97 
1.489' -0 489' 2.05 1.489' -0.489' 2 .03 
l 009' 0 .00% 2.01 1.009' 0 .009' 2 00 
0.519' .0.619' 1.95 0 .619' - 0.51 Y. 1.94 
0 .499' ·0.98% 2 .08 0 .989' -0.49% 2.04 
0 9 4% - 1.4 % 2 . 18 1.41 % -0.929" 2 . H 
on sulfamethazine and 
ch•ngc C O R 
0 .00 • 0 00. 1.98 o.oo . 0 00 • 
·0.51 % 0 007> 1.98 0 00% 0 5 1 % 
0 .00% -0.5% 2.00 0 OO'Yo ·0.57> 
0 .509' ·l.5'Yo 1.97 0.50Y. - 1 5 9' 
0.639' - 2 .89' 1.89 0 00,.. . 3 O'Yo 
1.039' -2.00% 1.98 0 519' -2 .49% 
0 509' -1. 489' 2.02 0.009' ·I 949' 
0 509' ·0.59' 1.99 0 00% -1 00% I-" 
0 .009' -1.029' 1.94 0 009' • l 02% 0 
0 009' • 1.459" 2 .0 4 0 .009" · 1.45% tD 
0 479" - 1.83% 2 . 13 0 .00 % - 2 30% 
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Figure 6.4: Changes in retail pr ice following res trictions (ba n) on sulfamethazine 
and use of different a l tern a ti ves (dollars per pound) 
Table 6.6: Changes in farm prices for barrows and gilts following reslrictions (ban) on 
sulfamethazine and use of different alternatives( dollars per hundredweight) 
Y~&r tf&tehnc vvn .,, 1:c,u.cychne 
change 
0 u 03 4J 03 0 00Yo 43 .03 
I 46 07 46 07 o.ooYo 40 07 
2 48 53 49 15 1.28% 48.86 
3 H 83 48.02 4 . 799' 4G ea 
4 42 11 44.54 5 .77% 43 19 
5 H 79 48 .0 7 4 .98% 47 01 
e 4V 83 51.60 3 .559' 51.00 
7 47 oo OU 2 .32% 47.92 
8 .. 05 45 01 2 .189' H . 71 
9 40 82 48.27 3. 109' 47.GO 
10 $0 19 $2 33 4 .269' 51 23 
COR: Change on Restriction 
WR : Wi th Restrictions (ban) 
.,. .,. 
ch•n•e COR 
O.OOYo 0 00Yt 
0 009' 0 009' 
0 68'l'o .0.59% 
I 85% -2 79" 
2 .$0" -3 .03" 
2.GG" -2 21" 
2 .36% -1 16" 
1.83% ·O 489' 
1.509' .Q.079' 
1.G7'r. -1.399' 
2 .07" - 2 JO" 
Tylo.,D .,. .,. Llacomyc1n .,, .,. Sulf&1h1nole 
ch .. nge COR ch anac COR 
43 03 0 .00'fo 0 .00'Yo 43 03 0 00.,, 0 OOYt 43 .03 
40 OG -0.029' -0.029' 40 07 0 009' 0 00'11. 46.07 
48 90 0.76% -0.519' 48 .67 0 29" -0 98'11. 48.57 
40.79 2.09% -2 509' 411.20 0 819' -3. 799' 45 9 4 
43 33 2 .909' .2.12" 42 58 1 12" -· 40 " 42.25 
H 17 3 .019' -1.87% 40 .32 I IG" -3 6 49' 45 .95 
61.16 2 .65" ·0.87% 60.3 4 I 029' ·2 44 9' 49.99 
48.03 2 .009' -0.259' H .43 0 . 799' -1 50" 47 17 
u .ao I. 709' -0 .4 79' H .3 4 O.GG9' . 1.4 9 " H . 14 
47 70 1.889' • 1.189' 47. IG 0 73" · 2 309' 40 92 
51 JG 2 33" -1.859'. 50 .64 0 909' -3 23 9' 50 33 
.,. 
ch a nae 
0 .00Yo 
0 OO'l'o 
0 08% 
0 24% 
0 .33" 
0 .35% 
0 .32" 
0 .239' 
0 .209' 
0 .219' 
0 279' 
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F igure 6.5: Changes in farm prices for barrows and gilts following rest rict ions (ban) 
on sulfamet hazine and use of differen t alternatives (dollars per hundred-
weight ) 
Table 6.7: Changes In net returns, farrow - finish, following restrictions (ban) on su l-
famethazine and use of different alternatives (dollars per hundredweight) 
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Figu re 6.6: Changes in net returns following restrictions (ban ) on sulfamethazine 
and use of different alternatives (dollars per hundredweight) 
Table 6.8: Changes in sow prices following restrictions (ban) on sulfamethazine and 
of different al tern ati ves (dollars per hundred weight) 
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Figure 6. 7: Changes in sow prices following restrictions (ban) on sulfamethazine and 
use of different alternatives (dollars per hundred weight ) 
Table 6.9: Changes in pork consumption following restrictions (ban) on sulfamethazine 
and use of different alternatives (million pounds) 
Yea.r tluellne WK .,. TcU&cycllnc 
ch~n1:e 
0 17H5 IH75 0 .00'1\ 17475 
I 17413 17418 0 .039' 11416 
2 16859 10773 -0.519' 16813 
3 173 81 17050 . ] 909' 17250 
4 17~85 1703 -2.319' 17578 
5 17905 IHU -2.01" 17701 
6 17510 17243 - 1.529' 17335 
7 17722 I 752 1 ·1. 139' 17&7& 
8 17978 I 776 4 • t.199' 17842 
9 17820 17338 • 1.809' 17 488 
JO 17450 17100 -2.019' 17273 
COR: Change on Restriction 
WR : With Restrictions (ban) 
'I'• ,.. 
change COR 
0.007> 0 00'1\ 
0.02% -0 019' 
-0 279' 0 249' 
-0. 759' I 179' 
. 1 08,. 1 .289' 
-1.109' 0 .939' 
. 1.009' 0 .539' 
-0.839' 0 .319' 
-0. 759' 0.449' 
-0.889' o a" 
- 1 01% I 019' 
Tyloatn ,.. ,.. L,,1ncomyc1n ,.. ,.. ~Ull~lhlUOle 
change COR chan1e• CO R 
17H5 O.OOYo O.OOY't 17475 0 007> 0 OO"h 17475 
17410 0 029' -0 01 9' 17415 0 019' -0 029' IH14 
10807 -0 319' 0 209' 16839 ·O 129' 0 399' 16853 
17250 ·0 .859' 1.079' 17233 .o 339' I 619' 17324 
17552 ·I ID9' 1.119' 17782 .o 489' I 899' 17840 
17683 .t.:U9' 0. 799' 17819 .o.u9' l.589' 17879 
17312 - 1.139' 0.409' 17433 -0 .44 9' l 109' 1707 
17558 -0.949' 0.209' 17857 .o.37'1't 0 . 789' 17702 
17824 - 0.859' 0 .3 49' 17918 ·0.339' 0 879' 17960 
17449 -0.97" 0 84" 17553 -0.38% J.24" 17000 
17250 ·I 159' 0 889' 17373 -0 44 " I 80% IH27 
,.. .,. 
ch &nge COR 
0 .00~ O.OO'l'o 
0 019' -0.029' 
-0 0 4'11. 0 0% 
-0 109' I 849' 
-0 149' 2 22% 
·0.159' I 909'. 
-0. 139' I 42% 
-0 . 11% 1.03% 
.o 109' 1.109' 
.o 119' 1.51 'l't 
- 0 139' l 919' 
Pork Consumption x 103 
118 
Baseline 
18.oo ---4f--------4-----+----+-----r-----r- w1ili.R'.esmcuon·······  
retiicyciiiie ______ _ _ 
11.90 -1-----1----1---'?""\- -+-----tnt"r---r- Tylan- --------
[illcomTx - - - - -
17.80 -1- ---1---~l--:7-~,_-+----f'-t--:'tT-'-lr---r- su1Tatillai01e - - · 
17 .50 --<l----~---U-J.L-J.~'---~.......Y.-'-.....----t----t\-y-1 -, -trr--
\ " 
\ '\ \ 
\ \ \ \ 
17.40 -1---.\-----1------1.!..¥~+---..,_, -tr+--'t, -+. ---t---+-: . ..... ,-.,,--t-
\ I' ti ,: 
' I I • ' \ 
\ I I / \ \', 
\ ! \ ") 17.30 ---+-__Jl---+-~L,-J-~f----+, H, - --t---T--+rt--
•. ~· . .. . . . 
17.20 ---+---4--+-~l-~.-f-----t----t-----':,-t--
: . . . . . . . 
16.80 --+-----lrf+-· -~----+-----t---+---
0.00 2.00 4.00 6.00 8.00 10.00 
Years 
Figure 6.8: Changes in pork consumpt ion following restrictions (ban) on sulfarnet-
hazine and use of different alternatives (million Pounds) 
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6.2 C h a n ge in demand 
In the earli er ec tion of the chapter it i a sumed that there are no change in 
demand in res ponse to a ban on sulfamethazine use. The purpose of this sect ion is 
t.o incorporate demand changes in response to a ban on sulfamet hazine under two 
ci rcumstances. Firstly, where no alte rnati ves a re avai lable to replace sulfamethazine 
use in pork production in response to fur ther restrictions on its use and secondly, 
where the re are alternatives to replace sulfamethazine use. 
It is hypothesized that there wi ll be perceived changes rn views of consumers 
about t he safety and wholesomeness of pork and pork products in response to a 
ban on sulfamethazine use in pork product ion. T his will cause the consumers to 
demand more of pork at the same price. ccording to Berger, if t he consuming public 
perceives the strategy of banning sulfamethazine to resul t in a more wholesome, safer 
food supply, then t he consumer demand will increase causing the demand curve to 
shift in a rightward direction . from DL to D2 (Figure 6.9). The resultant sruft in t he 
demand curve would push the price from the P1 level to a higher level, P 2 with a 
simultaneous increase in industry qua.ntity from Q1 to Q2 • 
Berger's st udy analyzed two demand shift scenarios. Firstly. it was assu med 
that consumers would be willing to pay l % more for safer compound and residue free 
pork product and secondly, that the con umer's will be willing to pay 5% more for 
residue and compound free meat. The combined effect of shifts in demand coupled 
with changes in supply are difficul t to interpret and a little complicated to forecast. 
However the FAPRI model allows for these interactions between supply and demand 
shifts and allow for adjustments over time. Tables 6.14 - 6.25 are estimates of these 
changes incorporated into the FA P RI pork model. 
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Figure 6.9: Change in demand due lo consumer percept ion of an improved safety 
in pork following a ban on sulfamethazine 
Further, use of alterna ti ves over sulfamethazine in swine product ion will lead to 
changes in production, consumption and price levels over the baseline levels. Even 
though these alternatives are presently considered safe in their use for human health 
and although their usage is presumed free of residue violations , due to consumer 
perception of meat containing chemical compounds, changes in demand with the use 
of any alternati ve will be smaller than t he situat ion where t here is a complete ban 
on use of any chemical compound in swine production. For p urpose of comparison it 
is assumed that shifts in de mand are same for all the a lternatives evaluated: 
l. Sulfathiazole (CSP 250) 
2. Lincomycin (lincomix) 
3. Tylos in (tylan) 
4. Tetracycline: chlortetracycline (aureomycin) and oxy tetracycline (terramycin ) 
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In the ab e nce of a true mea!)ure two demand !)hift s are e\'aiuated . For the ban. 
demand s hift of 1 a nd .) percent a re ernluated. Corresponding shift s fo r the use of 
alternatives are 0.5 pe rcent and ·I percent re pectively. For example, t he comparable 
demand shift s when a ban repre e nt s a .5 percent shift is a 4 percent shift for the 
alternative cenarios . A l percent shift resulting from a ban is reflected by a 0.5 
percent shift for the alternative scenari os. These changes in demand are then coupled 
wi th t he re pective changes in ·upply established in the pre,·ious sec tion. 
Results obtained from thi s a nalysis are tabulated and presented in Tables 6.14 
- 6.25 . A comparati\•e analysis of pe rcentage change in levels over baseline and 
ban le vels is also included in the I ab les. T he results are also graphed and presented 
in Figures 6.10 - 6.21. C hange in production, consumption and prices over the 
baseline and as compared between different alternatives can be seen with the use of 
t he gra phical pre entations. 
For a 1 percent increase in demand. unde r a total ban of sulfamet hazine with no 
alternati\·e sub tit utes . total production remained significantly lower than the base-
line. This may be explained in part by higher rates of death incidence in the absence 
of alternat ive compounds to sulfamethazine use. Also production costs increase under 
such scena rio . causinu sup ply to shift to the left. An increase in demand of 1 percent • 
is simply not ufficient to offset I hese highe r expenses of the producers causing the 
supply to d ec rease or shift to t he left resulting in production leYels much below the 
baseline. T he increase in price levels both at the retail and farm level are significant. 
Production and consumption st ill fall below the baseline levels. 
It is interesting to observe that for a 0.5 percent change in demand ( willingne s 
to pay ) coupled with the use of alternatives to sulfamethazine and changes in sup ply. 
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Table 6.JO: As umptions for different cenano follow-
ing a ban on ulfamethazine while a llowing 
al tern al i ves. 
Compound Decrease in Change in Change in [ 
Feed Efficiency Demand ~lortality 
(% ) ( o/C ) (% ) 
Tet racycl ine 2.3 0.0 0.0 
Tetracycline 2.3 0.5 o.o 
Tet racycline 2.3 ·tO 0.0 
Tylosin 2.6 I o.o 0.0 
Tylosin 2.6 0.5 0.0 
Tylo in 2.6 4.0 0.0 
Li neomycin 1.0 0.0 0.0 
Lincomycin 1.0 I o.5 0.0 
Lincomycin 1.0 4..0 0.0 
ulfathiazole 0.3 0.0 0.0 
ul fa thi azole 0.3 0.5 0.0 
S ulfathi azole 0.3 4.0 0.0 
. one .6 0.0 6.0 
~one .6 1.0 6.0 
None .6 5.0 6.0 
the to tal production nearly equaled or even exceeded t he base levels by insignificant ly 
small values in case of both sulfathiazole and lincomycin. T he total production re-
mained slightly lower for the scenari o of tet racycline and ty losin use. There is a better 
com promise in los of feed e fficiency wit h tylo in and tetracycline as compared to a 
situation where there are no ubs titutes lo replace sulfamethazine. Cost increase 
assoc iated wi t h re placing sulfamethazine with available a lternat ives is less than costs 
associated with rest ri ctions on sulfamethazine with no substitute replacements. This 
when coupled with an in crease in consumer confidence leading to a 0 .. 5 percent in-
crea e in demand , due to consumer perceptions of compound a nd residue free meat 
l 23 
Table 6.11: C hanges over baseline levels fo llowing res trictions (ban) on sul -
famethazi ne use and an increa e in demand by 1 % and the use 
of alternatives with an increase in demand of o .. 5% in pork pro-
duction at the end of tenth year 
Compound Production Retail price E'arm price Sow pri ce Consumption 
Sulfamethazine 17495 2.13 S0.19 34.76 17450 
ulfathiazole 175.57 2.14 S0.2 34. .s 17511 
Lincomycin 17502 2.14 S0.59 3.5.03 17457 
Tet racycline 17401 2.16 .5 1.1 3.5 .36 17357 
Tylosin 1737 2.16 51.31 35.43 17334 
With R estri ction 17000 2.23 .s..i.1 .5 37.04 1695 
products is sufficient to rai se product ion leve]s to almost equal baseline production. 
T he sow , retail and pork prices are projected to till increase and remain higher in 
all years of our analysis . 
Price increases associated with using tylosin and tetracycline to replace sulfamet-
hazine are projected to be much higher than base line levels. For sulfathiazole and 
lincomyci n. t he projected results are slightly different in that the production le vels ( in 
percent ) are higher only by insignificant amounts over the baseline production le\·el. 
Prices in general show high variability fo r these two compounds, moving up and down 
the baseline price levels. This becomes clear with araphical representations of results 
projected for sow prices (Figure 6.14 }, farm p rices (Figure 6.12). and pork retail price 
(Figure 6.11 ). The expected decline in feed efficiency with the use of sulfathiazole 
as a substitute to sulfamethazine is only 0.3 percent (Table 6.2 ). The effect on cost 
following an almost negligible percent decline in feed efficiency is more than offset 
by a corresponding increase in willingness to pay of 0.5 percent. For higher prices 
in the initial years following subst itu t ion of ulfamethazine with sul fathiazole due 
L 2-l 
Table 6.12: Changes over baseline levels following restri ctions (ban) on su l-
famethazine use and an increase in demand by .5o/c and t he use of 
alternatives wi th ;w increase in demand of 43 in pork production 
at the end of tenth year 
Compound Production Retail price Farm price Sow price Consumption 
S ulfamethazine 2.13 50.19 34.76 17450 
Sulfathiazole 2.15 50.06 34.9 1 092 
lincomycin 2.16 50. 36 35.15 L 037 
'Tetracycline 2.17 50.92 3.5.47 17936 
'Tylosin 2.1 .51.0.5 35.54 17912 
With Rest riction I 2.24 .53.72 37.09 17614 
to higher costs, the producers over react and produce more than the actual demand. 
This drives the price down until the time where supply falls shor t of demand and t he 
price increases. A 0.5 percent increase in demand is sufficient to offset the increase 
in costs even where sulfamethazine is replaced by lincomycin. 
Finally an anticipated increase of 4 percent in pork demand with the a lternative 
substitutes to sulfamethazine leads us to production and consumpt ion levels wh ich are 
much higher than the baseline and al so production and consumption leYels obtained 
for all the earlier scenarios. An increase of 5 percent in demand for meat free of 
any compounds indicated higher prices for sow, barrow and gilts and retail leYel 
at all times mainly because the cost of operating without alternative compounds 
is much higher . However , in thi s scenario t he quantity produced and consumed is 
projected to be higher than baseline levels. In situations where there are alternat ives 
to sulfamethazine use, prices fall to levels even below the baseline main.ly to encourage 
sale of excess pork and avoid large accumulation on ending stocks. 
3 change 
in demand 
0 
1 & 0.5 
5 & 4.0 
Baseline Ban 
2 .3 j' 2.6 
2.37 2.94 
2.37 2.i3 
I r - ·I 
Tetracycline 
2.51 
2.54 
2.3.5 
Tylsoin Lincomycin ulfat hiazole 
2 .. ')!.) 2AT 2...12 
2 .. 56 2.45 2.34 
2.37 :2. 2.s 2.20 
Table 6.13: C hanges in aYerage net returns for changes in demand following restric-
tions on sulfame thazine use in pork production ( dollars per hundred-
weight) 
A brief glan ce at Table 6.11 and 6.12 which list s the chanaes in pork production, 
pork consumption. sow price , farm price and retail price, adjusting for changes in 
demand. at the end of the tenth year help in unders tanding the effect of the use of 
each alternative compound in response to a ban on sulfamethazine in pork production . 
The values expressed in the nel returns are I he actual net returns observed 
for each year of our study. However, these \·alue can also be assumed to operate a 
expected net returns on the basis of which the producers base their future investment 
decisions. There is a time lag between the observed returns and the realization of 
investment decisions based on expected net ret urns . A close analysis of net return 
tables indicates an average net ret urns of $2.37 per hundredweight for the baseline. 
For each scenario. the ave rage net returns remain the highest for a complete ban on 
all antibiotic compounds in pork production. The avearge net return values obtained 
for sulfathiazole are the closet to the base line followed by lincomycin, tetracycline 
and finally, tylosin. This can be seen from table 6.13. 
Table 6.14: 
YeAr Hue line Wuh Reunc uon1 
19' incre ase 
0 1723• 1723 • 
I 17095 17102 
2 16538 164 18 
3 17131 16711 
• 17&• 9 17131 
5 17525 17054 
6 1 7111 16737 
7 17509 17200 
g 18014 17679 
9 17634 17215 
10 17495 17000 
Changes in pork production following restrictions (ban) on sulfamethazine 
use and with an increase in consumer demand of l % compared with use of 
alternatives and an increase in consumer demand of 0.5% (million pounds) 
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16.40 -1----l----,i-----,1-----t-----t-
0.00 2.00 4.00 6.00 8.00 10.00 
years 
Figure 6.10: Changes in pork production fol lowing restrictions (ban) on sulfamet-
hazine use and with an increase in consumer demand of 1 % compared 
with use of alternatives and an increase in consumer demand of 0.5% 
(million pounds) 
Yea.r B a..tehnt 
0 1.98 
J J 98 
2 10 
3 I 96 
t I 89 
s J 9S 
8 2.02 
7 1.99 
8 J .94 
9 2 .0 4 
JO 2 13 
Table 6.15: Changes in pork retail price following restricLions (ban) on sulfamethazine 
use and with an increase in consumer demand of l % compared with use of 
alternatives and an increase in consumer demand of 0.5% (mi llion pounds) 
Wllb H..eUrlC'10 n• percenu.ge T t>lracyhne percenl &ge Tylo11n percenu.gc L1ncomyc1n percen\a.g:e Su llalh1azole 
1,-. increa.se cha.ni:e 0 . ~9'0 incre&.te cha.n.r.e 0 .5>9t increa•e cha.n.re 0 b9'. lncre•• e chan.:e O.b9' increue 
J 98 0 00.,. J 98 0 00'11> J 98 0 00'11> J 98 0 00'11> l.98 
2 00 J 00% I gg 0 SJ% J gg 0 SI 9' 1.99 0 SJ'T. J.99 
2 OS 2 so.,. 2 02 I OO'T. 2.02 J.009' 2 OJ 0 50% 2 OJ 
1 06 s 109' l 99 l 539' I 99 I S3% I 98 I 02% I 97 
2 00 l 00% I 91 I 059' I 92 I S99'i I 90 0 539' I 89 
2 .0S 5 J29' J 118 I 509' I 98 J St 'T. I 96 0 51'7i l 9S 
2 10 t 009' 2 04 0 99'7i 2 OS J 499' 2 03 0 SO'T. 2 02 
2 OS 3 019'0 2 01 J 009'0 2 .0J l 0 1% 2 00 0 509' I 99 
I 99 2 S8% J 96 I 009'0 l.96 I 039' J 9S 0 .52% J 9t 
2 J l 3 t 3% 2 06 0 989'0 2 06 0 989' 2 OS 0 t 9 % 2 Ot 
2 23 t 709' 2 J6 I t 0% 2 16 I 41 'T. 2 It 0 t790 2 It 
percentage 
ch.i.n.r.e 
0 00'1\ 
0 SJ% 
0 SO% 
0 SJ% 
0 00'7i 
0 00% 
0 009' 
0 00% 
0 00% 
0 00% 
0 t 790 
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pork rer.a.il price 
Baseline 
2.i6 -1----1------1-----f------!-----t- Wiih.R:esrrfcuons·········· 
reiraC:)iCiine---------
2.14 --ll-----+-----1----+------T----t-t-- Tylan--- --- - ---
[iflcornTx - - - - - -
2.i2 --l----1----4------+----+---tiff- su!Tathiai1e - - -
years 
0.00 2.00 4.00 6.00 8.00 10.00 
Figure 6.1 1: Changes in pork .retail price following restrictions (ban) on sulfamet-
hazine use and with increase in consumer demand of 1 % compared with 
use of alternatives and increase in consumer demand of 0.5% (dollars 
per pound) 
Year Bu.chne 
0 43 03 
1 46 07 
2 48 53 
3 45 83 
4 42 11 
5 45 79 
6 49 83 
7 47 06 
8 44 05 
9 46 82 
10 50 19 
Table 6.16: Changes in farm prices for barrows and gil ts fol lowing restri ctions (ban) 
on su lfametha.zine use and with an increase in consumer demand of 1 % 
compared with use of alternatives and an increase in consumer demand of 
0.5% (million pounds) 
With Re1tncuon1 pcrcenta&c T ouuylin• perc:en&&ge Tylo"n percentage Lincomycin pcrceot&ge Su1r..1h1uolo 
1% incrt!a.:sc chang• 0.~9' incre1.sc c h&Rlt< O 59' incr<u• ch•nr< 0 ~9' iocre.ue ch.nit• 0 !ii9' incrt1.Je 
43 03 O.OO'f. 43 .03 0 .00'1> 43 03 0 .00'1> 43.03 0 00% 43 03 
46.93 1.80% 46.50 0 .93% 46 50 0 93% 46 5l 0 .96% 46.SI 
S0.34 3 72% 49 15 l.28% 49 19 136% 48 96 0 89% 48.86 
49.49 7. 99% 46 63 I 75% 40 74 I 99% 46 14 0 68% 45.88 
46 .03 9 31% 42 93 I 95% 43 07 2 27% 42 32 0 50% 41 99 
49 65 8 4 3% 46 67 1.92% 46 83 2 27% 45 99 0 H % 45.62 
53 21 6 78% 50 72 I. 79% 50 98 2 10% !>O 06 0 469'< 49 ii 
49 55 5 30% 47 83 1.64" 47 9 4 I 80% 47 34 0 59% 47 08 
-16 32 !> 15% H . 7!> I !>9% 44 84 l 80% 44 37 0 73% 44 17 
-19 80 6 36% 47 64 I n% HH I 96% 4 7 20 0 81% 46 96 
Si I!> 1 ao% 51 18 I 97% !>I 3 1 1 23% 50 59 0 80% 50 28 
pcrcen••ge 
change 
0 .00'1\ 
0 969' 
0 68% 
0 11 % 
-0 28% 
.on% 
-0 24% 
0 049' 
0 27% 
0 30.,. 
0 18% 
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frum prices 
54.00 
53.00 
52.00 
51.00 
50.00 
49.00 
48.00 
47.00 
46.00 
45.00 
44.00 
43.00 
42.00 
Baseline 
~+--~~~l--~~~1--~~~1--~~-;~~~-..~ 
Wiih-R:esrrlc.uons········ 
. . 
retiacycifue _______ _ _ 
-- -- ---- --- ----1------t-----+---~.r.. ---+----:,--t- Tylan 
f\ · LmcomTx - - - - - -. . . . 
! \ : suifat.iilai.01e - - -~+--~~~l--~~~1--~~~. -+-~.~~--t~~~-+~ 
" 
0.00 2.00 
·. · .... 
4.00 
. 
. 
! . t . . 
years 
6.00 8.00 10.00 
Figure 6.12: Changes in farm prices for barrows a nd gilts following restrict ions (ban) 
on sul famethazine use and with an increase in consumer demand of 1 % 
compared with use of alternatives and an increase in consumer demand 
of 0.5% (dollars per hundredweight) 
Table 6.17: 
Year Basehne- With R e1u1cuon• 
19' in c rea..se 
0 I 28 I 28 
I 3 73 2 20 
2 4 48 3 80 
3 3 36 4 71 
4 .o 62 I 03 
5 2.33 3 87 
6 6 15 7 20 
7 2 42 2 5 4 
8 .J 21 -1 .33 
9 0 68 I 24 
10 1 iO • 18 
Changes in net returns followi ng rest ri ctions (ban) on sulfamethazine use 
and with an increase in consumer demand of 1 % compared with use of 
alternatives and an increase in consumer demand of 0.5% (million pounds) 
percent•ge Teu.acyhne percent4ge. Tylo .. n percen tage L1ncomyc1n pcrcentagl! Su1fa.t h 1azole 
ch a.ni.e O ~9' incre•n· ch&nJte 0 .5'11e lnc rc·• •e chan«e 0 S90 lnc rc&l t c.h•nJC.e o . ~9' incre.ue 
0 007' I 28 0 00'10 I 28 0 .007' I 28 0.00'10 I 28 
. 4) 007' 3 52 -8 U7' 3 44 .5 87' 3 89 4 2991. 4 09 
15. 109' 4 45 .1 799' 4 40 .o 679' 4 83 3 35" 4 73 
40 209' 3 5 4 6 . 25'1'1 3 57 536" 3 41 I 49% 3 33 
266.00% -0 41 45.169' ·0.3 4 33 8799 -0.67 8.0691. .o 82 
66. 10% 2 60 14.609' 2 .67 II 60% 2 26 .3 00% 2 08 
17.0090 6 4 2 553% 6 49 4 39% 6 11 - 0.65% 5 9 4 
5 .00% 2 56 7 0290 2 .59 5 7990 2 43 0 . 41 % 2 36 
.g 90% .J l4 5.78% · 1 14 5 78" ·I 16 ·4.13% • J Ii 
82 490 0 86 26 .4 77' 0 .87 26 47% 0 78 14 7 1% 0 74 
5 4 107' 3 01 13 70% 3 07 11 857' 2 81 4.0 7% 2 07 
percenu.ge 
c h•n«e 
0 OO'A 
9 65% 
5 58" 
.o 899' 
32 269' 
.10 73% 
·3 .4190 
·2 48% 
.3 317" 
8 8'2" 
0 007' 
net returns 
7.50 
7.00 
6.50 
6.00 
5.50 
5.00 
4.50 
4.00 
3.50 
3.00 
2.50 
2.00 
1.50 
1.00 
0.50 
0.00 
-0.50 
-1 .00 
-1.50 
I"- ·~ .. . 
,fa ~/ . . /I~ . 
I I/! 
I 1(Jt .: ... \\ 
&' . 
. ' 
j! . 
/ .. 
/,../ 
.. 
0.00 2.00 
. . . . . . 
I . . l , 
. ~ . 
;i ' 
. 
. .. 
' . . I~ 
fN 
:J 
I~ 
!i 
~ 
4.00 
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Figure 6.13: Changes in net re turns fo llowing rest rictions (ban) on sul famethazine 
use and with an increase in consumer demand of 1 % compared wi t h use 
of alternatives and an increase in consumer dem and of 0.5% (dollars 
per hundred weight ) 
Yur Basf'hne 
0 34 00 
I 3 7 07 
2 37 20 
3 35 46 
4 32.55 
5 33 85 
6 35.55 
7 34 . J 7 
8 3 1 77 
9 33 21 
10 3 4 1t 
Table 6.18: Changes in sow prices following restrictions (ban) on sulfamethazine use 
and with an increase in consumer demand of 1 % compared with use of 
alternatives and an increase in consumer demand of 0.5% (million pounds) 
Wnh Rcilncuon1 ptrcen1a.ge Tetra.cyltne pe-rctnu.gt Tylo11n percenu.1c Lmcomyc1n prrccnlage Sulfa.th1a'Zole 
J % incrca..1c ch•n.at• 0. 5'C10 incrca.Je cha.n.at< 0 ~90 inert-out change o .~9'o increuc cb.~na:e 0 ~9' increue 
34 .00 0 00.,. 34 .00 o.oo-,. 34 00 o.oo-,. 3 4 00 0 OOYo 34 00 
37 .5:2 J 21% 37 .36 0 .78% 37 35 0 76% 37.40 0 89% 37.42 
38.34 2 90% 37.67 1. 109' 37.69 1.159' 37.58 0 86% 37 53 
37.86 6 76% 36.0 1 1.55% 36.08 I n % 35 70 0.68% 35.53 
35.16 8.00% 33. 11 I. 72% 33.21 2 03% 32. 71 0. t9% 32.49 
36.26 7 J2'Yo 34.42 1 .68% 3 4.52 J.97% 33 98 0.38% 33. 75 
37.5 4 5 .60% 36. 10 1.55% 36. 19 l.80% 35 . 70 0.42% 35.48 
35.60 4. !89'l. 34.65 l .409'l. 3 4.71 J .58% 3 4.36 0 56% 3 4.20 
33.05 4.00% 32.20 1.35% 3:2.25 l.51 % 31.99 0 69% 3J 87 
3 4 90 5 08% 33.71 l..!>0% 33.76 1.66% 33.46 0. 75% 33 83 
3i Oi 6 !>5% 35.36 1 73% 35 43 J .93% 3!> 03 0 78% 34 85 
percenlage 
ch an.ate 
0.00.,. 
0.94% 
0 72% 
0 20% 
0 0 . 18% 
-0.309' 
.o 20% 
0.09% 
0 36% 
0 36% 
0 26% 
SOW prices 
38.50 
38.00 
37.50 
37.00 
36.50 
36.00 
35.50 
35.00 
34.50 
34.00 
33.50 
33.00 
3250 
32.00 
31.50 
0.00 
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Figure 6.14: Changes in sow prices following restrictions (ban) on sulfamethazine 
use and with an increase in consumer demand of 1 % compared with use 
of a lternatives and an increase in consumer demand of 0.5% (Dollars 
per hundredweight) 
Table 6.19: 
Yc.ar Ha•chnc \Vitb Rc 5tncl1on• 
19' lncrcu.c 
0 174 7!> 1747!> 
I 1741 3 17423 
2 168!>9 16742 
3 1738 1 16973 
t 17865 17345 
5 17905 17430 
6 17510 17132 
7 17722 17411 
8 17978 17646 
9 17620 17205 
10 174 50 16958 
Changes in pork consumption following restrictions (ban) on sulfarnethazine 
use and with an increase in consumer demand of 1 % compared with use of 
a lternatives and an increase in consumer demand of 0.5% (million pounds) 
perceniagc Tct n.cyhac perccn1agc Tylo.,n pe-rccnta.gc L1ncomyc1n puccol•gc ::>u1fath1a:101c 
ch;a.n .u~ 0 ~9'0 incrc•.t c ch.an gc 0 ~9' incrc&..Jc ch&n K• 0 ~9' incrca.1ic ch.ange 0 ~9' incrc&U: 
0 oo,.. 1747!> 0 00'1\ 1 74 7~ 0 00'1\ 1141!> 0 OO'll> 1747!> 
0 06'K 17418 0 02'K 17417 0 0 2'K IHI!> 0 Ol'K 17414 
.o 80% 16837 .o 13% 16831 .o 16% 16864 0 .03% 16878 
-2.3!>% 17326 ·O 32% 17309 .o 41 % 1740 1 0 12% J7HI 
·2 91% 17788 .o 43% 17764 .o 56% 17894 0 16% 17952 
-2 65% 17825 -045% 17800 -0.58% 17937 0 . 18% 17997 
·2 15% 17435 .o 42% 17412 -0.55% 17534 0 . 14% 17589 
·l.75% 17651 .o 40% 17632 .Q 50% 17735 0 07% 17781 
· I 85% 17904 ·O 41'1\ 17887 ·O 50% 17982 0 02% 18024 
.2 35% 17536 .o 47% 17516 .o 59% 17621 0 OI Y. 17668 
.2 80% 17357 ·O 53% 17334 .o 66')\, 17457 0 04 ~ 17511 
pcrccn1ag:c 
ch .. ns:c 
0 00'1\ 
0 00" 
0 11% 
0 3 491. 
0.49% 
0.51% 
0 45% 
0 33% 
0 26% 
0 27% 
035% 
pork consumption x l o3 
137 
18.00 
............ \ ,/ 11 "" 'I\ t "" ' /.\ '1.:' I I \ ,, \\ d ,, I I .~ ~ \ _,, ' ' I I 
1' .__.\  { \~I ,. ' I\ ,, I j I ~  \ ,, .· ':, I\ I ~ 
1{: \\~ 1: ,I \\ ,, I' > ' I I ,'t . \ \ 1\ .. ~ \ .. ' I .. 
i(: q / '' \\ ,, /1 > • ,'t . ' . H ~ I f , .. 
.'t~ '1 'I \\ \ ~ ' Ii ,, ' '" , , 1, ,, 1. .·'.. ,., 
I l'/ •' . '~, i-• . ' 
17.90 
17.80 
17.70 
17.60 
17.50 
17.40 
,,, 
: ' 
tf . . . . 
' 
.. .. 
J 
.. . . . ~ : 
' f 
. . 
17.30 
17.20 
j . 
q, . . 1 
17.10 
. f 
17.00 
I 
' 
16.90 . 
' 
16.80 ~/ 
16.70 
0.00 2.00 4.00 6.00 8.00 10.00 
Baseline 
Wliii'R:esincuons········ 
T'eiiacyciille ____ __ __ _ 
Tylan----------
----------Lincomix 
su1Tatiilaii1e - - -
years 
Figure 6.15: Changes in consumption following restrictions (ban ) on sulfamcthazine 
use and with an increase in consumer de mand of 1 % compared with use 
of alternatives and an increase in consumer demand of 0.5% (million 
pounds) 
Table 6.20: 
Yur B&.u:hne Wllh ReJU1c&1on• 
~% incre ue 
0 1723t l i234 
I 17095 17090 
2 16538 16635 
3 17131 17324 
4 17649 18004 
5 17525 1796 1 
6 17111 175 16 
7 1 7509 17806 
8 18014 18185 
9 17634 11758 
10 174~~ 17661 
Changes in pork production following restrictions (ban) on sulfamelhazine 
use and with an increase in consumer demand of 5% compared wilh use of 
a llernalives and an increase in consumer demand of 4% (million pounds) 
perccncage TetrAc)'hne perccnugc Tylo•in perccnt~ge Ltncomyc 1n percen La.ge Su1f&lh1&zole: 
c hange 49'0 inc rcue ch&ngc • 9Ei increue change 49' increuc ch•ni:c 4% incrc.J.4c 
0 00"9 17234 0 00'111 17234 0 .00'111 17234 0 OOYo 17234 
-0 03% I 7086 -0.0S'Yo 17086 -0 OS% 17084 -0 06% 17083 
0 .59% 16716 1.08 " 16709 1.03 'It 16746 I 26'1t 16762 
1.13% 17830 2 9 1 % 176 12 2.81 % 17711 3.39% 17HS 
2 01% 18361 4 03 % 18335 3 .89 % 18472 4 .66'Yo 18533 
2 49% 18268 4 24 % 18242 4.09 % 18385 4.91 'Yo 1844 8 
2 37% 177!>3 3 75 % 17728 3.6 1 % 17859 4 37 'Yo 17917 
1 70% 17998 2 79 % 17977 2 67 % 18091 3 .32 r. 18 14 2 
0 95% 18399 2 14 ,.. 18379 2 03 % 18484 2 6 1 % 18531 
0 70% 18030 2 25 " 18009 2 13 9' 18121 2 76 'Yo 18170 
o ns% 17985 2 80 % 17981 2 66 'Yo 18087 3 J S 'Yo 18142 
percentage 
chana.c 
0 00'111 
-0 07% 
1.35% 
3 64% 
5 0 1% 
5 27% 
4 7 1% 
3 62% 
2 879' 
3 04% 
3 70% 
.-
w 
CX> 
pork production x 1 o3 
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Figure 6. 16: Changes in pork production following restrictions (ban) on sulfamet-
hazine use and with an increase in consumer demand of 5% compared 
with use of alternatives and an increase in consumer demand of 4% 
(million pounds ) 
Yur Ba .. line 
0 I 911 
I I 98 
2 2 00 
3 I 96 
4 I 119 
5 l 95 
6 2 02 
7 I 99 
II I 94 
9 2 04 
10 2 13 
Table 6.21: Changes in pork retail price following restrictions (ban) on sulfamethazine 
use and with an increase in consumer demand of 5% compared with use of 
alternatives and an increase in consumer demand of 4% (dollars per pound) 
wuh Res&ncuon1 percenta.gt T•iracyhne ptrctnt 11gt Tylosin percen tage L1ncomycm percent.a.gc ::,uUa.th1a.2ole 
!.% increa..Je ch••~• 4% increa.Jc chanu 4,. iacreue- chan~• 49' increuc ch an~• 4% incrcue 
I 911 0 00~ 1 .98 0 00~ 1.98 0 .00~ I 98 0 .00~ I 911 
2. 11 6 57% 2 011 5 05\r. 2 011 5 05% 2 011 !>.05% 2.011 
2 13 II 50% 2 09 4 509' 2 09 4 509' 2 08 4 00% 2 011 
2 .07 5 619' 2 00 2 0 49' 2.00 2 0 4% I 99 1 539' I 911 
1.96 3 70% I 89 0 00% I 119 0 00% I 87 ·I 091.G I 811 
2 01 3 08% I 94 .o 5%1 1.94 .o 59'1 I 92 . 1 !>'r.4 I 91 
2 07 2 4119' 2 02 O.OO'r. 2.02 0 00% 2 00 .o 9%9 J 99 
2 O!> 3 029' 2 01 I 01% 2.0J I 01% J 99 0 009' I 99 
2 05 4 12" I 911 2 06% I 98 2 06% 1 97 I S!>9' I 96 
2 14 4 90% 2 09 2 4S% 2 09 2 459' 2 07 I 4 79' 2 07 
2 24 !> 169' 2 17 I 88% 2.18 2 3S% 2 16 I 419' 2 IS 
percentage 
I ch an~• 
0 .00'11. 
5 0!>9' 
4 009' 
I 029' 
·I 59% 
-2 05% 
· I 499' 
0 00" 
I 039' 
I H% 
0 94% 
141 
pork retail price 
j 
. 
. 
I . . I . . ,, . ,, t' /, . f ,, 
.. ~· .. .' ~ .. : l/l .. · ...... : , I i I 
,,,'l . I/ I . . 1, 
!/ 
,, . 
I/ I ,, . . \1 : ·· ..
!/ \\ . .. i I/ I ·. : '1 ~\ I I 
J {\1 \.\ ·· .. ·· .  ; ,, I . /, 
j I I (/I ,,, f\:' !1 . \ . ,, . 
2.24 
2.22 
2.20 
2.18 
2.16 
2. 14 
2.12 
2.10 
2.08 
2.06 
2.04 
2.02 
2.00 
1.98 
1.96 
1.94 
1.92 
1.90 
1.88 
1.86 
I / I\ 1'\ \\1 // ~;:~~\ ,,, I '·· \\\\ \ ,.. .... Ji,, /I 11 '\~ ~'f 
~I \\ f ,, I \I 
\\ f' 1' " ·~ I' I/ /, 
\\, I I 
, 
,\ 1 I 
/I 
1/ 
0.00 2.00 4.00 6.00 8.00 10.00 
Baseline 
Wliii.R:esiTicuon········ 
T"etiacyciille __ ___ __ _ 
------------Tylan 
LmcomTx - - - - -
su1Tathiai01e - - · 
years 
Figure 6. 17: Changes in pork retail price following restri ctions on sulfamethazine 
use and with an increase in consumer demand of 5% compared wi t h 
use of alterna tives a nd an increase in consumer demand of 4% (dollars 
per pound) 
Year Baseline 
0 43 03 
l 46 07 
2 48 53 
3 45 83 
4 42 l1 
5 45 79 
8 49 83 
7 47 06 
8 44 05 
9 46 82 
10 50 19 
Table 6.22: Changes in farm prices for barrows a nd gilts following restrictions (ban ) 
on sulfamethazioe use and with an increase in consumer demand of 5% 
compared with use of a lternatives and an increase in consumer demand of 
4 % (dollars per hundred weight) 
W ith Rcdriction& percent a.a:<' Teua.cyline pucenu.ge Tylo•in percentage Lincomydn pcrcenta.gc S ullalh iuole 
5% incrca.tc c h.\n,;c 4% inc rease ch anJtC 4 '10 incrca6e Chi\nJtC 4 Vo incrca..st: chan~e t % incrc;uc 
43 03 0 OO'l'o 43 .0J O.OO'l'o 43.03 0.00'!\ 43 .0J 0 .00'!\ 43 OJ 
50 48 9 S7% 49 S9 7.6 4% 49 59 7 04% 49 .60 7.06% 49 60 
52 72 8 63% 5 1 15 5 40!r. 5 1 20 5 50% 50 94 4 97% 50 83 
49 03 6 98% 46 2 1 0 83% 46 33 I 09% 45.72 ·0.24% 45 46 
43 92 4 303 41 19 -2.18% 4 1.32 .1 88% 40.60 ·3.59% 40 29 
46.97 2 58% 44 .41 ·3.01% 44 .56 ·2 .69% 43. 76 -4 .43 % 43 4 l 
51.00 2 35% 48 76 ·2. 15% 48.91 · I 85% 18 10 .J. 4790 47 75 
48 76 3 61% 47 0 4 ·0.04% H .16 0.2J'i'O 46.S2 ·1.15% 46 24 
46 49 5.54% 44 85 1.82% 44 .9 4 2 .02% 44 43 0.86% 44 21 
50 00 6 79% 4 7 85 2 .20% 47.96 2 43% 4 7 .40 1.24% 47 15 
5:1 72 7 03% 50 92 1.45% 51.05 I 71% 50.36 0.34% 50 06 
percenu .ge 
c hanic 
0 00~ 
7 66% 
4 74% 
·O 81% 
- 4 32% 
. 5 20% 
. 4 17% 
·I 74% 
0 36% 
0 70% 
.o 26% 
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farm prices 
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Figure 6.18: Changes in farm prices for barrows and gilts following restrictions (ban) 
on sulfarnethazine use and with increase in consumer demand of 53 
compared with use of alternatives and increase in consumer demand of 
4% (dollars per hundredweight) 
Y c&r Ba.teltnc 
0 I 28 
l 3 73 
2 4 48 
3 3 36 
4 .o 62 
5 2 33 
6 6 15 
7 2 42 
8 ·I 21 
9 0 .88 
10 2 70 
Table 6.23: Changes in net returns following restrictions (ban) on sulfamelhazi ne use 
and with an increase in consumer demand of 5% compared with use of 
alternatives and an increase in consumer demand of 4% (dollars per hin-
dredweight) 
Wuh R c.atrk • 1on• pt"rcc-nt•gc Tctr•cyltnc p er cC"nl•gc Tylo11n perccnl•gc- L1ncomyc1n perccnt .. gc Sulf&t h1a101c 
~9' inc rc uc cha.n3e 4 9' incrc iUe chan1tc 49' incrc uc ch•n~c 49' incrc-a..tc cha.n1tie 49' incrc.uc 
l 28 0 00'10 I 28 0 00.,, I 28 0 00.,, l 28 0 OO'r• I 28 
5 84 Ml 57% 6 .69 79 36% 6 60 76.94,. 1 05 89 01% 7 25 
6 24 39 29% 6 .50 45 09% 6 4G 44 209' 6 66 48 66% 6 75 
4 27 27 089' 3 13 ·6 859' 3 17 .5 65% 2 99 - 11 0 1 % 2 92 
·1.10 77 42% ·2.16 248 39% ·2 11 240.329' -2.41 288 719'. -2.53 
l 18 . 49 36% 0.32 -86 27% 0 .39 ·83 26% 0.0 1 -99 .57% ·O 15 
4 99 . JS 86% 4 44 .77 80% 4 51 -26 67% 4 14 -32 68% 3 97 
I 76 .27 279' I 77 ·21186% 1.81 -25 217' 1.6 1 .33 47% I 53 
-1 14 .5 79% ·I 03 · 14 88% ·I 02 ·15 70% ·I 08 . 10 74% ·1 11 
1. 46 114 71% 1.09 60 29% 111 83.24% I 00 47 011% 0 95 
3 75 38 89% 2 78 2 96% 2 82 4 11% 2 59 . 4 07% 2 19 
pcrcrntagc-
cha.nge 
0 00\1'• 
9 4 37% 
50 67% 
·1310% 
308 OG% 
·106 44 % 
·35.45% 
-36 789' 
-8.26% 
39 71 % 
• 7 78% 
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Figure 6.19: Changes in net returns following restrictions (ban) on sulfamethazine 
use and with an increase in consumer demand of 5% compared with 
use of alternatives and an increase in consumer dem and of 4% (dollars 
per hundredweight) 
Year s~seline 
0 34 00 
1 37.07 
2 3 7.26 
3 35 .46 
4 32.55 
5 33 8.!> 
6 35.55 
7 3 4 17 
8 3 1. i7 
9 33. 21 
10 3 4. 76 
Table 6.24: Changes in sow prices following restrictions (ban) on sulfa metbazine use 
and with an increase in consumer demand of 5% compared with use of 
alternatives and an increase in consumer demand of 4% (dollars per hun-
dredweight) 
Wu b Jle1triciion• ptrctnu.ge T enacylinc pcrcen,agc Tyloain pcrccntAge Lincomycin pt>rccn \agc S ulfathi~zolc 
.S9' incrca.Jc cha.n11:c 4% inc rcatc ch•nite ~7' increat~ cha nit• 4% increa5e cha nitc 4~ incrcat e 
34 00 0 00.,. 34.00 0.00'n 34.00 0 .00'i"O 34.00 O. OO 'i"O 3 4 00 
40 47 9 17% 39 95 7 77% 39.94 774% 40 .00 7 .90% 40 03 
40 .39 8.40% 39.4 1 5.77% 39.H 5 .85.,. 39.31 5 50% 39.26 
37.82 6.66.,. 35.95 1.38% 36 02 1 58% 35.63 0 18% 35 46 
33 90 4. 15% 32 07 -1.47% 32 16 - J.20% 31.68 -2.67% 3 1 47 
3 4 69 2 48% 33.08 ·2.27% 33 17 .2.01% 32.66 .3 52% 32 .. 
36.30 2 40.,. 3 4 98 .1 60% 35 07 · l .35% 3 4 57 ·2 76% 3 4 36 
35.30 3 31% 3 4.3 1 0. 41% 34.38 0 .111% 3 4.00 .0.50% 33 83 
33 n 5 .19% 32 49 2 27% 32 .54 2 .42% 32.25 1 5 1% 32 12 
35.33 6 .38% 3 4 10 2 .68% 34 16 2 86% 33.85 1.93% 33.71 
37.09 6 .70% 35 47 2 0 4 % 35.5 4 '2 24% 35.15 112% 3 4 98 
pcrccn,agC" 
ch•nAt" 
0 OO'i'i 
7 98.,. 
5 37% 
0 00% 
.J.32% 
. 4 17% 
.J 35% 
. 1 00% 
J.10% 
1 51% 
0 63% 
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Figure 6.20: Changes in sow prices following restrictions (ban) on sulfamethazine 
use and with an increase in consumer demand of 5% compared with 
use of alternatives and an increase in consumer demand of 4% (dollars 
per hundredweight ) 
Table 6.25: 
Year Buehne Wuh Ret u1cuont 
!.~ increa.ac 
0 1747!> 17475 
l 1741 3 17426 
2 16859 16935 
3 1738 1 17569 
4 17865 18213 
5 1790!> 1834 1 
6 17510 17918 
7 17722 18024 
8 17978 181!>4 
9 17620 17744 
10 17450 JiG14 
Changes in pork consumption following restrictions (ban) on sulfamethazine 
use and with an increase in consumer demand of 5% compared with use of 
alternatives and an increase in consumer demand of 4% (million pounds) 
percen,a.ge Teua.cyhne perccnlagc Tylo11n percent.age Lmcomycm percent.age Sulla1h1uol< 
ch an«• 490 increue chanu 4% incre1.te ch an«• 49' increu c cha.n11ee 49'. in crea11e 
OOO'i'o 17475 0 OO'i'o 17475 0 .00% 17475 O.OO'i'o 17475 
0 07% 1741 8 0.03% 17418 0 .03% 17416 0 .02% 17415 
0.45% 17014 0.92% 17008 0 .88% 17042 1 .09% 17058 
1.08% 17866 2.79% 17849 2.69% 17945 3 .2 4% 17988 
1.95% 1M72 3 96% 18547 3 .82% 18683 4 .!>8% 18744 
2.H% 18651 4. 17% 18624 4.02% 18767 4.81% 18831 
2 33% 181!>7 3.70% 18132 3 .5!>% 18264 4 .31% 18322 
I 70% 18217 2 79% 18196 2 .67% 18311 3 .32% 18362 
0.98% 18366 2 .16% 18347 2 05% 184!>2 2 .6 4% 18498 
0 .70% 18014 2 .24 9'< 17993 'U2% 18104 2 .7!>% 18153 
0 94% 17936 2 79% 17912 2 .6!>% 18037 3 36% 18092 
pcrcenu.ge 
ch•n«• 
0 .00'i'o 
0 01% 
118% 
3.49% 
4.92% 
5 17% 
4.60'. 
3.61% 
2 89% 
3.02% 
3 .68% 
consumption x l o3 
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Figure 6.21: Changes in consumption following restrictions (ban) on sulfamethazine 
use and with an increase in consumer demand of 5% compared with 
use of alternatives and an increase in consumer demand of 4% (million 
pounds) 
L.30 
6.3 ummary 
In summa ri zing the projected scena rios of pork production, an increase in a ll 
prirc le ve ls over baseline price levels acco mpanied by a reduction in product ion and 
consumption leve ls over base li ne was obse rved for a ll the scenarios cons idc r<'cl where 
W<' a.5sume no changes in dem and. The impact on pork production following a ba 11 
on sulfamet,haz ine use was the largest where t hc-re were no a\·ailable a lte rna ti ves to 
sulfamethazine. Significant increase in price levels and a s igni ficant decrease in pro-
ductio n and consumption levels over I he baselin<' was observed for th is scenario. The 
lowest impad was obtained for sulfalhiazole as an al Lernat.ive to sulfameLh az ine. F'o r 
a change in dema nd of 0.5 pe rcent in response to use of alte rnatives , p roduction and 
consumpt ion lcvf'ls were ma rgina lly low<'r than baseline for tetracycline a nd Lylosin . 
for lincomycin the results projected indicated levc'ls to approximate baseline levels 
very closely, while use of sulfathiazole indicated higher production and consumption 
leve ls a long with variability of sow prices. farm prices for barrows and gilt.s, and 
pork re ta il price. Highe r production and consumpt ion leve ls and vari able price lev-
els over baseline levels is observed wi t h the use of aJ I other a lternative compound 
when coupled with a 4 percent increase in demand. The best results were observed 
for sulfathiazole use followed by lincomycin , t hen tetracycline and finally, ty losin . 
Marginal increases in pork re tail, sow, and farm prices, high production and con-
sumption leve ls over baseline for pork were projected for a ban on sulfamcthazinc 
while a llowing for the use of sulfathiazolc . Use of sulfaLhiazole as a subs titute Lo sul -
fam ethazine indicated variable price l<'vels with production and consumption levels 
higher than baseline for scenarios incorporating changes in demand. For t he other 
scenarios results observed wi t h t he use of sulfa thi azole approxima ted base line price 
levels . a nd production and consu mption levels VNY wel l. Results µroject<>d for a 
ban 011 sulfameLhazi ne use without alternatives indicale<l higher sow. farm and pork 
retai l prices a nd lower pro<luclion and consum ption kvels fo r all scenarios <>xcept 
when coupled with a 5 percent increase in demand where a lthough the p rice levels 
rem ai11ed highe r than base line . Lhe production and consumption levels we re higher 
t han base! i ne . 
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CH APTER 7. SUMMARY AND C ONCLUSIO NS 
7 .1 Su m m ary 
The increased response to antibiotics in the presence of nutritional st resses is of 
economic importance to li \'estock producers. ince it is seldom economically desi r-
able for the producer to provide the nutrient sources or levels necessary to promote 
maximum rate of gain . However, numerous tudies support the idea that the major 
benefit de rived from the inclusio n of antibioti cs as routine feed additi ve result from 
their suppression or control of subclinical or nonspeci fic diseases . 
It is well recognized that antibiotics effective in improving the performance of 
a nimals have one thing in common. their ability to suppress or inhibit the urowth of 
certain micro-organisms. Their chemical com position and bacterial spect rum varies 
great ly. ome of the effective anti biotics are readily absorbed into the vascular system 
of the host animal, whereas others are hard ly absorbed at all. 
The chemical composition, bacterial spect rum. and abso rption and excretion 
patterns of these drugs certainly influences bactericidal and bacteriostati c properties 
and effectivene agai nst sp ecific sys temic infections. T hese same ch aracteristics, 
however, are less associated with growth promoting activities. 
Many users perceive pressure from reg ulatory forces in response to their con-
ti nued usage of ulfamethazine. '" Lot" testing usi ng "SOS can cause major market 
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di sruption with producer potentially at ri k of losing hipment with each delivery. 
thus. causing economic losses to producer. Embargoes for ·'violative residue·'' can 
be \"ery co tly. interfering with orderly marketing and increasing production co ts 
due lo sa le of hogs of hei'tvier than desirable weight . This has di scouraged many a 
sulfamethazine users into di scont inuing working with sulfamethazine. 
Residue violations a re usuall y preceded by inappropri ate management practices 
which in turn re ult in embaraoe enforcing economic co t on producer. In re ponse 
to a ban on suHa methazine in pork production, alternate modes of pork production 
that may be con idered are : 
1. A ban on ulfamethazine wit.h no alternatives to cons ider 
2. i\Iore and new research to arrive at a new alternative compound to subst itute 
the use of ulfamethazine in pork production 
3. A ban on sulfamethazine followed by use of existing alternat ive compounds 
Removal of older antibiotics from use in livestock wi ll increase cos t of production 
as it will force u e of drugs still covered with patent protection in addition to removing 
some of effective antibiotics in terms of increased rate and efficiency of gain. 
On an average. it takes FDA about three and a half years to process NADA s 
(New Animal Drug Application ). It takes a company 3-10 years to develop data for 
filing. Thus, it is 7-15 years before eventually a drug is de,·eloped a nd marketed at 
an average cost of 3-30 million dollars . This rules out t he possibility of developing 
a new drug which may be economical and as efficient as sulfamethazine even in the 
near future. 
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In the preceding chapter the alternatives considered in response to a ban on use 
of sulfamethazine were provided. It was assumed that due to perceived safety of pork, 
consumers would demand more pork in response to a ban on use of sulfamethazine. 
Further the study also assumed that the increase in willingness to pay would be 
larger for pork produced without the use of any alternative compounds as compared 
with pork produced with use of alternative compounds to sulfamethazine. The study 
assumes five scenarios for these responses as their information is not readily avail-
able. For pork produced without any alternative compounds to sulfamethazine1 two 
scenarios were assumed, a 1 percent and a .5 percent increase in consumer demand 
(willingness to pay). Pork produced with use of alternative compounds to sulfamet-
hazine, were expected to face a lower increase in demand (willingness to pay) but 
higher than that with sulfamethazine use. Two scenarios were assumed: a 0 .. 5 percent 
increase in demand and a 4 percent increase in demand. To account for the possibility 
where t hey may be no increase in demand in response to a ban of sulfame thazine in 
pork production, another scenario was considered. 
In our study the best alternative that comes up m response to a ban on sul-
famethazine is sulfat hiazole. However, the issue remains if a ban on sulfamethazine 
drug in pork production will eventually lead to a ban in use of sulfa drugs in general • 
for purpose of pork production. If yes, we need to need to review our search for 
the next best alternative . This is suggested by our study to be lincorillx. Although 
lincomix is commonly used in pork production, it is not well absorbed systemically 
and is thus less e:ffecti ve in combating respiratory diseases. Tetracyclines would seem 
to be a effective compound in such a situation. Thus to come to conclude which is 
the best alternative to sulfamethazine depends on the fut ure use of sulfathiazole and 
1.5.5 
ulfa drug in pork product ion. Tetracycline . chlortetracycline and ox:ytet racycl ine , 
remain the mot \·iable and ·afe alternatives. 
7.2 Ideas fo r furthe r resea r ch 
Thi study has assumed for purpo es of economic analysis the change in demand 
to vary between 0.5 percent to 5 percent for different scenario . These estimate 
were arbitrary and based on some indirect research. An attempt to eYaluate the 
actual willingness to pay and willingness to accept of consumers in response to a ban 
on ulfamethazine while allowing alternative compounds needs to be estimated and 
studied. [n thi s study it was assumed that consumers may respond by increasinu their 
willingness to pay anywhere between 0.5 percent and 4 percent for use of alternate 
drugs . In response to a ban of sulfamethazine with no alternatives to consider, these 
figures were assumed to be between 1 and 5 percent. 
This study has recommended alternati\·e trategies in response to a ban on ul-
famethazine. It is uggested that further research be carried to st ud y if any of these 
evaluated policies have tructured impacts on the industry and producers in that 
how are the maller producers going to adapt themselves versus the laruer producers 
and which of the two will have to absorb mo t of the cost increases . Also it needs 
to be estimated how the industry will adapt to the changes if any of the evaluated 
st rategies was to be implemented. What are the implications for management prac-
tices and how is the indus try going to convince the consumers about t he safety of 
pork and pork products when produced with these alternative compounds, such that 
they demand more. \.Yhat are the economic implications of t hese changes on the 
industry and the economy? This study in an attempt to study the most [ea ible 
alternative to ulfamethazine in pork production did not study the consumer and 
producer surplus changes for diffe rent sC'enario . Further analysis in an attempt to 
s tudy a good alternative to sulfamethazine in pork production should also involve 
consumer and producer surp lus a ualysis both before and after a ban on sulfamet-
hazine unde r assumptions of no alternatives a nd available alternative . Finally, the 
present study assumes exports and imports to be exogenously determined. However, 
a ban on sulfamethazine i expected to infad impact upon the pork export and 
imports of the count ry. ince in the presen t the u e of ulfamethazine has not been 
banned in the L .. studies on Germany·s pork export and import market, where use 
of sulfamethazine in pork production has been banned, can be u ed to extrapolate 
the effects of a similar ban in United States. These are some of the que tions this 
study has left unanswered and which require further study. 
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APPENDIX FAPRI PORK MODEL EQUATIONS 
Pork Docum entation, 2SLS, 1965-1990 
1. Log of Per Capita Pork Consumption. Wholesale Wt. basis 
LOG( PKPCC W) = 0.335 
- 0. 61 *LOG(PKRETP / P CIUW ) 
+ 0.360*LO G( BFRETP / P CIUW) 
+ 0.00 *LOG(C'KRETP / P CIUW ) 
+ 0. 145*LO G((ZCENFABW / POPTOTW)/ P CIUW ) 
- 0.907*(P OP7.5PW / POPTOTW ) 
- 0.047*D 45 
ELASTICITIES: 
PKRETP = -0. 6 
BFRETP = 0.36 
CKRETP = 0.008 
INCOME = 0.145 
PKRETP = P ork retail price 
BFRETP = Beef retaiJ price 
C'KRETP = Chicken retail price 
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PC' IUW = Consumer price index , Total of all items 
POPTOTW = Total pop. including armed forces overseas 
POP75W = Population-U.S. , Age 75+ 
ZCENFABW = Personal consumption expenditure, Food and Beverage 
DUM 3 = 1in1983 . 0 otherwise 
DUM 4 = 1 in 19 4, 0 otherwise 
2. Pork ending stocks, C.S. 
PKSTK = - 167.125 
- 14 76 .61 *(PI<RETP-PKRETP(-1) )/ PPIW 
+ 0.030*PKPROD 
+ 52.639*SHIFT7 
+ 139.517*DUM73 
+ 127.501 *D M75 
ELASTICITIES: 
PKRETP = -0.92 
PKPROD = 1.50 
PKRETP = Pork retail price 
PKRETP(-1) = Lag of pork retail price 
PKPROD = Pork , Total production 
PPIW = PPI: All items, U.S 
SHIFT78 = 1 if ztime i, 1977 0 otherwise 
DGM73 = 1 in 1973, 0 otherwise 
• 
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D UM75 = 1 in 1975, 0 otherwise 
3. Pork total production 
PKPROD = 594.207 
+ 0.330*(PKSOWKS + PKBORKS) 
+ 0.147*( PKBAGKSD + PKBAGKSI) 
+ 0.000S*( TREND*( PKBAGKSD + PKBAGKSI)) 
ELASTICITIES: 
PKSOvVKS = 0.11 
PKBORKS = 0.02 
PKBAGKSD = 0.83 
PKBAGKSI = 0.004 
PKSOWKS = Hogs , Sow slaughter 
PKBORKS = Hogs, Boar slaughter 
PKBAGKSD = Hogs, Barrow and gilt domesti c slaughter 
PKBAG KSI = Hogs, Barrow and gilt imported slaughter 
TREND = ztime - 1964 
4. Hogs, Sows farrowed 
PKSOWFAR = 986.17 
+ 0.911 *PKHOGNBR(-1) 
+ 0.01.S*(TREND*PKHO GNBR(- l )) 
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+ 0. 36*(PKGLTADD ) 
- 0. 3 3*{PKSOWKS) 
- 987.67*D M7 
- 941.728* DUM75 
+ 946 . 56* D701 
ELASTICITIES: 
P K HOGNBR(-1) = 0. 74 
PKGLTADD = 0.33 
PKSOWKS = -0.1 .5 
PKHO GNBR(- 1) = Hogs, Breeding hogs on farm, Dec. 1st 
PKGLTADD = Hogs, Gilts added to the breeding herd 
PKSOWKS = Hogs, Sow slaughter 
TREND = ztime - 1964 
DUM78 = 1 in 1978 , 0 otherwise 
DUM75 = 1 in 1975 , 0 otherwise 
DUM701 = 1 in 1970 and 1971 , 0 otherwise 
5. 7-market sow price / PPI, All items, U .S 
LOG{PKSOWPM/ PPIW) = 3.677 
- 0.305*LOG(PKSOWKS + PKBORKS) 
+ l.269*LOG(PKRETP / PPIW) 
- l.308*LO G(Z\;\/RHP20W / PPIVV) 
- 0.233*SHIFT88 
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+ 0.217*D723 
ELASTICITIES: 
PKSOWKS = -0.30.5 
PKBORKS = -0.305 
PKRETP = 1.269 
ZWRHP20W = -1.308 
PKSOWKS = Hogs , Sow slaughter 
PKBORKS = Hogs, Boa r slaughter 
PKRET P = Pork retail price 
PPIW = PPI, All i tems U.S 
ZWRHP20W = Average hourly earnings. Food and Kind products 
SHIFT 8 = 1 if ztime > 1987, 0 otherwise 
D723 = 1 in 1972 and 1973, 0 otherwise 
6. 7-market Barrow and gilt price / PPI, All items, U.S 
LOG( PKBAGP~/PPIW ) = 8.427 
- 0.453*LOG( PKBAGKSD + PKBAGKSI) 
+ l.396*LO G(PKRETP / PPIW) 
- 0.664*LO G(ZWRHP20W / PPIW ) 
- 0.130*SHIFT88 
- 0.138*D667 
ELASTICITIES: 
PKBAGKSD = -0.45 
16c 
PKBAGK 'I = -OA.5 
PKRETP = l.396 
ZWRHP20W = -0.664 
PKBAGKS D = Hogs Barrow and gilt domestic slaughter 
PKBAGKSI = Hogs , Barrow and gi lt imported slaughte r 
PKRETP = Pork retail price 
PPIW = PPL All items, ll .S 
ZvVRHP20W = Average hourly earnings. Food and kind 
SHIFT = 1 if ztime ...., 19 7. 0 otherwise 
D667 = 1 in 1966 and 1967, 0 otherwise 
7. Hogs, Boar slaughter 
PKBORKS = - 993.743 3 
-L 0.l 15*PKHO G NBR(-1 ) 
- 0.0 4* (PKSOWKS - PKGLTADD) 
-..- 332.462* LOG (TRE D ) 
+ 219 . 29*D 166 
ELASTICITIES : 
PKHOGNBR(-1) = 1.24 
PKSOvVKS = 0 .. 52 
PKGLATDD = 0.52 
PKHOGNBR = Hogs , Breeding hogs on farms. Dec . 1 
PKSOW.KS = Hogs, Sow slaughter 
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PKGLTA DD = Hogs, Gilts added t.o the breeding herd 
TREND = ztime - 1964 
DUM66 = l in 1966 , 0 otherwise 
8 . Hogs, Barrow and gilt domestic slaughter (PKBAGKS - PKBAGKSI) 
PKBAGKSD = - 157.54.13 
+ 0.502* PKPIGCRP 
+ 0.943*PKHOGFRM{-1) 
+ 6116.49*SHIFT83 
- 4578 .51 *DUM73 
+ 3614.79*DUM76 
ELASTICITIES: 
PKPIGCRP = 0.58 
PKHOGFRM(- 1) = 0.60 
PKPIG CRP = Hogs, Pig crop 
PKHOGFRM = Hogs, market hogs on the farm, Dec. 1 
SHIFT83 = 1 if ztime > 1982, 0 otherwise 
DUM73 = 1 in 1973, 0 otherwise 
DUM76 = 1 in 1976 , 0 otherwise 
9. Hogs _ umber of breeding hogs added to herd 
PKHOGNBR - PKHOGNBR(-1 ) = - 3132.28 
• 
110 
T 1.522.06""( ( CPPKSLHG )/ ( C'PPKGRA N - C'PPK -PP )) 
+ 21.22 .. ( ( C'PPKSLHG (-1 ) )/ ( C'PPKGRA -(- 1) 
+ CPPKSU PP(- 1)) - 43.23*TREND 
+ .534..44*D77 - 779 .04*D 67 
ELASTICITIES: 
C'PPKSLHG = 0.10 
C'PPKGRAr-; = -0 .06 
C'PPKSUPP = -0.05 
C'PPKSLHG = Pork, Cost of production, Slaughter hog receipts 
C' PPKGRAN = Pork, Cost of production, Cash expense for grain 
CPPKSUPP = Pork, Cost of production, Cash expense for protein supplements 
TREND = ztime - 1964 
D77 = 1 in 1977 and 197 , 0 otherwise 
D 67 = l in 19 6 and 19 7, 0 otherwise 
10. Hogs , Sow slaughter 
PKSOWKS = -1:26 .35 
+ 0.304*PKHOGNBR(-1) 
- 113 .88*((CPPKSLHG + CPPKCLSW )/ 
(CPPKGRAN + C'PPKSUPP + CPPKPAST 
+ CPPKVET + CPPKHAUL + C'PPKMARK 
+ C'PPKBED + CPPKFLE + CPPKREP 
+ CPPKLABR + CPPK 1A -l-)) 
lll 
- 720.6.59* ' HIFTl.5 
+ T.56 .027*D UM66 
- 93 .293*DUM73 
- 610.353* DUM76 
ELASTICITIES: 
PKHOG BR(-1) = 0 .. 53 
C'PPKSLHG = -0.32 
C' PPKGRAN = 0.12 
C'PPKS UPP = 0.09 
PKHOGNBR = Hogs. Breeding hogs on farms Dec. 1 
C' PPKSLHG = Pork, Cos t of production, Slaughter hog receip ts 
CPPKCLSW = Pork , Cost of production, Cull sow receipts 
CPPKGRAN = Pork, Cost of production. Cash expense for grain 
CPPKSUPP =Pork. Cost of production. Cash expense for protein supplements 
C'PPKPAST = Pork, Cost of production, Cash expense for pasture 
CPPKVET = Pork Cost of production, Cash expense for veterinarian and med. 
CPPKHA L = Pork. Cost of production , Cash expense for livestock hauling 
CPPK IARK = Pork, Cost of production, Cash expense for marketing 
C'PPKBED = P ork Cost of production Cash expense for bedding 
CPPKFLE = Pork , Cost of production Cash expense for fuel, lube, and elec. 
CPPKREP = Pork , Cost of production, Cash expense for repairs 
CPPKLABR = Pork , Cost of production, Cash expense fo r hi red labor 
CPPKMANU = P ork, Cos t of production. Cash expense for manure credit 
PPIW = PPI. AU items . U.S 
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SHIFT75 = 1 if ztime > 1974, 0 otherwise 
DUM66 = l in 1966, 0 ot herwise 
DUM73 = 1 in 1973, 0 otherwise 
DUM76 = 1 in 1976 0 otherwise 
Pork Identities 
1. U .S breeding hogs on farm, Dec. 1 
PKHOGNBR = 0.99*PKHOGNBR( -1) + PKGLTADD - PKSOWKS 
2. U .S pig crop 
PKPIGCRP = PKSOWFAR *PKPIGILT 
3. Pork supply 
PKSUPP = PKPROD + PKSTK(-1) + PKIMPT 
4. Pork, civilian disappearance, Carcass wt. , U.S 
PKCDIS = PKSUPP - PKEXPT - PKSTK 
5. Per capita pork consumption, Carcass wt. 
PKP CCW = PKCDIS/ POPTOTW 
6. Per capita pork consumption, Retail wt. 
PKPCCR = PKP CCW*PKRETCNV 
7. U.S market hogs on farms, Dec. 1 
PKHOGFRM = (l-PKPIGD)*( PKHOGFRM(-1 )) 
+ (PKPIG CRP - PKBAGKSD - PKBAGKSI) 
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Pork. Cost of production 
1. Pork. Cost of production, laughter hog receipt 
C' PPKSLH G = - l. 2 
+ 0.9.57*PKBAGPM 
ELASTICITIE ': 
PKBAGP:\ I = 1.03 
PKBAGP:'.\I = Hous. Barrow and gilt. seven market price 
2. Pork , Cos t of production , Cull sow receipts 
CPPK C'LS\h/ = 10.9 1 
+ 0.066*PI<SOWPM 
- l.377•PKPIGLIT 
- 0A69*D 01234 
ELA T IC'IT IES: 
PK OWP:\l = 1.05 
PKPIGLIT = -4.l 
PKSOWPM = Hogs Sow seven market price 
PKPIGLIT = Hogs, pigs per litter 
D 01234 = 1 in 1980, 19 1. 19 2, 19 3, and 19 4, 0 otherwise 
3. Pork. Cost of production. cash expense for grain 
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CPPKGRAN = - 1.67 
+ 4.042*C'RPFRM(-1) 
T 2.978*C'RPFRM 
ELASTICIT IES: 
CRPFRM = 0.48 
CRPFRM(-1) = 0.6.5 
CRPFRM = Corn season average farm price 
4. Pork, Cost of production Cash expense for protein supplements 
CPPKSUPP = 3.529 
+ 0.042*SMP44D(-1 ) 
+ l.713*D734 
ELASTICITIES: 
SMP44D(-1) = 0.68 
SMP44D = Soybean meal price, Decatur 44 percent protein 
D734 = 1 in 1973 and 1974, 0 otherwise 
. 5. Pork 1 Cost of production Cash expense for veterinary and medicine 
CPPKVET = 0.067 
+ 0.005*PPIW 
+ 0.058*D756 
ELASTICITIES: 
• 
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PPIW = 0. 4 
PPIW = PPI, All i tems, US 
D756 = 1 in 1975 and 1976, 0 otherwise 
6. Pork Cost of production, Cash expense for livestock hauling 
CPPKHAUL = 0.024 
+ 0.001 *PP ICF ULW 
+ 0.032*SHIFT86 
ELASTICITIES: 
PPICFULW = 0.67 
PPICFULW = PPL Ind. comm. Fuel and related 
SHIFT86 = 1 if ztime > 19 .5, 0 otherwise 
7. Pork Cost of production, Cash expense for marketing 
CPPMARK = 0.067 
+ 0.002*PPIW 
+ 0.001 *PKBAGPM 
+ 0.044*D M78 
E LASTICITIES : 
PPIW = 0.58 
PKBAGPM = 0.20 
PPIW = PPI, All items, US 
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PKBAGPM = Hogs . Barrow and gilt se,·en market price 
DUM7 = l in 1978 . 0 otherwise 
8. Pork, Cost of Production , Cash expense for bedding 
CPPKBED = - 0.005 
+ 0.001 *PPIW 
+ 0.039*DUM81 
ELASTICITIES: 
PPIW = 1.03 
PPIW = PPI All items, US 
DUM81 = 1 in 1981 0 otherwise 
9. Pork 1 Cost of production , Cash expense for fuel , lube, and elect ri city 
CPPKFLE = 0.166 
+ 0.018*PPICFULW 
+ 0.327*SHIFT86 
ELASTICITIES: 
PPICF ULW = 0. 2 
PPICF ULW = PPI, Ind. commod., Fuel and related 
SHIFT86 = 1 if ztime > 1985, 0 otherwise 
117 
10. Pork , Cost of production 1 Cash expense for repairs 
C'PPKREP = 0.19:3 
+ 0.020*P PIC'METW 
- 0.166*DUM88 
ELASTICITIES: 
PPICMETW = 0.91 
PPICMETW = PPI , Ind. commodity, Metals and products 
DUM 8 = 1 in 1988. 0 otherwise 
11. Pork Cost of production , Cash expense for hired labor 
CPPKLABR = - 0.212 
+ 0.166*ZWRHP20W 
+ 0.091 *D845 
ELASTICITIES: 
ZWRHP20W = 1.21 
ZWRHP20W = Average hourly earnings, Food and kind products 
D845 = 1 in 1984 and 1985, 0 otherwise 
12. Pork, Cost of production, Cash expense for manure credit 
CPPKMANU =- 0.058 
LI 
- 0.000 * P P ICHM\V 
- 0.0006*"P P IC'PETW 
ELA T IC'1T1ES: 
PP CC' HMW - 0.4:3 
PPIC'PETW = 0.22 
PP I C'H~l\V = PPI, Chemical and allied products 
PPIC' PET\iV = PPL Ind. commodity. Ref. petrol products 
J 3. Pork. Cost of product ion. Ca h expense for general farm overhead 
CPPKGFO = - 0.2i9 
+ 0.025*PPIW 
-+- 1.504 * D 67 
+ o .. 50 •sHIFT 
ELASTICITIES: 
PPI\V = 1. 10 
PPIW = PPL All items, US 
RIFT = 1 if ztime > 19 i. 0 otherwise 
14. Pork, Cos t of production, Cash expenses for insurance and taxes 
CPPKTAX = 0.225 
+ 0.0004*FI LAND 
+ 0.002*ZTXCB PW 
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+ 0.ll.5*DUM 5 
ELASTICITIES: 
FIVLAND = 0.3.5 
ZTXC'BSPW = 0.2 
FIVLAND = Farm income, Value of land 
ZTXCBSPW = Ind. bus. tax-state and local prp. 
DUM8.5 = 1 in 198.5 0 otherwise 
15. Pork, Cost of production, Cash expense for interest 
CPPKINT = 0.738 
+ 0.011 *(CPPKEXP*ZINTAAA) 
+ 2.417*DUM82 
+ 2.407*DUM86 
ELASTICITIES : 
ZINTAAA = 0.02 
CPPKEXP = 0.008 
CPPKEXP = All pork expenses 
ZINTAAA = Yield for corporate bond 
DUM82 = 1 in 1982, 0 otherwise 
DUM86 = 1 in 1986, 0 otherwise 
16. Pork Cost of production, Cash expense for capital replacement 
• 
hO 
C'PPKC'APR = L.93i 
+ 0.037*P P fv\· 
ELASTIC'ITIE 
- L623*D l\fi4 
+ l.136*DUM79 
PPIW = 0.62 
PPIW = PPI. All item . C 
Dl:M7.J: = 1 in 1974, 0 otherwise 
OC:\Ii9 = l in 1979. 0 otherw.ise 
